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ROLE OF p16INK4a AND BMI-1 IN OXIDATIVE STRESS-INDUCED 
PREMATURE SENESCENCE IN HUMAN DENTAL PULP STEM CELLS 
 
Human mesenchymal stem cells (MSCs) have a therapeutic potential in 
tissue engineering and regenerative medicine. Human dental pulp stem cells 
(hDPSCs) have proven to be a good source for cell therapy as pulp tissue is easily 
available from teeth after extraction without ethical issues. Cell therapy requires a 
large number of cells, thus, an in vitro expansion step is required before 
implantation. Long-term in vitro culture entails the inconvenience of senescence 
following a certain number of passages, thereby losing hDPSCs stemness 
properties and regenerative potential. Currently, the in vitro culture of MSCs is 
carried out under ambient oxygen tension (21% pO2). However, the local oxygen 
tension varies between 3-6% pO2 within the organism depending on the 
vascularization of the tissue and its metabolic activity. Mimicking physiological 
conditions in cell culture experiments is a useful tool to gain knowledge. Thus, the 
aim of this study was to compare long-term in vitro culture of hDPSCs under 
ambient (21% pO2) and physiological (3% pO2) oxygen partial pressure, and to 
determine whether hyperoxia can alter the physiology and affect the senescence of 
normal adult stem cells.  
First, we investigated if ambient oxygen tension could induce oxidative 
stress in hDPSCs during long-term culture. Oxidative stress reflects an imbalance 
between the systemic manifestation of reactive oxygen species (ROS) and the 
biological ability of a system to readily detoxify the intermediates and to repair the 
resulting damage. Oxidative stress is known to produce damage to biomolecules 
such as DNA, carbohydrates, lipids and proteins. Therefore, we assessed ROS 
levels, mitochondrial membrane potential, protein and lipid oxidation, as well as 
antioxidant gene expression during long-term hDPSCs in vitro culture. Our data 
revealed increased ROS levels, protein carbonylation and lipid oxidation, and a 
disruption of the mitochondrial membrane potential in the cells that were cultured 
under ambient oxygen tension. Furthermore, these cells showed an upregulation of 
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the expression of manganese superoxide dismutase, catalase and glutathione 
peroxidase genes, suggesting an increased antioxidant defence to withstand 
increasing ROS production. Thus, ambient oxygen tension induces oxidative stress 
in hDPSCs in vitro culture. 
Senescence was described as an irreversible state of cell cycle arrest, which 
is accompanied by morphological alterations, reduced proliferation rate, apoptosis 
resistance and increased expression of senescence-associated β-galactosidase 
activity and p16INK4a. The CDKN2A gene, also known as the INK/ARF locus, 
encodes both p16INK4a and p14ARF, which are cell cycle regulators. The p16INK4a 
protein inhibits cyclin D-dependent CDK4 and CDK6 to prevent phosphorylation 
of the retinoblastoma protein (pRb). The hypophosphorylated form of pRb 
sequesters E2F transcription factors, preventing them from coordinately activating 
a suite of genes required for DNA replication. The p14ARF protein binds to the 
MDM2 E3 ubiquitin ligase to prevent p53 polyubiquitylation and to facilitate p53 
activation. In turn, the p53 transcription factor regulates an extensive group of 
genes that are commonly induced by cellular stress leading to apoptosis. We then 
determined some senescence characteristics in hDPSCs cultured under both 
oxygen tension conditions. Cells that were cultured under ambient oxygen tension 
rapidly began to show enlarged and flattened phenotypes and decreased their 
regenerative potential as they only reached 15 passages, while those cells that were 
cultured under physiological oxygen tension reached 25 passages and preserved a 
“younger” phenotype. Accordingly, 21% pO2 was accompanied by increased β-
galactosidase activity, increased expression of p16INK4a and reduced expression of 
p14ARF. Taken together, our results suggest that oxidative stress induces a 
premature senescence of hDPSCs cultured under ambient oxygen tension. 
Another characteristic that is not included in the definition of stem cell 
senescence, but should be taken into consideration, is the loss of stemness 
properties. hDPSCs are adult stem cells that express pluripotency-related genes. 
Those genes are the four transcription factors: OCT4, SOX2, KLF4 and c-MYC, 
abbreviated to, “OSKM”, and they are involved in the induction and maintenance 
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of pluripotency. hDPSCs cultured at 3% pO2 showed high levels of OCT4 and 
SOX2 at early stages, but their expression was downregulated as passages 
accumulated. However, at advanced passages, these cells upregulated the KLF4 
and c-MYC expression. On the other hand, hDPSCs cultured at 21% pO2 showed a 
downregulation of all four OSKM factors along passages. Taken together, our data 
suggest that ambient oxygen tension entails a loss of the stemness properties in 
long-term in vitro culture. 
Finally, we aimed to investigate a possible relation between p16INK4a and 
OSKM expression in hDPSCs. A well described upstream regulator of the 
INK/ARF locus is BMI-1. Through repression of target gene expression, the BMI-1 
protein regulates a myriad of cellular processes critical for cell growth, cell fate 
decision, development, senescence, apoptosis, and self-renewal of stem cells. Thus, 
we tested whether BMI-1 regulates hDPSCs fate while modulating p16INK4a and 
OSKM gene expression. To this end, we first analysed BMI-1 protein expression 
in hDPSCs in long-term culture under either oxygen pressure percentage. Our 
results show that hDPSCs cultured at 3% pO2 retained constant levels of BMI-1 
along passages. However, hDPSCs cultured at 21% pO2 showed higher BMI-1 
protein levels at early stages, which rapidly plummeted as passages accumulated. 
These data suggest that ambient oxygen tension accelerated BMI-1 protein 
degradation. We next proceeded to silence BMI-1 gene expression in hDPSCs 
cultured under ambient oxygen tension by siRNA transfection. Knocked-down 
hDPSCs exhibited the same amount of BMI-1 protein as hDPSCs cultured under 
physiological oxygen tension. Interestingly, following transfection, p16INK4a 
expression was not altered, but OCT4 and SOX2 expression levels were 
upregulated.  
Taken together, we can conclude that in vitro culture carried out under 
ambient oxygen tension causes an oxidative stress-induced premature senescence 
and a loss of the stemness properties of hDPSCs. Moreover, BMI-1 levels should 
be kept in a balance that allows normal stem cell proliferation, while preventing 
stem cell senescence thereby maintaining proper stem cell homeostasis. 
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PAPEL DE p16INK4a Y BMI-1 EN LA SENESCENCIA PREMATURA 
INDUCIDA POR ESTRÉS OXIDATIVO EN CÉLULAS MADRE DE 
PULPA DENTAL HUMANA 
 
INTRODUCCIÓN Y OBJETIVOS 
Las células madre son aquellas células que se dividen asimétricamente para 
producir una copia de sí mismas y una segunda célula que seguirá su camino hasta 
convertirse en una célula diferenciada y especializada. Así pues, las células madre 
que podemos encontrar en el organismo adulto comparten al menos dos 
características. En primer lugar, se pueden hacer copias idénticas de sí mismas 
durante largos períodos de tiempo; esta capacidad de proliferar se refiere como 
auto-renovación a largo plazo. Segundo, pueden dar lugar a tipos celulares 
maduros que tienen morfologías características y funciones especializadas. Las 
células madre mesenquimales humanas (CMM) tienen pues un potencial 
terapéutico en ingeniería de tejidos y en medicina regenerativa. En particular, las 
células madre de pulpa dental humana (CMPD) han demostrado ser una buena 
fuente de células para la terapia celular porque el tejido pulpar es fácilmente 
accesible y carece de problemas éticos.  
Sin embargo, las terapias celulares requieren de un elevado número de 
células, para lo cual es necesaria una etapa de expansión celular in vitro previa a la 
implantación. A su vez, el cultivo in vitro a largo plazo lleva implícito el 
inconveniente de la senescencia tras un cierto número de pases, momento en el 
cual las células pierden su capacidad de autoregeneración, característico de las 
células madre. Por esta razón, el estado de senescencia debe tenerse en cuenta para 
poder obtener células madre de buena calidad que puedan ser utilizadas en las 
terapias celulares. 
Actualmente, el cultivo in vitro de las CMM se lleva a cabo bajo tensión de 
oxígeno ambiental (21% pO2). Sin embargo, dentro del organismo, la tensión de 
oxígeno a nivel local oscila entre el 3-6% pO2, dependiendo de la vascularización 
del tejido y de su actividad metabólica. El cultivo celular debe tratar de imitar las 
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condiciones fisiológicas del organismo, por lo tanto, el objetivo de este estudio fue 
el de comparar el cultivo in vitro a largo plazo de las CMPD bajo ambas 
concentraciones de oxígeno: ambiental (21% pO2) y fisiológica (3% pO2). Así, 
existen trabajos que muestran que altas concentraciones de oxígeno pueden causar 
estrés oxidativo a través de la producción de especies reactivas de oxígeno (ROS) 
que pueden dañar lípidos, proteínas y ADN, cambiando el metabolismo de la 
célula. En este contexto, es interesante destacar que cultivar las CMM en 
condiciones de hipoxia, o mejor dicho, de “normoxia” fisiológica, antes del 
trasplante podría mejorar el potencial regenerador de tejido. Además, la reducción 
de los niveles de oxígeno se acompaña de una mayor tasa de crecimiento, 
sugiriendo que el estrés oxidativo es un factor contribuyente en la senescencia 
celular. 
La senescencia se describe como un estado irreversible de detención del 
ciclo celular, que se acompaña de alteraciones morfológicas, una menor tasa de 
proliferación, resistencia a la apoptosis y un aumento de la expresión de la 
actividad β-galactosidasa asociada a la senescencia y de p16INK4a. El crecimiento 
celular está controlado por dos vías principales: una que implica la proteína 
retinoblastoma (pRb), la cual regula la salida del ciclo celular en la fase G1 y otra 
que implica la participación de la proteína p53, que induce la detención del 
crecimiento o apoptosis en respuesta al estrés celular. El gen CDKN2A, también 
conocido como locus INK/ARF, codifica los genes p16INK4a y p14ARF, que son 
reguladores del ciclo celular. La proteína p16INK4a inhibe las ciclinas dependientes 
de quinasa CDK4 y CDK6, para prevenir la fosforilación de la proteína del 
retinoblastoma (pRb). La forma hipofosforilada de pRb secuestra los factores de 
transcripción de E2F impidiéndoles activar de forma coordinada una serie de genes 
que son necesarios para la replicación del ADN. La proteína p14ARF, por su parte, 
se une a la ubiquitin ligasa MDM2 E3 para facilitar la activación de p53. A su vez, 
el factor de transcripción p53 regula un grupo extenso de genes que son 
comúnmente inducidos por el estrés celular que conduce a la apoptosis.  
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Otra característica que no está incluida en la definición de senescencia de las 
células madre, pero que debería de tomarse en consideración, es la pérdida de la 
pluripotencia o capacidad de autoregeneración. La pluripotencia va ligada a la 
expresión de unos factores de transcripción, conocidos como: OCT4, SOX2, KLF4 
y c-MYC, y abreviados como "OSKM". Dichos genes están involucrados tanto en 
la inducción como en el mantenimiento de la pluripotencia en las células madre. Es 
decir, estos genes son capaces de borrar la huella epigenética de las células 
somáticas hasta convertirlas en las conocidas células madre pluripotentes inducidas 
(iPSC), cuyas características se equiparan a las de las células madre embrionarias. 
Finalmente, se pretendió investigar una posible relación entre la senescencia 
y la pérdida de pluripotencia de las CMPD, ambas asociadas al cultivo in vitro a 
largo plazo. Un posible nexo de unión es la proteína BMI-1. Dicha proteína 
modula la compactación de la cromatina a través de la metilación de las histonas 
en los nucleosomas; es por tanto un regulador epigenético. Más concretamente, 
BMI-1 es un represor génico, cuya diana mejor descrita es el locus INK/ARF. 
También se sabe que BMI-1 juega un papel clave no sólo en la prevención de 
daños al ADN, sino también en el mantenimiento de la función mitocondrial y la 
homeostasis redox. Así pues, la proteína BMI-1 regula una amplia gama de 
procesos celulares críticos para el crecimiento celular, la decisión del destino 
celular, el desarrollo, la senescencia, la apoptosis y la auto-renovación de las 
células madre. Por lo tanto, nos propusimos investigar si BMI-1 regula el destino 
de las CMPD al modular la expresión de los genes p16INK4a y OSKM.  
Nuestro objetivo principal fue pues el de analizar el papel de p16INK4a y de 
BMI-1 en la senescencia inducida por el estrés oxidativo en células madre de pulpa 
dental a largo plazo. 
 
METODOLOGÍA 
En primer lugar, analizamos si la tensión de oxígeno ambiental induce estrés 
oxidativo en las CMPD durante el cultivo a largo plazo. Para ello se midió la 
producción de especies reactivas del oxígeno (ROS) y el potencial de membrana 
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mitocondrial por citometría de flujo. También se analizaron los niveles de 
malondialdehído (MDA) como marcador de la peroxidación lipídica por 
cromatografía líquida de alta eficacia (HPLC) y los niveles de carbonilación 
proteica por western blot. Además de estos marcadores, también se determinaron 
los niveles de las enzimas antioxidantes: manganeso superóxido dismutasa 
(MnSOD), glutatión peroxidasa (GPx) y catalasa (CAT), mediante la técnica de la 
reacción en cadena de la polimerasa (PCR). 
A continuación, analizamos si la tensión de oxígeno ambiental provoca una 
senescencia prematura inducida por estrés oxidativo en las CMPD durante el 
cultivo a largo plazo. Para ello, analizamos la morfología celular por microscopía y 
determinamos la actividad de la enzima β-galactosidasa por citometría de flujo. 
Paralelamente, comparamos la expresión de los genes p14ARF y p16INK4a por PCR 
para determinar la vía de señalización implicada en la senescencia prematura de las 
CMPD cultivadas al 21% pO2. 
Seguidamente, analizamos si la tensión de oxígeno ambiental produce una 
pérdida de pluripotencia en las CMPD durante el cultivo a largo plazo, para lo cual 
medimos la expresión de los factores OCT4, SOX2, KLF4 y c-MYC por PCR. 
Por último, comparamos la evolución de la expresión de BMI-1 tanto a nivel 
génico como proteico, en las CMPD durante el cultivo a largo plazo bajo ambas 
presiones de oxígeno. Finalmente, mediante la introducción de pequeños ARN de 
interferencia (siRNA), se silenció la expresión de BMI-1 para ver si tenía algún 
efecto sobre la expresión de los factores de pluripotencia. 
 
RESULTADOS Y DISCUSIÓN 
Las CMPD normalmente residen a bajas concentraciones de oxígeno. En los 
mamíferos, incluidos los humanos, en el momento en que el oxígeno llega a los 
órganos y tejidos, la concentración de oxígeno cae a 2-9%, con una media de 3% 
en la pulpa dental. A pesar de este hecho, todavía es común cultivar células al 21% 
pO2. Sin embargo, la función celular normal requiere un entorno estable de 
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oxidación-reducción. El exceso en la tensión de oxígeno se ha descrito como un 
factor importante que podría desestabilizar la homeostasis redox celular. 
El estrés oxidativo refleja un desequilibrio entre la producción de especies 
reactivas del oxígeno (ROS) y la capacidad de detoxificación de los productos 
intermedios o de reparar el daño resultante. En el presente estudio, mostramos que 
la reducción del nivel de oxígeno ambiental condujo a una disminución del estrés 
oxidativo intracelular y del daño a biomoléculas durante el cultivo a largo plazo. 
Nuestros datos revelaron un aumento de los niveles de ROS, de la carbonilación de 
proteínas y de la oxidación de lípidos, así como una caída del potencial de 
membrana mitocondrial de las CMPD que se cultivaron a tensión de oxígeno 
ambiental. Además, estas células mostraron una sobreexpresión de las enzimas 
MnSOD, CAT y GPx, lo cual sugiere un aumento de la defensa antioxidante para 
hacer frente a la creciente producción de ROS. Por lo tanto, nuestros datos sugieren 
que el cultivo in vitro al 21% pO2 conlleva un estrés oxidativo. 
En este estudio, demostramos que las CMPD cultivadas a tensión de oxígeno 
ambiental cambiaron su morfología mostrando formas más aplanadas o alargadas, 
los cual se acompañó de un incremento de residuos en el medio de cultivo. 
Además, la tasa de proliferación de las CMPD se redujo significativamente a 
tensión de oxígeno ambiental, puesto que las células cultivadas al 3% pO2 
alcanzaron 25 pases mientras que las cultivadas al 21% pO2 sólo alcanzaron 15 
pases en el mismo periodo de tiempo. Estas observaciones se acompañaron de una 
mayor actividad de la enzima β-galactosidasa asociada a la senescencia a lo largo 
de los pases, lo que sugiere que estas células estaban entrando en un estado 
senescente. De hecho, aquí se demuestra que las CMPD se pueden mantener en 
cultivo durante al menos 25 pases manteniendo un fenotipo “más joven” y 
conservando la cinética de proliferación cuando éstas se cultivan a presión de 
oxígeno fisiológica. Es decir, durante el cultivo a largo plazo bajo tensión de 
oxígeno ambiental, las CMPD pierden gradualmente su potencial proliferativo y 
muestran signos cada vez mayores de senescencia tales como fenotipos más 
grandes y niveles incrementados de SA-β-Gal. 
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En conjunto, nuestros resultados sugieren que las CMPD cultivadas a 
tensión de oxígeno ambiental se someten a una senescencia prematura, que se 
evidencia por el agrandamiento del fenotipo, la reducción del potencial 
proliferativo y el aumento de la actividad SA-β-Gal. Este fenómeno parece ser 
causado por la acumulación de ROS, dando lugar a la senescencia prematura 
inducida por estrés. 
De hecho, durante mucho tiempo se ha sabido que una tensión reducida de 
oxígeno promueve el crecimiento y prolonga la vida replicativa de las células 
humanas mantenidas en cultivo. Los ROS tienen importantes funciones en la 
señalización celular, pero su papel en la regulación de la progresión del ciclo 
celular es poco conocido. Los niveles de ROS aumentan significativamente a 
medida que las células pasan de la fase G1 a la fase S del ciclo celular y son 
necesarios para la entrada en fase S. Sin embargo, los puntos de control del ciclo 
celular también se activan por aumento de ROS, lo que indica que la proliferación 
celular se basa en mantener los niveles de ROS dentro de un rango funcional. 
La senescencia es una característica normal de las células, por la cual 
pierden su capacidad replicativa tras un número finito de divisiones. Las vías 
inhibitorias del ciclo celular p16INK4a/pRb y p14ARF/p53 representan dos 
importantes vías que controlan la proliferación, y su inactivación puede extender el 
número límite de divisiones de células mitóticas en mantenidas cultivo. Dado el 
papel de p16INK4a en la regulación del ciclo celular y la reciente implicación del 
estrés oxidativo en la senescencia de las células madre, se investigó un posible 
vínculo entre la producción de ROS y la expresión de p16INK4a. Nuestros resultados 
muestran que las CMPD cultivadas a largo plazo al 21% pO2 presentaban signos de 
senescencia, que se acompañaban de un aumento en los niveles de expresión de 
p16INK4a y una reducción en los niveles de expresión de p14ARF. De acuerdo con 
esto, las células humanas generalmente expresan cantidades crecientes de p16INK4a 
cuando se aproximan a su límite de vida útil in vitro. De hecho, las señales de 
estrés como los ROS estimulan la activación de la transcripción de p16INK4a y 
desempeñan funciones importantes en la iniciación, así como el mantenimiento, de 
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la senescencia celular. Por esta razón, añadimos un agente antioxidante para ver si 
podíamos restablecer los niveles de expresión de p16INK4a. El tratamiento con 
Trolox 50 µM pudo rescatar los niveles de expresión de p16INK4a en el cultivo a 
largo plazo de CMPD al 21% pO2. En conjunto, podríamos decir que una baja 
tensión de oxígeno podría retrasar la senescencia de las CMPD mediante la 
regulación negativa de la expresión de p16INK4a. 
Las CMPD cultivadas al 3% pO2 mostraron elevados niveles de expresión de 
los genes OCT4 y SOX2 en los primeros pases, pero su expresión disminuyó 
conforme se acumulaban pases, lo cual sugiere que estos dos factores estarían 
implicados en la inducción de la pluripotencia. Sin embargo, en pases avanzados, 
estas células mostraron elevados niveles de expresión de los genes KLF4 y c-MYC, 
sugiriendo el papel de mantenimiento de la pluripotencia de estos dos factores. Por 
su parte, las CMPD cultivadas al 21% pO2, mostraron menores niveles de 
expresión de los cuatro factores OSKM a lo largo de los pases. En conjunto, 
nuestros datos sugieren que la tensión de oxígeno ambiental acelera la pérdida de 
la pluripotencia durante el cultivo a largo plazo. Este resultado fue consistente con 
otros hallazgos, lo cual sugiere que un microambiente con bajo contenido de 
oxígeno proporciona una condición óptima para el mantenimiento de las 
propiedades de las células madre. 
Nuestros resultados muestran que las CMPD cultivadas al 3% pO2 
conservaban unos niveles constantes de la proteína BMI-1 a lo largo de los pases. 
Sin embargo, los niveles de BMI-1 en las CMPD cultivadas al 21% pO2 no se 
mantuvieron constantes, sino que se desplomaron conforme se acumulaban los 
pases. Se sabe muy poco sobre la regulación post-transcripcional de BMI-1. 
Recientemente, se ha sugerido que BMI-1 es una proteína de corta duración. 
Algunos investigadores han publicado que BMI-1 podría ser un sustrato de AKT; 
la activación de la vía de señalización de AKT coincide con la fosforilación de 
BMI-1 lo cual le confiere mayor estabilidad. Por el contrario, la vía de señalización 
de p38 dependiente de estrés oxidativo hace que BMI-1 se degrade y pierda su 
capacidad modificadora de la cromatina. Además, también se ha sugerido que los 
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niveles de BMI-1 están regulados por degradación proteasomal. Colectivamente, 
estas observaciones apoyan la noción de que los niveles de BMI-1 están regulados 
por las vías de señalización dependientes de estrés oxidativo en las células madre. 
Curiosamente y a pesar de ello, las CMPD de pase 5, cultivadas al 21% pO2 
mostraron mayores niveles de BMI-1, tanto a nivel génico como proteico. Así 
pues, se procedió a silenciar la expresión del gen BMI-1 en dichas células, hasta 
equiparar los niveles de proteína en las CMPD cultivadas bajo ambas presiones de 
oxígeno. 
A continuación, analizamos los efectos de dicho silenciamiento sobre la 
senescencia y la pluripotencia de las CMPD. Los resultados obtenidos demuestran 
que los niveles de expresión de p16INK4a no se vieron afectados, sin embargo, los de 
OCT4 y SOX2 sí. Tras reducir los niveles de BMI-1 en las CMPD jóvenes 
cultivadas al 21% pO2, los factores OCT4 y SOX2 incrementaron su expresión 
hasta igualarse a la de las CMPD jóvenes cultivadas al 3% pO2. Es decir, este 
resultado sugiere, que el silenciamiento parcial de BMI-1 es capaz de rescatar la 
expresión de OCT4 y SOX2 en las CMPD cultivadas bajo tensión de oxígeno 
ambiental. 
 
CONCLUSIONES 
En conjunto, podemos concluir que el cultivo in vitro mantenido a tensión 
de oxígeno ambiental provoca una senescencia prematura inducida por estrés 
oxidativo y una pérdida de la expresión de los factores de pluripotencia en las 
CMPD. 
Además, los niveles de BMI-1 deben mantenerse en un equilibrio que 
permita la proliferación normal de las células madre, al tiempo que previene la 
senescencia de las células madre, y por tanto, el mantenimiento de la homeostasis 
de las células madre. 
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1.1 STEM CELLS 
1.1.1 Definition 
In its canonical view, a stem cell is presented as one that divides 
asymmetrically to produce a copy of itself and a second cell that is on its path to 
differentiate (Figure 1.1). This second cell may have one of many characteristics 
depending on the context of its development. In certain instances, this cell would 
be a precursor type that undergoes terminal differentiation. Alternatively, a cell 
generated from asymmetric division could itself be a progenitor that amplifies 
itself and then differentiates into one of many cell types. These cells have a finite 
proliferative potential, and eventually exhaust themselves once they give rise to 
differentiated progeny. Finally, an asymmetric cell division from a stem cell could 
generate a copy of itself and a second stem cell with a more limited potential for 
self-renewal.  
Stem cells are generated in the embryo. They persist in specific niches 
where they can remain mitotically quiescent for long periods of time. Stem cells 
expand their numbers as they self-renew by symmetric division. They can also 
maintain their numbers and produce rapidly dividing progenitors by asymmetric 
division (Martinez-Agosto et al., 2007). 
 
Figure 1.1 Stem cells dynamics.  
Taken from: Martinez-Agosto et al. (2007). 
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1.1.2 Classification 
The definition of a stem cell inevitably requires an assessment of its 
potential to give rise to a number of differentiated progeny. This potential can vary 
among different tissue types, and by the origin and requirement of a particular type 
of stem cell (Jaenisch and Young, 2008).  
 
1.1.2.1 Potency 
According to their potency, we can divide stem cells in four groups: 
- Totipotent stem cells are defined as those that can give rise to all tissues in 
an organism, including germ line, embryonic and extra-embryonic tissues. 
The zygote is the only totipotent stem cell. 
 
- Pluripotent stem cells originate from the inner cell mass of the embryo and 
give rise to all tissues in vivo, except trophoblasts. In this group we include 
embryonic stem cells (ESCs). 
 
- Multipotent stem cells are more limited in their potency. Adult stem cells 
(ASCs) such as hemaetopoietic stem cells constitute the classic example of 
a multipotent stem cell, which can give rise to a large repertoire of 
differentiated cell types belonging to the lymphoid and myeloid lineages.  
 
- Stem cells can also be unipotent if they are only capable of giving rise to a 
single cell type that is constantly produced throughout the life span of the 
organism. The best described example is the germ line stem cell (GSC), 
which can generate a single differentiated cell fate: either an egg (ovum) or 
a sperm.  
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1.1.2.2 Origin 
According to their origin, stem cells can be classified into ESCs and ASCs. 
Several strategies have been employed to induce the conversion of differentiated 
cells into an embryonic state in order to supply the ethical problems associated 
with ESCs. All these approaches led to the generation of a new cell type, 
commonly referred to as “induced pluripotent stem cells” or iPSCs. 
 
 Embryonic stem cells (ESCs)  1.1.2.2.1
As stated before, an embryonic stem cell (ESC) is defined by its origin. It is 
derived from the blastocyst stage of the embryo. The blastocyst is the stage of 
embryonic development prior to implantation in the uterine wall. At this stage, the 
preimplantation embryo is made up of 150 cells and consists of a sphere made up 
of an outer layer of cells (the trophectoderm), a fluid-filled cavity (the blastocoel), 
and a cluster of cells on the interior (the inner cell mass).  
The first documentation of the isolation of embryonic stem cells from 
human blastocysts was in 1994 (Bongso et al., 1994). In 1998, James Thomson and 
his colleagues reported methods for deriving and maintaining human ESCs from 
the inner cell mass of human blastocysts that were produced through in vitro 
fertilization (IVF) and donated for research purposes (Thomson et al., 1995; 
Thomson et al., 1998). Since then, techniques for deriving and culturing human 
ESCs have been refined. The ability to isolate human ESCs from blastocysts and 
grow them in culture seems to depend in large part on the integrity and condition 
of the blastocyst from which the cells are derived. In general, blastocysts with a 
large and distinct inner cell mass tend to yield ESCs cultures most efficiently. 
As we have previously said, ESCs are pluripotent cells that can give rise to 
cells from the three germ layers: endoderm, mesoderm and ectoderm (Amit et al., 
2000; Itskovitz-Eldor et al., 2000; Reubinoff et al., 2000; Schuldiner et al., 2000). 
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 Induced pluripotent stem cells (iPSCs) 1.1.2.2.2
Great advances were expected in the field of regenerative medicine; 
however, there were some problems with medical treatments involving human 
ESCs. First, there is a bioethical issue because a fertilized egg is used to generate 
ESCs. In addition, when ESCs are applied to an organ in regenerative medicine, 
the recipients must be given an immunosuppressant drug to prevent transplant 
rejection (Miyazaki et al., 2012). 
The use of induced pluripotent stem cells (iPSCs) solved the problems 
mentioned above. In 2006, iPSCs were generated from mouse embryonic 
fibroblasts (MEF) (Takahashi and Yamanaka, 2006). They were then generated 
from human dermal fibroblasts the following year (Takahashi et al., 2007). The 
iPSCs are reprogrammed from differentiated somatic cells by going back to an 
undifferentiated state similar to ESCs. Both ESCs and iPSCs are defined as 
pluripotent and are able to differentiate into three germ layers (endoderm, 
mesoderm and ectoderm) as well as self-renew. Thus, iPSCs may solve the 
problems related to clinical applications.  
Some of the reprogramming methods reported include: nuclear transfer, cell 
fusion, reprogramming using cell extracts and direct reprogramming (Figure 1.2).  
 
Figure 1.2 Strategies to induce reprograming of somatic cells.  
Taken from: Yoon and You (2011). 
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Strategies for reprogramming somatic cells 
 
• Nuclear transfer 
In 1952, Briggs and King succeeded in producing the tadpole, the first 
cloned animal, from the cell nucleus of a frog in the blastocyst stage (Briggs and 
King, 1952). For mammals, the first nuclear transfer-derived cloned sheep was 
generated in 1986 by transferring a blastomere nucleus from a four- to eight-cell 
sheep embryo to an enucleated unfertilized egg; in the following year, the cloned 
mouse was produced by transferring nuclei from eight-cell mouse embryos to 
enucleated two-cell embryos (Robl et al., 1986; Tsunoda et al., 1987).  
In addition, cloned animals were produced successfully using nuclear 
transfer techniques with many types of somatic cells, including cumulus cells, 
leukocytes, hepatocytes, neuronal cells, myocytes, lymphocytes and germ cells 
(Brem and Kuhholzer, 2002; Hochedlinger and Jaenisch, 2002; Jaenisch et al., 
2004). Nuclear transfer reprograms the cell nuclei of differentiated somatic cells by 
transplanting them into an enucleated oocyte. In order to create a cloned embryo 
without using sperm after nuclear transfer, the egg was activated by electrical or 
chemical stimulation.  
However, an unfertilized egg must be procured for clinical applications and 
immunological rejection may occur due to genetic factors from the nuclei isolated 
from somatic cells and the oocyte. In 2007, it was reported that only 2 cells out of a 
total of 304 oocytes were successfully created as ESCs by nuclear transfer (Byrne 
et al., 2007), suggesting a low induction efficiency. 
 
• Cell fusion 
Cell fusion is another reprogramming method. The somatic cell genome is 
highly reprogrammed in a syncytium where cell division occurs repeatedly with 
the nuclei of ESCs and somatic cells mixed (Tada et al., 2001; Tada et al., 2003). 
Therefore, it is supposed that ESCs are able to reprogram the somatic cells by 
Introduction 
 8 
deleting their properties and overwriting the somatic cell genome with the 
properties of ESCs.  
ESC hybrids formed teratomas in immunodeficient mice and they generated 
chimera embryos after blastocyst injection, which demonstrates the pluripotency of 
ESC hybrids. It has been reported that the pluripotent cells can also be generated 
from mice and human beings through reprogramming using cell fusion (Surani, 
2005; Yu et al., 2006). 
It is currently unknown whether the somatic cell nuclei can be 
reprogrammed by cell fusion with only the cytoplasmic elements of ESCs or if the 
nuclear elements are also needed. It is desirable to selectively remove only the 
chromosomes of ESCs from the fused nuclei, but it is technically difficult (Pralong 
et al., 2005). It will be a long time before this advanced technique is used in 
clinical applications.  
 
• Reprogramming using cell explants 
Another reprogramming method inserts cell extracts, which are obtained 
from pluripotent stem cells such as ESCs, into somatic cells. As described in the 
previous section on “Cell fusion”, ESCs have a specific characteristic that 
reprograms the somatic cells. The cell extract is chemically isolated from ESCs 
and consists of reprogramming factors that enter into the somatic cells and induces 
their reprogramming.  
It was reported in 2005 that culturing HEK293 and NIH3T3 cells with the 
factors isolated from human embryonic carcinoma NCCIT cells increased the 
expression levels of undifferentiation markers, including OCT4, and that the cells 
could be induced to differentiate into neurogenic, adipogenic, osteogenic and 
endothelial lineages (Taranger et al., 2005). However, they could not be 
differentiated into three germ layers in vivo. Thus, this reprogramming method 
may be incomplete. 
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• Direct reprogramming 
In 2006, it was reported that four transcription factors (OCT4, SOX2, KLF4 
and c-MYC), named OSKM, were introduced into MEFs to generate iPSCs 
(Takahashi and Yamanaka, 2006).  
Transcription factors are one of the groups of proteins that read and interpret 
the genetic print in the DNA. They bind to the DNA and help initiate a program of 
increased or decreased gene transcription. As such, they are vital for many 
important cellular processes. The octamer-binding transcription factor OCT4 
belongs to the POU transcription factor family and is crucial to sustain a 
pluripotent state of ESCs. It is known that the level of OCT4 decreases with the 
stage of cell differentiation and OCT4 does not occur in mature somatic cells (Loh 
et al., 2006). The Kruppel-like factor 4 (KLF4) functions as a transcriptional 
repressor in opposite to other members of the KLF family (they are transcriptional 
activators). KLF4 may regulate the expression of genes, which have a pivotal role 
in crucial cell processes, including cell proliferation/ differentiation and stem cells 
programming (Yet et al., 1998). SOX family consists of twenty genes encoding 
transcription factors characterized by conserved high mobility group domain which 
is involved in DNA-binding. SOX genes are essential in sex determination, embryo 
development, and maintenance of stem cell status  (Sarkar and Hochedlinger, 
2013). In normal conditions, c-MYC transcription factor plays an important role in 
cell proliferation regulation, differentiation, and apoptosis, as well as cell 
transformation (Sodir et al., 2011). 
In addition, a teratoma was formed by transferring iPSCs into the 
subcutaneous tissue of a nude mouse and cells were able to differentiate into the 
tissues of three germ layers (Takahashi and Yamanaka, 2006). Later, Abad and 
colleagues demonstrated that full reprogramming can also occur in vivo by 
transitory induction of the four factors OCT4, SOX2, KLF4 and c-MYC in mice 
which resulted in teratomas emerging from multiple organs (Abad et al., 2013). 
Furthermore, microinjection of these factors into a mouse blastocyst led to the 
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production of a chimera mouse, indicating these were germ line factors that were 
maintained in the next generation. These findings suggested that the pluripotency 
of these cells was equivalent to that of ESCs (Okita et al., 2007). Since then, direct 
reprogramming has been widely studied by introducing these transcription factors 
or various other factors. The pluripotent stem cells are induced by various somatic 
cells, including fibroblasts, blood cells and keratinocytes (Loh et al., 2006; 
Grinnell et al., 2007; Duinsbergen et al., 2008; Huangfu et al., 2008; Kim et al., 
2008b; Ebert et al., 2009; Kim et al., 2009). 
It is unclear how the introduction of these transcription factors generates 
iPSCs equipped with the same functions of ESCs. Recent reports suggest that 
OCT4, SOX2 and NANOG may downregulate the expression of genes involved in 
the induction of differentiation of cells to maintain their undifferentiated properties 
and all four factors (including c-MYC) cause the epigenetic changes, such as the 
chromatin modification and DNA methylation, that generate iPSCs. The promoter 
regions of NANOG and OCT4 genes were reported to be demethylated in iPSCs as 
well as in ESCs (Takahashi and Yamanaka, 2006). 
 
 Adult stem cells (ASCs) 1.1.2.2.3
Adult stem cells (ASCs), like all stem cells, share at least two 
characteristics. First, they can make identical copies of themselves for long periods 
of time; this ability to proliferate is referred to as long-term self-renewal. Second, 
they can give rise to mature cell types that have characteristic morphologies 
(shapes) and specialized functions. Typically, stem cells generate an intermediate 
cell type or types before they achieve their fully differentiated state. The 
intermediate cell is called a precursor or progenitor cell.  
ASCs can be organised into three groups regarding their original layer: 
ectoderm, mesoderm and endoderm. Ectodermal cells will give rise to skin and 
neurons; mesodermal cells will generate cardiac, muscle, blood and bone cells; and 
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endodermal cells will produce visceral cells, such as pancreatic, lung, kidney or 
thyroid cells. 
Friedenstein and colleagues were the first in successfully isolate 
mesenchymal stem cells (MSCs) which come from the mesoderm (Friedenstein et 
al., 1970). MSCs can be isolated from dental pulp, periodontal ligament (Gronthos 
et al., 2000), deciduous teeth (Miura et al., 2003), periosteal (Nakahara et al., 
1991), synovial membrane (De Bari et al., 2001), muscle (Bosch et al., 2000), 
adipose tissue (Zuk et al., 2002) and trabecular bone (Tuli et al., 2003). MSCs are 
able to produce cells from the mesodermal layer, such as chondrocytes, 
osteoblasts, adipocytes (Pittenger MF et al., 1999), myoblasts (Wakitani et al., 
1995), tendon cells (Altman et al., 2002), odontoblasts (Gronthos et al., 2000; 
Miura et al., 2003) and cementoblasts (Kemoun et al., 2007).  
Alternatively, ASCs may differentiate into a tissue that would arise from a 
different germ layer. In this case, the cells would be deemed to show plasticity or 
pluripotency (Song and Tuan, 2004). For example, MSCs may differentiate into 
ectoderm-derived neural cells (Azizi et al., 1998; Kopen et al., 1999). 
 
1.1.3 Human dental pulp stem cells (hDPSCs)  
In the present study, we used dental pulp stem cells from healthy human 
donors (hDPSCs). Teeth are originated between both ectoderm and mesoderm 
layers (Lumsden, 1988). The ectodermal portion will give rise to the enamel, while 
mesodermal portion will produce dentin, pulp and cement tissues (Ruch, 1985; 
Thesleff and Sharpe, 1997). The dental pulp, a soft tissue found within the core of 
the tooth, consists primarily of connective tissue, an extensive blood capillary 
system, nerves, fibroblasts, odontoblasts, and immune cells. The primary function 
of the pulp is to form dentin through the actions of odontoblasts, although 
nutritional (Vongsavan and Matthews, 1992), immune defence (Jontell et al., 
1998), and sensory roles (Holland, 1994) are also apparent.  
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hDPSCs express multiple stem cell markers including mesenchymal, and 
embryonic markers (Patel et al., 2009; Govindasamy et al., 2010; Guimaraes et al., 
2011; Osathanon et al., 2011). In vitro, hDPSCs can be readily induced to 
differentiate into mesenchymal lineage cell types of osteoblasts/odontoblasts, 
chondrocytes and adipocytes (Gronthos et al., 2002; Zuk et al., 2002; Zhang et al., 
2006; Grottkau et al., 2010). Additional studies have also indicated the potential 
for myogenic (Zhang et al., 2006; Kerkis et al., 2008; Nakatsuka et al., 2010), 
melanocytic (Stevens et al., 2008), neuronal (Woodbury et al., 2000; Gronthos et 
al., 2002; Zuk et al., 2002; Zhang et al., 2006), and hepatocytic (Ishkitiev et al., 
2012) differentiation.  
 
1.1.4 hDPSCs isolation  
hDPSCs isolation can be achieved by enzymatic digestion of the dental pulp 
tissue. Digestion enzymes are proteins that brake intercellular junctions of the 
connective tissue that support tissues, thus releasing cells. Pulp tissue consists of a 
heterogeneous population of cells: stromal cells, vascular cells, endothelial and 
perivascular cells, nerve cells, mastoid cells, T lymphocytes and macrophages, all 
within an extracellular matrix rich in collagen, fibronectin and laminin which are 
the main substrate of matrix metalloproteinases (MMPs), especially interstitial 
collagenases (Goldberg and Lasfargues, 1995; Nakata et al., 2000). MMPs 
participate in the degradation and replacement of the extracellular matrix of all 
body tissues including bone, enamel and dentin. 
Interstitial collagenases are one of the most used groups for pulp tissue 
digestion. Collagenase MMP-1, 8 and 13 initiate the degradation of collagen I, II 
and III, which continue their degradation by other MMPs and non-MMPs 
proteolytic enzymes. These enzymes depend on cofactors such as calcium and zinc 
to exert their action; collagen degradation. The resulting collagen fragments are 
easily denatured and transformed into gelatine. Once gelatine is formed, MMP-2 
and MMP-9 degrade it in thousands of tiny fragments. 
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Other types of metalloproteinases can be used, such as dispase II (Gronthos 
et al., 2000; Laino et al., 2005; Papaccio et al., 2006; Koyama et al., 2009; 
Waddington et al., 2009) and thermolysin (Perry et al., 2008; Woods et al., 2009). 
Dispase is a neutral metalloproteinase from Bacillus polymyxa which requires 
calcium for its activity. This enzyme cuts fibronectin and collagen IV, both 
components of the dense lamina and anchoring fibrils of the basement membrane. 
Thermolysin is an extracellular metalloproteinase, isolated from gram-
positive bacteria Bacillus thermoproteolyticus (Klopman and Bendale, 1989). It 
requires a zinc ion for its catalytic activity and four calcium ions for its thermal 
stability. In comparison with other proteins that are denatured against heat, 
thermolysin does not undergo any conformational change to at least 70°C 
(Matthews et al., 1974). This enzyme is specific for cleaving peptide bonds 
containing hydrophobic amino acid residues such as L-leucine, L-isoleucine, valine 
and L-phenylalanine, and furthermore it is especially useful for the partial 
hydrolysis of polypeptides which do not contain arginine or lysine. The mechanism 
of action for thermolysin was proposed by Matthews in 1988, which suggests, 
from a series of structural studies, that the zinc ion of the native thermolysin forms 
a coordination complex with three ligands provided by the protein and a fourth 
ligand provided by a water molecule in which the zinc ion has two functions: 
polarizing the carbonyl group of the substrate and facilitating the deprotonation of 
the nucleophilic water. 
Another complementary method consists of a chemical disaggregation of the 
pulp tissue with ethylene diamine tetra acetic acid (EDTA) at a concentration of 
0.02% (w/v). It is a divalent cation chelator in phosphate buffered saline or Krebs 
buffer without calcium and magnesium and is also used together with trypsin to 
increase disintegration.  
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1.1.5 In vitro stem cell culture 
Dental hDPSCs have become a vital tool in medicine thanks to their easy 
retrieval and the possibility of maintaining them in culture to expand them. In 
order to be able to carry out any therapy with stem cells, it is necessary to have a 
very high number of cells. Most mesenchymal stem cells have a limited life-span 
in vitro, which means that they can only expand to a certain limit of cell divisions 
before they enter a senescence state and cease to proliferate. 
Many scientists have reported that the long-term culture of stem cells is 
accompanied by a morphology known as "fried egg", and is characterized by a 
reduction in the ability to differentiate. For this reason, the senescent state must be 
taken into account in order to obtain good quality stem cells that can be used in cell 
therapies. 
 
1.1.5.1 Oxygen tension influence on stem cell culture 
Most conventional in vitro cell cultures are performed under ambient oxygen 
concentration (20-21% pO2/160 mm Hg), which is often referred to as “normoxia”. 
In contrast, in vivo mesenchymal stem cells (MSCs) are not exposed to such a high 
concentration of oxygen. MSCs are developed in environments with low oxygen 
tension, that ranges between 1 and 7% pO2 in the bone marrow (Chow et al., 2001; 
Harrison et al., 2002), 10-15% pO2 in the adipose tissue (Bizzarri et al., 2006) and 
13-18% pO2 in blood and lungs (Steurer et al., 1997).  
Mean values of 3-6% pO2 (20-40 mm Hg) are commonly accepted in most 
tissues, including dental pulp, although the actual concentration of oxygen in situ 
depends on tissue vascularization and its metabolic activity (Ward, 2008). This fact 
suggests that in vitro cell culture should be performed under low oxygen tension 
conditions to mimic their natural physiological environment. El Alami and 
colleagues determined the growth rate of hDPSCs under physiological oxygen 
tension, and investigated the cell signalling pathways underlying the decreased 
stem cell proliferation during routine culture under ambient oxygen tension (El 
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Alami et al., 2014). Moreover, culturing hDPSCs under ambient oxygen tension 
conditions entails an oxidative stress-induced premature senescence (Mas-Bargues 
et al., 2017). 
It is interesting to note that cultivating MSCs under conditions of hypoxia, 
or rather, physiological “normoxia”, prior to transplantation improves tissue 
regenerative potential (Rosova et al., 2008). 
 
1.2 OXIDATIVE STRESS 
1.2.1 Definition 
Oxidative stress is defined as an alteration of the balance between 
prooxidant species and antioxidants, in favour of the former (Sies, 1985).  
Despite the physiological role of some reactive oxygen species, they can 
also lead to undesired oxidation reactions, against which organisms have had to 
develop antioxidant defences (Halliwell, 1996). The formation of a certain number 
of free radicals is a normal and inevitable process since they are the product of an 
infinity of chemical reactions essential for the cellular life. These reactive species 
do not cause oxidative damage under normal conditions because the cell is 
provided with a large amount of antioxidant mechanisms (Slater, 1984). 
When there is an imbalance between prooxidant and antioxidant substances 
in favour of the former, the result is oxidative damage, which can affect various 
molecules, and which can be reflected in their physiological functions. Thus, 
oxidative stress can be caused by an excess of pro-oxidants, a deficiency of 
antioxidant agents, or by both factors at the same time. 
 
1.2.2 Free radicals  
Free radicals are chemical species that contain one or more unpaired 
electrons in its valence layer, which makes these species to have a high reactivity 
(Fridovich, 1978). They are characterized by their great oxidizing power and their 
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very short life (Simic and Taylor, 1988). 
These chemical species are abundant in living systems. Moreover, some 
authors in their study on the origin and evolution of life propose free radicals as 
one of the causes of the origin of life in our planet (Harman, 2001). Thus, on the 
one hand oxygen gives rise to life and on the other hand, because of its ability to 
form different free radicals, it is capable of damaging essential structures for its 
development, such as DNA, proteins, carbohydrates and lipids (Sies, 1983). In 
addition, free radicals participate in physiological processes such as aging (Pacifici 
and Davies, 1991) and exhausting physical exercise (Davies et al., 1982; Sastre et 
al., 1992).  
In nature, free radicals are mostly compounds derived from oxygen and are 
called reactive oxygen species (ROS). These species are either highly reactive or 
capable of giving rise to reactive species. Some of them are real free radicals 
derived from oxygen, such as the hydroxyl radical. Others, like H2O2, are not really 
radical in the strict sense of their definition. In addition, there are other non-
oxygen-derived radical species that are taking interest in recent years, such as those 
derived from nitrogen (RNS). 
ROS may have an exogenous or endogenous origin (Finkel and Holbrook, 
2000). Endogenous ROS are produced inside the cell. Many biological processes 
release ROS as waste products, via cellular signalling pathway or as a defence 
mechanism (Morgan and Liu, 2011). Among them, we can include the Fenton-
Haber-Weiss reaction, the nicotinamide adenine dinucleotide phosphate reduced 
family (NADPH oxidases), peroxisomes, cytochrome p450, cytokines, growth 
factors, lipooxygenase, cyclooxygenase and, above all, mitochondrial electron 
transport chain (Finkel and Holbrook, 2000; Balaban et al., 2005) It is composed of 
a series of proteins with redox capacity that reduce molecular oxygen until the 
formation of a molecule of water. This reaction is coupled to oxidative 
phosphorylation, in which energy is produced in the form of adenosine 
triphosphate (ATP).  
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Exogenous ROS come from sources outside the body, such as diet, 
xenobiotics, tobacco smoke, pollution, ionizing radiation and ultraviolet light. 
Regarding in vitro stem cell culture, the main exogenous ROS are those generated 
due to “hyperoxia”. In fact, high oxygen tension can cause oxidative stress through 
the production of ROS that can damage lipids, proteins and DNA (Wiseman and 
Halliwell, 1996). Therefore, moderate hypoxia may lower the intracellular 
generation of ROS as well as its accumulation (Miller et al., 1987) (See section 
1.2.5). 
 
1.2.2.1 The “Free Radical Theory of Aging” 
The “Free Radical Theory of Aging” was formulated by Harman in 1956 
and it proposes that free radicals derived from oxygen are responsible for the 
oxidative damage that occurs with age at the cellular and tissue level (Harman, 
1956). Antioxidant systems are not able to cope with all the ROS that are generated 
continuously throughout the life of the cell, which ends up causing oxidative 
damage in it, and by extension, on the tissues.  
There are many experimental evidences in favour of this theory. Old animals 
have higher oxidation rates than young ones, and have oxidized proteins, oxidized 
forms of DNA and lipids accumulation (Stadtman, 1992; Sohal et al., 1993; 
Hamilton et al., 2001; Bokov et al., 2004). In principle, this could be attributed to a 
higher rate of free radicals generation by old organisms. 
Also, in favour of this theory, there are numerous studies carried out in 
various organisms, which suggest that the reduction of oxidative stress or the 
increase of resistance to it, is related to the prolongation of life (Miquel and 
Economos, 1979; Harman, 1982; Harrington and Harley, 1988; Phillips et al., 
1989; Orr and Sohal, 1994; Parkes et al., 1998; Finkel and Holbrook, 2000; Melov 
et al., 2000; Ruan et al., 2002; Ishii et al., 2004; Huang et al., 2006; Zou et al., 
2007; Kim et al., 2008a; Quick et al., 2008; Dai et al., 2009; Shibamura et al., 
2009).  
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Although the free radical theory of aging is among the most studied and 
accepted of all the hypotheses of the aging mechanism, several studies have 
generated ambiguity and controversy of the same (Muller et al., 2007; Perez et al., 
2009a; Perez et al., 2009b; Lapointe and Hekimi, 2010; Salmon et al., 2010). For 
example, the vast majority of studies in mice show no change in life-span after the 
increase or reduction of antioxidant enzyme activity (Huang et al., 2000). It has 
also not yet been shown to extend life in clinical trials in humans, who were given 
antioxidant substances (Howes, 2006; Bjelakovic et al., 2007). 
 
1.2.2.2 Defence mechanisms: physiological antioxidants 
Since humans have evolved in the presence of oxidizing substances, 
evolution has provided these organisms with systems capable of dealing with this 
type of reactive substances. An “antioxidant” is any substance that, when present 
in low concentrations compared to the oxidizable substrate, significantly decreases 
or inhibits the oxidation of this substrate (Sies, 1993; Halliwell and Gutteridge, 
1995). From the point of view of cellular physiology, we can divide them into 
primary, secondary and tertiary antioxidants: 
 
Primary antioxidants prevent the formation of new species of free radicals. 
These antioxidants act by converting existing free radicals into less harmful 
molecules, or by preventing their formation. This group includes superoxide 
dismutase (SOD), glutathione peroxidase (GPx), catalase and metal binding 
proteins that limit the availability of iron necessary for the formation of the OH- 
(Halliwell and Gutteridge, 1986). 
 
Secondary antioxidants are non-enzymatic scavengers that act when there is 
a free radical overproduction and enzyme systems are overflowing, thus preventing 
chain reactions. It includes glutathione, vitamin E, vitamin C, uric acid, bilirubin 
and albumin (Halliwell and Gutteridge, 1990).  
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Tertiary antioxidants repair biomolecules damaged by free radicals. Among 
them, intracellular proteolytic systems act to degrade oxidatively damaged 
proteins, thus avoiding their accumulation (Davies et al., 1987b; Pacifici and 
Davies, 1991). We can also highlight the DNA repair enzymes, methionine 
sulfoxide reductase and phospholipase-A2 that cuts the oxidized phospholipids of 
the membrane (Sevanian et al., 1985).  
 
1.2.3 Oxidative stress and biomolecules damage 
1.2.3.1 Oxidative damage to lipids 
Among the main types of biomolecules, lipids, and especially 
polyunsaturated fatty acids, are the most susceptible of being attacked by free 
radicals (Cheeseman and Slater, 1993), such as the hydroxyl (HO-), peroxide 
(ROO•), alkoxy (RO•) and alkyl (R•) radicals, which are the main generators of 
oxidative lipid damage.  
The process of oxidative damage to lipids, termed lipid peroxidation, begins 
when a free radical attacks a carbon in the aliphatic chain of a fatty acid, a 
hydrogen atom is released, and an alkyl radical is formed (Halliwell, 1994; 
Krinsky, 2012). This reaction is preferably produced in the carbons contiguous to 
double bonds of the polyunsaturated fatty acids, since the formed radicals can be 
stabilized by resonance with the double bond. Peroxide radicals can react with side 
chains of other polyunsaturated fatty acids, thereby spreading the radical chain 
reaction (Halliwell, 1994).  
Thus, a single attack by a free radical results in the formation of a large 
number of oxidation products, in particular aldehydes, mainly malondialdehyde 
(MDA), and isoprostanes, 4-hydroxynonenal, and short chain hydrocarbons such 
as ethane and pentane (Freeman and Crapo, 1982; Cheeseman and Slater, 1993). 
Many of the aldehydes formed react rapidly with the cellular components causing 
DNA mutations, and produce structural and functional damage by reacting with 
proteins (Krinsky, 2012).  
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Lipid peroxidation is considered a very important factor in the aging of 
aerobic cells (Lippman, 1985), because oxidative damage to lipids of the 
membrane is an important factor in the decrease of the fluidity of the membranes, 
and therefore will affect its functionality (Shigenaga et al., 1994). MDA is a very 
reliable marker of the lipid peroxidation profile. 
 
1.2.3.2 Oxidative damage to proteins 
All the amino acids present in the proteins have residues susceptible of being 
attacked by the free radicals, mainly by the hydroxyl radical (Stadtman, 1992). 
Within the physiological amino acids, tyrosine, phenylalanine, tryptophan, 
histidine, methionine and cysteine are the most oxidative processes that suffer 
(Davies et al., 1987a).  
In the process of oxidative damage to proteins, some amino acids such as 
lysine, proline and arginine are oxidized to carbonyl groups, so that the carbonyl 
content of proteins can be used as an indicator of oxidative damage to them. Other 
amino acids such as histidine, cysteine and methionine, also undergo oxidative 
damage, but do not form carbonyl derivatives (Stadtman, 1992).  
As a consequence, protein exposure to free radicals can lead to a 
conformational change of the protein, thus producing modifications in its primary, 
secondary and ultimately tertiary structure, which, in turn, can lead to a loss or 
modification of its biological function, which is usually irreversible and may cause 
the protein denaturation (Dean et al., 1993). In addition, if such dysfunctional 
proteins are not degraded, the hydrophobic residues may form protein aggregates 
which give rise to the protein complex known as lipofuscin (Hohn et al., 2013).  
 
1.2.3.3 Oxidative damage to DNA 
We can find more than twenty by-products after an oxidative attack to DNA. 
Among them, the oxidation of 2-deoxyguanosine to 8-hydroxy-2-deoxyguanosine 
(8-oxo-dG) is one of the most frequent lesions, and is of great importance because 
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of its high mutagenic effect, since during replication it will produce purine 
transformations (Kasai and Nishimura, 1984).  
Oxidative damage associated with proteins and DNA should not be 
considered independently. The accumulation of inactive forms of reparative 
enzymes may increase the accumulation of oxidative damage in the DNA, so that 
they can enhance each other. When replication of damaged DNA occurs prior to 
repair or when damaged DNA is repaired incorrectly, a mutation occurs (Breen and 
Murphy, 1995). Therefore, oxidative lesions to DNA appear to be involved not 
only in cell aging, but also in the pathogenesis of diseases associated with 
advanced age.  
Mitochondrial DNA (mtDNA) suffers much more oxidative damage than 
nuclear (Richter et al., 1988), since it presents certain traits that make it especially 
susceptible to be attacked by oxidizing agents: it lacks histones that can receive the 
attack instead of the DNA (Johns, 1995), the repair system is less effective (Suter 
and Richter, 1999) and, it is very close to the mitochondrial electron transport 
chain, one of the main production systems of reactive oxygen species (Giulivi and 
Davies, 1993). Another distinctive factor of mtDNA is that it has no introns, so that 
modification of any base usually affects a zone of coding DNA (Ames et al., 1993) 
and its impact is therefore more important.  
 
1.2.3.4 Oxidative damage to carbohydrates 
Carbohydrates, such as mannose and mannitol, react easily with the 
hydroxyl radical for its removal. Monosaccharides and disaccharides resist the 
action of ROS. Glucose constitutes a sensor of the superoxide radical, by holding it 
and preventing its action on other molecules. Therefore, it has been observed that 
various polysaccharides act as cellular protective agents (Albertini et al., 1996).  
Oxidative damage to carbohydrates is important when it comes to structural 
function polysaccharides, since polysaccharides are depolymerized by free radicals 
leading to degenerative processes. A special case is that of hyaluronic acid whose 
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structural function is to maintain the viscosity of the synovial fluid. It has been 
observed that superoxide dismutase is able to protect against the depolymerization 
of hyaluronic acid in the synovial fluid (McCord, 1974). Proteoglycans are subject 
to similar oxidative bursting (Greenwald and Moy, 1980).  
 
1.2.4 Oxidative stress markers 
Given the importance of the damage that oxidative stress can cause in cells 
and in the organism, in recent years we have tried to find indices that allow us to 
measure it. Among the proposed indicators, one of the most relevant is the 
oxidized / reduced glutathione ratio (GSSG/GSH) characteristic of oxidative stress, 
so that an imbalance causes an alteration of the cellular redox state (Sies, 1986).  
In addition to this ratio, there are specific markers that allow measuring 
oxidative damage to the aforementioned biomolecules. Malondialdehyde (MDA) 
and hydroxynonenal (HNE) are the most commonly used to measure lipid damage, 
although pentane and ethane levels can also be considered. 8-oxo-dG is an 
indicator of oxidative DNA damage, and carbonyl groups and 2-oxohistidine are 
used as markers of oxidative damage in proteins (Hageman et al., 1992).  
On the other hand, mitochondria play a key role in the genesis of free 
radicals. Mitochondrial membrane potential (ΔΨm) is critical to maintaining the 
physiological function of the respiratory chain to generate ATP. Mitochondrial 
dysfunction supposes a collapse of the respiratory chain and therefore an increase 
in ROS production. Several fluorescent probes can be used to determine 
mitochondrial membrane potential in a variety of cell types, as well as direct 
determination of free radicals.  
The four markers used to measure oxidative stress used in this study are 
described in the Methods section: Dihydrorodamine-123 (DHR123) for ROS 
production, the methyl ester tetramethylrodamine (TMRM) as an indicator of 
mitochondrial membrane potential, malondialdehyde (MDA) for lipid peroxidation 
and carbonyl groups for protein damage.  
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1.2.5 Oxidative stress and stem cells 
The common cell culture is performed at 21% pO2 (ambient oxygen tension) 
which is far from the physiological “normoxia” of adult stem cells, and as 
expected, is accompanied by an increase in ROS production and creates an 
oxidative stress environment. “Hyperoxia” has been described as an important 
destabilizing factor of cellular redox homeostasis (Fan et al., 2008).  
High oxygen tension can cause oxidative damage via production of free 
radicals, damaging lipids, proteins and DNA (Wiseman and Halliwell, 1996). 
Culturing under ambient oxygen tension has a negative impact on the physiological 
function of stem cells: cell proliferation and migration are affected (Rodrigues et 
al., 2010), as well as osteogenic differentiation potential (Hung et al., 2012). 
p38MAPK, p21 and Nrf-2 signalling pathway has been described as the link 
between the oxidative stress induced by culture at 21% pO2 and the lower 
proliferation rate of hDPSCs (El Alami et al., 2014). 
It has also been reported that the reduction of oxygen levels leads to a 
decrease in intracellular levels of oxidative stress as well as oxidative damage. This 
is accompanied by a higher proliferation rate, suggesting that oxidative stress is a 
contributing factor in cellular senescence (Ho et al., 2007). On the other hand, 
culture at 3% pO2 increases mRNA levels as well as protein levels of OCT4, SOX2 
and c-MYC transcription factors in stem cells of dental origin (Zhou et al., 2014). 
In other words, long-term culture under conditions of physiological 
“normoxia”, without oxidative stress, has been shown to maintain the 
mesenchymal cell phenotype and to prevent senescence (Bigot et al., 2015).  
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1.3 CELLULAR SENESCENCE 
1.3.1 Definition 
Cellular senescence was formally described when Hayflick and colleagues 
showed that normal cells had a limited ability to proliferate in culture (Hayflick 
and Moorhead, 1961; Hayflick, 1965). These experiments showed that human 
fibroblasts initially underwent robust cell division in culture. However, gradually 
(over many cell doublings) cell proliferation declined. The non-dividing cells 
remained viable for many weeks, but failed to grow despite the presence of ample 
space, nutrients and growth factors in the medium.  
Soon after this discovery, the finding that normal cells do not indefinitely 
proliferate spawned two important hypotheses. The first hypothesis stemmed from 
the fact that many cancer cells proliferate indefinitely in culture. Cellular 
senescence was proposed to be an anti-cancer or tumour-suppressive mechanism. 
In this context, the senescence response was considered beneficial because it 
protected organisms from cancer. The second hypothesis stemmed from the fact 
that tissue regeneration and repair deteriorate with age. Cellular senescence was 
proposed to recapitulate the ageing, or loss of regenerative capacity, of cells in vivo 
(Campisi and d'Adda di Fagagna, 2007). In fact, cancer and longevity require a 
durable cell proliferation potential and, therefore, those mechanisms that limit 
indefinite proliferation provide cancer protection but favour ageing (Serrano and 
Blasco, 2007).  
 
1.3.2 Cell cycle 
The cell cycle is an ordered set of events, culminating in cell growth and 
division into two daughter cells. The stages are G1-S-G2-M (Figure 1.3). The G1 
stage stands for "GAP 1". The S stage stands for "Synthesis", where DNA 
replication occurs giving rise to a pair of sister chromatids linked by proteins called 
cohesins (Nasmyth et al., 2000). The G2 stage stands for "GAP 2". The M stage 
stands for "mitosis", and it is when nuclear (chromosomes separate) and 
Introduction 
 25 
cytoplasmic (cytokinesis) division occur. Mitosis is further divided into 4 phases, 
prophase, metaphase, anaphase, and telophase. 
 
1.3.2.1 Cell cycle checkpoints 
Cell cycle checkpoints are regulatory pathways that control the order and 
timing of cell cycle transitions and ensure that critical events such as DNA 
replication and chromosome segregation are completed with high fidelity (Gardner 
and Burke, 2000). In addition, checkpoints respond to damage by arresting the cell 
cycle to provide time for repair and by inducing transcription of genes that 
facilitate repair. Checkpoint loss results in genomic instability and has been 
implicated in the evolution of normal cells into cancer cells. Recent advances have 
revealed signal transduction pathways that transmit checkpoint signals in response 
to DNA damage (Elledge, 1996).  
Before initiating DNA replication, cells in the G1 phase of the cycle may 
enter a resting phase known as G0. G0 cells are not in the state of growth or 
proliferation (Vermeulen et al., 2003). When cells are in G0 phase, they are 
commonly named as quiescent. This cell cycle arrest is reversible and in the 
presence of the appropriate signals, these cells can re-enter the cycle and continue 
their proliferation (Blagosklonny, 2011).  
 
1.3.2.2 Cell cycle regulation 
Cyclin-dependent kinases (CDKs) are serine/threonine kinases and their 
catalytic activities are modulated by interactions with cyclins and CDK inhibitors 
(CDKIs). Close cooperation between this trio is necessary for ensuring orderly 
progression through the cell cycle. In addition to their well-established function in 
cell cycle control, it is becoming increasingly apparent that mammalian CDKs, 
cyclins and CDKIs play indispensable roles in processes such as transcription, 
epigenetic regulation, metabolism and stem cell self-renewal (Lim and Kaldis, 
2013). Each stage of the cell cycle is regulated by different cyclins, CDKs and 
Introduction 
 26 
CDKIs (Figure 1.3).  
Cyclins activate CDKs by binding to them. There are multiple CDK-cyclin 
complexes that play specific roles at various phases in the cell cycle. These 
complexes include three interphase CDKs (CDK2, CDK4, and CDK6), one mitotic 
CDK1, and ten cyclins belonging to four different classes (A-, B-, D-, and E-type 
cyclins). 
CDK activity is regulated by two types of inhibitors: INK4 proteins (INK4a, 
INK4b, INK4c, INK4d) and Cip/Kip family proteins (p21, p27, and p57) (Sherr 
and Roberts, 1995). Together, these cell cycle inhibitors function as a brake system 
that inhibit proliferation in multiple tissue types.  
 
 
Figure 1.3 Cell cycle regulation checkpoints.  
Taken from: Hochegger et al. (2008). 
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1.3.3 Senescence versus quiescence 
Senescence is thought to differ from less-durable forms of cell cycle arrest 
(for example, quiescence) in several ways (Table 1.1). When mitogen-dependent 
dividing cells are deprived of extracellular growth factors or exposed to anti-
proliferative cytokines or contact inhibition, they exit the cell cycle into a non-
proliferating quiescent state (G0). Although G0 and G1 phase cells cannot be 
distinguished by DNA content, quiescent cells comparatively produce reduced 
numbers of ribosomal RNA (rRNA) and proteins, have decreased metabolic 
activity, do not express G1 CDK activities (Pardee, 1989; Sherr and Roberts, 
1995).  
 
Table 1.1 Senescence versus quiescence. 
 SENESCENCE QUIESCENCE 
Growth arrest Permanent Transient 
DNA content Diploid or Tetraploid Diploid 
Metabolism High Low 
Molecular effectors p16
INK4a, pRb 
p14ARF, p53 and p21Cip1 p21
Cip1, p27Cip2 
Markers 
SA-β-Gal, p16INK4a, DNA 
damage response, SASP and 
SAHF 
None 
 
Taken from: Sharpless and Sherr (2015). 
 
By contrast, adherent senescent cells emerging in culture in response to 
stress display an enlarged cell size and increased biomass, and they produce 
abundant stress granules (Kuilman et al., 2010; Rodier and Campisi, 2011; 
Campisi, 2013). Quiescent and senescent cells can be viably maintained in cell 
culture even after months of cell cycle arrest, but quiescent cells can re-enter the 
Introduction 
 28 
cell cycle in response to mitogenic and developmental cues, whereas senescent 
cells cannot (Serrano et al., 1997; Beausejour et al., 2003; Blais et al., 2007; 
Burkhart and Sage, 2008; Indovina et al., 2013; Kareta et al., 2015).  
 
1.3.4 Senescence biomarkers 
Adherent senescent cells attached to plastic culture dishes undergo 
morphological alterations, such as flattening, vacuolization and accumulation of 
stress granules (Kuilman et al., 2010; Rodier and Campisi, 2011; Campisi, 2013). 
Increases in cell size relative to proliferating cells in culture may reflect a 
continuation of anabolic processes, such as protein and membrane synthesis, in 
senescent cells that have exited the cell cycle.  
Senescent cells routinely express senescence-associated β-galactosidase 
(SA-β-Gal) and p16INK4a, and most secrete inflammatory cytokines and other 
signalling molecules — including interleukin-1 (IL-1), IL-6, IL-8, vascular 
endothelial growth factor A (VEGFA) and matrix metalloproteinases (MMPs) — 
as part of a senescence-associated secretory phenotype (SASP) (Coppe et al., 2008; 
Rodier et al., 2009). Human cells undergoing senescence exhibit an unusual pattern 
of heterochromatin that is present in discrete nuclear subdomains, known as 
senescence-associated heterochromatic foci (SAHFs), which are associated with S-
phase-promoting gene loci, such as E2F target genes (Narita et al., 2003). HP1-γ 
has proven to be a positive marker of SAHF in adenomas but negative in 
adenocarcinomas, suggesting that senescent cells exist in premalignant tumours but 
not in malignant ones (Collado et al., 2005). 
Collado and colleagues also analysed some de novo markers identified by 
using DNA microarray analysis in order to detect oncogene-induced senescence. 
These de novo markers were p15INK4b, Dec1 and DcR2 (Collado et al., 2005). 
The next figure provides a brief description of the most commonly used 
markers of cellular senescence (Figure 1.4). 
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Figure 1.4 Biomarkers of senescence.  
Taken from: Sharpless and Sherr (2015). 
 
This schematic figure depicts different damaged organelles, including: the 
nucleus, containing damaged chromatin (SAHF); mitochondria with internal 
cristae producing ROS; and abundant lysosomes expressing β-galactosidase. 
Vesicles emanating from the Golgi apparatus contain secreted cytokines and 
chemokines which is known as the senescence-associated secretory phenotype 
(SASP), leading to paracrine signalling.  
The cyclin-dependent kinase (CDK) inhibitor p16INK4a in the cytoplasm 
prevents CDK4 and CDK6 from assembling into functional holoenzymes with 
their allosteric regulators, the D-type cyclins. Thus, preventing the import of active 
kinases into the nucleus and inhibiting the phosphorylation of nuclear 
retinoblastoma protein (pRb) (Sharpless and Sherr, 2015).  
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1.3.4.1 Hypertrophic phenotype 
Hayflick already stated that senescent cells show an enlarged cytoplasm that 
doubles the size of non-senescent cells (Hayflick, 1965). The typical senescence 
phenotype consist of enlarged cell with multiple or enlarged nuclei, prominent 
Golgi apparatus and sometimes a vacuolated cytoplasm  (De Cecco et al., 2011).  
 
1.3.4.2 Growth arrest 
The hallmark of cellular senescence is an inability to progress through the 
cell cycle. Senescent cells arrest growth, usually with a DNA content that is typical 
of G1 phase, yet they remain metabolically active. Once arrested, they fail to 
initiate DNA replication despite adequate growth conditions. This replication 
failure is primarily caused by the expression of dominant cell cycle inhibitors. In 
contrast to quiescence, the senescence growth arrest is essentially permanent 
because senescent cells cannot be stimulated to proliferate by known physiological 
stimuli (Campisi and d'Adda di Fagagna, 2007). 
 
1.3.4.3 Apoptosis resistance 
Apoptosis entails the controlled destruction of cellular constituents and their 
ultimate engulfment by other cells. Like senescence, apoptosis is an extreme 
response to cellular stress and is an important tumour-suppressive mechanism. But, 
whereas senescence prevents the growth of damaged or stressed cells, apoptosis 
quickly eliminates them (Roat et al., 2007).  
It is not clear what determines whether cells undergo senescence or 
apoptosis. One determinant is cell type; i.e., damaged fibroblasts and epithelial 
cells tend to senesce, whereas damaged lymphocytes tend to undergo apoptosis. 
The nature and intensity of the damage or stress may also be important (Roux and 
Blenis, 2004). Most cells are capable of both responses. The senescence and 
apoptosis regulatory systems therefore communicate — probably through their 
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common regulator, the p53 tumour suppressor protein (Thakur et al., 2007). 
 
1.3.4.4 β-Galactosidase activity 
The most commonly used senescence marker, primarily because of its ease 
of detection in tissues, is senescence-associated β-galactosidase (SA-β-Gal) 
activity measured at pH 6.0 (Dimri et al., 1995). Endogenous β-galactosidase in 
humans is a lysosomal enzyme optimally active at pH 4.0–4.5, so its detection at 
suboptimal pH 6.0 connotes its very high level of expression in senescent cells 
(Kurz et al., 2000; Lee et al., 2006a). 
This activity at pH 6.0 allowed the identification of senescent fibroblasts and 
keratinocytes in aged human skin biopsies, and subsequently became known as 
senescence-associated β-galactosidase (SA-β-Gal). Several laboratories have since 
then, used the SA-β-Gal assay on a variety of cells and tissues to demonstrate the 
onset of replicative senescence in culture (Reznikoff et al., 1996; Serrano et al., 
1997; Bodnar et al., 1998; Tsukamoto et al., 1998; van der Loo et al., 1998; 
Matsunaga et al., 1999) and in vivo (Mishima et al., 1999; Sigal et al., 1999).  
 
1.3.4.5 p16INK4a expression 
The second most commonly used marker is the expression of p16INK4a, a 
selective inhibitor of cyclin D-dependent CDK4 and CDK6 (Serrano et al., 1993). 
The CDKN2A gene encoding p16INK4a is closely chromosomally linked to 
CDKN2B, which encodes a second INK4 family member, p15INK4b (Figure 1.5). 
Moreover, RNAs specified by exons 2 and 3 of the CDKN2A gene are co-opted 
into distinct transcripts originating from another upstream promoter and exon, 
where their coding sequences are translated in an alternative reading frame (ARF)  
(Quelle et al., 1995); the resulting protein is p14ARF in human and p19ARF in mouse. 
The p16INK4a and p15INK4b proteins inhibit cyclin D-dependent CDK4 and CDK6 to 
prevent phosphorylation pRb. The hypophosphorylated form of pRb sequesters 
E2F transcription factors, preventing them from coordinately activating a suite of 
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genes that are required for DNA replication. The ARF protein binds to the MDM2 
E3 ubiquitin ligase to prevent p53 polyubiquitylation and to facilitate p53 
activation. In turn, the p53 transcription factor regulates an extensive group of 
genes that are commonly induced by cellular stress (Levine, 1997). These include 
the CDK2 inhibitor p21CIP, which inhibits CDK2-mediated pRb phosphorylation 
during progression through the G1 phase of the cell division cycle (Weinberg, 
1995).  
The tumour suppressor pathways, p14ARF/MDM2/p53 and p16INK4a/pRb, 
have been shown to play critical roles in the induction of cellular senescence (Sherr 
and DePinho, 2000; Agherbi et al., 2009). However, the relative contributions of 
p16INK4a and p14ARF to senescence continue to be puzzling. p19ARF expression is the 
more critical determinant of replicative senescence of cultured mouse embryonic 
fibroblasts (Kamijo et al., 1997), whereas p16INK4a is a key regulator of in vitro 
senescence in human cells (Chandler and Peters, 2013). Notably, deletion and 
silencing of the entire CDKN2A–CDKN2B locus and mutations inactivating 
p16INK4a are among the most frequent genetic events encountered in malignant 
human tumours, implying that, as with inactivation of RB1 and TP53, loss of 
CDKN2A–CDKN2B enables cells to bypass tumour-suppressive restraints that are 
imposed by senescence.  
However, both pathways are connected. pRb and p53 pathways are linked to 
each other by p21CIP1. p21CIP1 inhibits CDK2-mediated pRb phosphorylation during 
progression through the G1 phase of the cell division cycle (Sharpless and Sherr, 
2015). Unlike the roles of pRb and p16INK4a, the role of the CDK inhibitor p21CIP1 
in senescence and tumour suppression remains controversial (el-Deiry et al., 1993; 
Harper et al., 1993; Xiong et al., 1993). Expression of p21CIP1 in response to 
transient DNA damage produces a reversible cell cycle pause that provides time 
for DNA repair and facilitates cell survival (Deng et al., 1995; Wang et al., 1997; 
Martin-Caballero et al., 2001). Furthermore, inactivation of p21CIP1 does not 
abrogate senescence in commonly used in vitro model systems (Pantoja and 
Serrano, 1999).  
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By contrast, consistent with observations that p21CIP1 expression has been 
associated with prolonged proliferative arrest occurring in the setting of chronic 
DNA damage (Di Leonardo et al., 1994), more than 4 days of experimentally 
enforced p21CIP1 expression has been reported to initiate senescence (Sang et al., 
2008). Activation of high levels of p21CIP1 by stress-induced p53 during the G2 
phase also seems to facilitate senescence induction (Spencer et al., 2013; Krenning 
et al., 2014). Even if p21CIP1 is important for the initiation of senescence in some 
settings, its expression does not persist in senescent cells (Alcorta et al., 1996; 
Robles and Adami, 1998; Stein et al., 1999). Therefore, p21CIP1 cannot be used as a 
reliable marker of the senescence phenotype.  
 
 
Figure 1.5 The INK/ARF locus (CDKN2A-CDKN2B).  
Taken from: Sharpless and Sherr (2015). 
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1.3.4.6 Senescence associated secretory phenotype (SASP) 
Cells undergoing senescence exhibit profound changes in their 
transcriptomes. A major consequence of this is the secretion of many dozens of 
factors, including cytokines and chemokines (Campisi, 2005). The first indication 
of changes in the secretome of human cells accompanying senescence was reported 
for fibroblasts undergoing replicative senescence. Microarray analysis revealed a 
strong inflammatory response, as seen in wound healing (Shelton et al., 1999). 
Subsequent work from various laboratories has revealed that cells undergoing 
either replicative or premature senescence display profound changes in their 
secretome, termed the senescence-associated secretory phenotype (SASP) (Coppe 
et al., 2008; Rodier et al., 2009).  
It has been proposed that the normal function of the SASP is to restore tissue 
function in two ways: first, by stimulating less-damaged neighbouring cells to 
engage in tissue repair; and second, by attracting inflammatory cells to eliminate 
senescent cells and turn off SASP-mediated signals. However, this restorative 
process may fail when the extent, duration or frequency of the damage exceeds 
repair capacity. The end result is an aberrant accumulation of senescent cells that, 
contrary to their initial purpose, aggravate tissue dysfunction (Serrano, 2017a). 
 
1.3.4.7 Senescence associated heterochromatin foci (SAHF) 
Cellular senescence can be associated with an altered chromatin structure, at 
least in vitro. While DNA dyes display overall homogenous staining patterns in 
cycling or quiescent human cells, senescent cells often show strikingly different 
punctate staining patterns (Kuilman et al., 2010).  
The organization of DNA in heterochromatin contributes to nuclear 
organization, chromosome structure, and gene silencing (Dillon and Festenstein, 
2002; Lachner and Jenuwein, 2002). There are two types of heterochromatin: 
constitutive and facultative. The constitutive heterochromatin mainly comprises the 
pericentric regions of the chromosomes and is important for the segregation of 
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chromosomes and the silencing of repetitive elements. Facultative heterochromatin 
is controlled during development and contributes to gene regulation during 
differentiation. A different type of optional heterochromatin is then identified; the 
senescence associated heterochromatin foci (SAHF), which appears in the 
senescent cells (Parry and Narita, 2016). 
These SAHF are specifically enriched in methylated lysine 9 of histone H3 
(a modification catalyzed by the histone methyltransferase Suv39h1), while histone 
H3 lysine 9 acetylation and lysine 4 methylation (both euchromatin markers) are 
excluded from SAHF (Narita et al., 2003). Senescent cells display increased 
binding of heterochromatin-associated proteins in the promoters of several E2F 
target genes. SAHF formation is circumvented by interference with p16INK4a/pRb 
pathway signalling, correlating with bypass of senescence.  
Very little is known about the effector mechanism of cellular senescence, 
but the global chromatin reorganisation may not simply be a senescence marker, 
but rather play a key role in the senescence mechanism. In fact, there is a strong 
correlation between SAHF formation and the irreversibility of the senescence 
phenotype (Narita, 2007). 
 
1.3.4.8 Telomere shortening 
It is unquestionable that telomere shortening is a universal mechanism that 
limits the proliferative potential of normal cells lacking endogenous telomerase. 
Most human primary cells do not express high levels of telomerase and, therefore, 
are subject to a progressive erosion of their telomeres with each cell generation 
(Blasco et al., 1999). The inability of which to add telomeric repeats to 
chromosome ends eventually leads to telomere deprotection and a DNA damage 
response (DDR) that limits cellular proliferative lifespan (Harley et al., 1990; 
Blasco et al., 1997).  
In turn, enforced expression of telomerase can bypass replicative senescence 
and maintain chromosomal integrity. However, whether senescence relies 
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exclusively or not on telomere shortening is still an open question. In fact, telomere 
shortening and dysfunction can occur in non-senescent cells, and senescence can 
be triggered by many stresses that are independent of telomere shortening in 
human cells in vitro (Sharpless and Sherr, 2015). 
Thus, even though the role of telomere shortening as a barrier to 
immortalization is clearly established, the full effects of “telomerization” on 
senescence are still to be defined (Serrano and Blasco, 2001). 
 
1.3.5 Oxidative stress-induced senescence  
According to the theory of free radical aging (Harman, 1956), ROS appear 
as toxic species that cause oxidative damage to biomolecules, however, there are 
other points of view that consider ROS as essential for cell survival. In 
physiological conditions, ROS have a regulatory role in a wide range of functions, 
since they act as second messengers. These pathways include gene regulation, cell 
signalling, cell differentiation, cell senescence, and apoptosis among others. Under 
ROS overproduction conditions, signalling regulation can be altered and could lead 
to the activation of dangerous signalling pathways, as well as to premature cellular 
senescence and its drift in the aging (Afanas'ev, 2010; Hekimi et al., 2011). 
Nowadays, ROS generate a great interest because they are involved in the 
cellular senescence process: elevated ROS levels are associated with replicative 
senescence by shortening telomeres and stress-induced senescence, directly 
damaging DNA and inducing a DNA damage response (DDR) (Campisi and 
d'Adda di Fagagna, 2007; Sohal and Orr, 2012). This increase leads to damage to 
DNA and DDR, forming a positive feedback loop that initiates senescence (Passos 
and Von Zglinicki, 2006; Passos et al., 2010). Before senescence begins, cells 
increase the mitochondrial network, as well as the number of mtDNA molecules 
and the mitochondrial production of radicals. Thus, the DDR is the onset of 
cellular senescence irrespective of the cause of origin and is capable of causing 
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mitochondrial dysfunction as a late consequence (Passos et al., 2007a; Passos et 
al., 2007b; d'Adda di Fagagna, 2008). 
Mitochondrial dysfunction leads to a high production of ROS, both being the 
cause and effect of a continuous DDR, causing a wide range of changes as a result 
of the signalling through several transcription factors, such as p53 and p16INK4a, 
necessary for cellular senescence (Passos et al., 2009). ROS contribute 
stochastically to the long-term maintenance of DNA damage by generating a stable 
and self-sustaining feedback loop sufficient to maintain cell arrest in response to 
DNA damage both in vivo and in vitro (Passos et al., 2010). 
 
1.4 BMI-1 AND STEM CELL BIOLOGY 
1.4.1 Definition 
Gene expression patterns are largely regulated by reprogrammable 
epigenetic regulatory mechanisms that control the local chromatin conformation 
(Jaenisch and Bird, 2003). The repeated specific pattern of gene expression 
established by epigenetic machinery during multiple rounds of cell division 
establishes cellular identity. Epigenetic regulation is significantly achieved by 
modulating nucleosome dynamics through histone tail modifications.  
The major molecular machines that dictate gene expression pattern through 
histone tail modification and chromatin modulations are global epigenetic 
modifiers, such as trithorax group (TrxG) and polycomb group (PcG) proteins, 
which trigger transcriptional activation and repression of target gene, respectively 
(Mills, 2010). PcG proteins form primarily two large multi-subunit polycomb-
repressive complexes (PRCs), namely, PRC1 and PRC2. In humans, PRC1 is 
composed by BMI-1, RING1A/B, PCGF, CBX and HPH, while PRC2 is 
composed by EZH, SUZ12 and EED. These complexes in association with other 
epigenetic markers establish target gene repression through histone tail 
posttranslational modifications (Muller and Verrijzer, 2009; Simon and Kingston, 
2009; Margueron and Reinberg, 2011).  
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Generally, PRC2 initiates histone tail modification by mono-, di-, and 
trimethylation of histone 3 at lysine 27 (H3K27me) residue with the help of its 
catalytic subunit enhancer of zeste homolog 2 (EZH2) methyl transferase enzyme, 
and this modification promotes the recruitment of PRC1 through its 
chromodomain-binding proteins, which then recognizes the H3K27me marker 
established by PRC2 (Spivakov and Fisher, 2007). PRC1 catalyses 
monoubiquitination of histone 2A at lysine 119 residue (H2AK119ub) to maintain 
target gene repression with the help of its catalytic subunit RING1A/B, which is an 
E3 ligase. RING1A/B protein activity is significantly enhanced by its association 
with another PRC1 component BMI-1 (B-cell specific moloney murine leukaemia 
virus integration region 1) (van Lohuizen et al., 1991). 
We are now going to summarize BMI-1 gene and BMI-1 protein structures, 
the regulatory mechanisms that control BMI-1 expression, and finally the cellular 
pathways that are regulated by BMI-1 repressing activity.  
 
1.4.2 BMI-1 gene and BMI-1 protein structure 
The human BMI-1 gene, composed of 10 exons and 9 introns, is localized on 
the short arm of chromosome 10 and encodes 37 kDa protein composed of 326 
amino acids (Alkema et al., 1993). BMI-1 protein structure is highly evolutionarily 
conserved and has several protein domains: - An N-terminal RING finger domain (RF) - A central helix-turn-helix (HTH) domain - A carboxyl terminal PEST-like domain - Two nuclear localization signals KRRR and KRMK  
Figure 1.6 shows BMI-1 gene and BMI-1 protein structure. The RF domain 
of BMI-1 is required for its association with RING1B E3 ligase, a catalytic 
component of PRC1, to activate PRC1 activity (Li et al., 2006). The RF and HTH 
domains are important for BMI-1 localization at DNA strand break and crucial for 
the recruitment of DNA damage repair machinery, prevention of cellular 
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senescence, and cancer cell survival (Itahana et al., 2003; Ginjala et al., 2011; 
Balasubramanian et al., 2015). The C-terminal PEST domain is rich in proline (P), 
glutamic acid (E), serine (S), and threonine (T) and is critical for BMI-1 protein 
turnover (Yadav et al., 2010). 
 
Figure 1.6 BMI-1 gene and BMI-1 protein structure. 
Taken from: Sahasrabuddhe (2016). 
 
1.4.3 BMI-1 gene and BMI-1 protein regulation 
BMI-1 is expressed ubiquitously in almost all types of tissues. However, its 
expression levels are high in brain, lungs, thymus, kidney, gonads, salivary glands, 
placenta, blood, bone marrow, and stem cells of several lineages. It is 
overexpressed in several cancer subtypes and serves as a biomarker for these 
cancer types. BMI-1 plays a critical role in cellular physiology and hence the 
transcript and protein levels of BMI-1 are tightly regulated in diverse cell types. 
For the past several years, many investigators are trying to understand the 
regulation of BMI-1 at transcriptional, posttranscriptional, and posttranslational 
levels. However, the comprehensive knowledge on BMI-1 regulation by different 
mechanisms is still scarce.  
BMI-1 gene expression is transcriptionally regulated by the number of 
transcription factors in a context- and lineage-dependent manner. BMI-1 gene 
expression is positively regulated by SP1, TWIST1, FOXM1, ZEB1, E2F1, 
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SALL4, n-MYC, c-MYC, and HDACs, whereas its expression is negatively 
regulated by MEL18, NANOG, and KLF4.  
Gene expression is regulated at different levels, including regulation of 
mRNA activity after synthesis. This regulation may operate at the level of RNA 
processing for maturation, its transport to correct subcellular localization, its 
stability and finally translation of its coded information into protein. These 
regulations occur through interaction of cellular factors with mRNA sequence 
elements located within 5′- and 3′-untranslated regions of unprocessed mRNA, 
including secondary structures, internal ribosome entry sites, and poly-A tail. Post-
transcriptional regulations can be achieved through the activity of target-specific 
microRNA expression. The miRNAs are short 21-23 nucleotide RNA sequences 
that control the level of expression of target gene through controlling transcription 
as well as mRNA stability. Several miRNAs, such as miR-452, miR-218, miR-494, 
miR-495, miR-215, miR-16, etc… are implicated in the regulation of BMI-1 gene 
expression (Sahasrabuddhe, 2016). 
Finally, post-translational regulations can be of two types: (1) reversible 
regulation and (2) irreversible regulations. The reversible protein modifications 
such as acetylation, phosphorylation, sumoylation, or ubiquitination can either alter 
the protein function or often direct protein to irreversible regulation through 
ubiquitin proteasome system (UPS)-mediated protein degradation. Post-
translational regulation of BMI-1 is not significantly characterized. BMI-1 protein 
is reported to be regulated by UPS-mediated protein degradation. Some studies 
have shown that BMI-1 C-terminal PEST domain is critical for BMI-1 protein 
stability and within this region a consensus motif DSGSDKANS is recognized by 
an E3 ligase β-TrCP, which regulates BMI-1 protein turnover and consequent 
oncogenic activity (Sahasrabuddhe et al., 2011).  
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1.4.4 BMI-1 role in cellular physiology  
Trough repression of target gene expression in a lineage- and context-
dependent manner, BMI-1 regulates a myriad of cellular processes critical for cell 
growth, cell fate decision, development, senescence, aging, DNA damage repair, 
apoptosis, and self-renewal of stem cells (Figure 1.7) (Bhattacharya et al., 2015).  
 
Figure 1.7 Upstream and downstream signalling pathways of BMI-1. 
Taken from: Sahasrabuddhe (2016). 
 
1.4.4.1 BMI-1, cell cycle and senescence 
Since epigenetic events such as histone modification have been implicated in 
senescence, it follows that genes involved in chromatin remodelling and gene 
expression, such as members of the Polycomb and Trithorax families, might be 
directly involved in decisions that affect stem cell fate, including self-renewal, 
senescence, and possibly aging. Polycomb and Trithorax proteins form large 
multimeric structures, which can lead to repression or activation of gene 
expression, respectively, via a concerted process of chromatin modifications 
(Simon and Tamkun, 2002; Orlando, 2003). 
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As stated before, the normal cell cycle progression and regulation is tightly 
controlled by a variety of molecular checkpoints that supervise the various 
biological functions of the cell that occur within the different phases of the cell 
cycle (Medema and Macurek, 2012). BMI-1, being a transcriptional repressor and 
a PcG protein, plays an important role in cell cycle regulation (van der Lugt et al., 
1994). BMI-1 controls self-renewal and cell cycle by regulating the tumour 
suppressor proteins p16INK4a y p14ARF (Dimri et al., 2002; Park et al., 2004). BMI-1 
promotes CDK4 and CDK6 activity by repressing the INK4A/ARF locus (Jacobs et 
al., 1999). BMI-1 can also directly regulate p53 stability, further stressing its role 
in cellular proliferation and tumour genesis by negatively acting through the 
pRb/p53 pathway (Calao et al., 2013; Su et al., 2013). Thus, BMI-1 promotes cell 
proliferation by suppressing p16INK4a/pRb and/or p14ARF/MDM2/p53 tumour 
suppressor pathways. For example, it has been published that BMI-1 is necessary 
for an efficient self-renewal of hematopoietic stem cells, as well as of neural stem 
cells, but is less necessary for the differentiated progeny (Molofsky et al., 2003; 
Park et al., 2003).  
 
1.4.4.2 BMI-1 and stem cell self-renewal 
ESCs derived from the inner cell mass of a blastocyst are stem cells with 
unique properties of pluripotency and self-renewal. The unique identity of ESCs is 
governed by a network of transcriptional factors along with epigenetic features 
(Liang and Zhang, 2013). Compared with differentiated cells, ESCs display 
distinctive chromatin features related to its unique properties. The chromatin in 
ESCs is in an “open” state, with more accessible chromatin domains and less 
heterochromatin foci. In contrast, highly condensed heterochromatin foci are 
prevalent in lineage-committed somatic cells (Aoto et al., 2006; Meshorer and 
Misteli, 2006; Meshorer et al., 2006; Efroni et al., 2008). The pluripotent state of 
ESCs is enforced by epigenetic factors closely linked to the pluripotency 
transcription factor network (Orkin and Hochedlinger, 2011; Young, 2011).  
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Polycomb group genes (PcGs) are usually considered as being 
transcriptional repressors that are required for maintaining the correct spatial and 
temporal expression of homeotic genes during development (Bracken et al., 2006). 
In addition to being essential regulators of embryonic development, the PcGs have 
also emerged as key players in the maintenance of the adult stem cell populations  
(Molofsky et al., 2004; Valk-Lingbeek et al., 2004). For example, BMI-1 is 
required for the self-renewal of hematopoietic and neural stem cells (Lessard and 
Sauvageau, 2003; Molofsky et al., 2003), while overexpression of EZH2 is capable 
of blocking the differentiation of muscle myoblasts (Caretti et al., 2004) and 
preventing hematopoietic stem cell exhaustion (Kamminga et al., 2006). 
Furthermore, Lee and colleagues found that PcG target genes are 
preferentially activated during ESCs differentiation and that the ESCs regulators 
OCT4, SOX2, and NANOG cooccupy a significant subset of these genes. These 
results indicate that PcG occupies a special set of developmental genes in ESCs 
that must be repressed to maintain pluripotency and that are poised for activation 
during ESCs differentiation (Lee et al., 2006b).  
 
1.4.4.3 BMI-1 and oxidative stress 
Genome integrity is constantly challenged by endogenous (metabolic) and 
exogenous (environmental) sources. To combat threats posed by DNA damage, 
cells have evolved mechanisms that are collectively termed as the DNA damage 
response (DDR). DDR involves a plethora of proteins whose sequential 
recruitment and function at DNA damage sites are modulated by numerous highly 
dynamic and reversible modifications, including phosphorylation, ubiquitination, 
acetylation, methylation and sumoylation.  
BMI-1 is known to play a key role not only in preventing DNA damage, but 
also in DDR. Mitochondrial ROS has been shown to be a prominent agent for 
oxidative DNA damage. Some researchers have demonstrated that independent of 
p16INK4a, BMI-1 has a role in maintaining mitochondrial function and redox 
Introduction 
 44 
homeostasis (Liu et al., 2009). Further, cells lacking BMI-1 have significant 
mitochondrial dysfunction accompanied by a sustained increase in ROS that is 
sufficient to engage the DDR pathway. Thus, BMI-1 prevents oxidative DNA 
damage (Wang et al., 2011). 
Apart from protecting against oxidative DNA damage, BMI-1 has been 
shown to be a key component in DDR, as it is required and sufficient to recruit the 
DDR machinery to DNA double-strand break sites in response to radiation 
(Facchino et al., 2010). Following DNA damage, BMI-1 tethers its RING finger to 
DNA, and associates more stably with damaged compared to undamaged 
chromatin (Ismail et al., 2010). Therefore, by inhibiting ROS-induced oxidative 
DNA damage along with facilitating DDR, BMI-1 contributes to maintaining 
genome integrity.  
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2.1 GENERAL AIM 
Our main purpose was to analyse the role of p16INK4a and BMI-1 in oxidative 
stress-induced senescence in long-term human dental pulp stem cells (hDPSCs) 
cultures. 
 
 
2.2 SPECIFIC AIMS 
The specific aims of this study were: 
• To analyse if ambient oxygen tension induces oxidative stress in hDPSCs 
during long-term culture.  
 
• To analyse if ambient oxygen tension mediates an oxidative stress-
induced premature senescence (SIPS) in hDPSCs during long-term 
culture. 
 
• To analyse whether this oxidative stress-induced premature senescence 
(SIPS) is mediated by p16INK4a pathway. 
 
• To analyse if ambient oxygen tension induces a stemness potential loss in 
hDPSCs during long-term culture. 
 
• To analyse if BMI-1 controls hDPSCs fate by p16INK4a, SOX2 and OCT4 
regulation during long-term culture under ambient oxygen tension. 
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2.3 JUSTIFICATION OF THE STUDY 
2.3.1 In vitro stem cell maintenance: 3% versus 21% oxygen tension 
Like embryonic stem cells, mesenchymal stem cells (MSCs) also reside in 
low oxygen concentrations. In mammals including humans, MSCs are located in 
perivascular niches close to the vascular structure in almost all tissues (Shi and 
Gronthos, 2003; Crisan et al., 2008; Zannettino et al., 2008; Mohyeldin et al., 
2010). Despite residing near the blood vessels, in different tissues where they are 
found, the oxygen concentrations are low (Harrison et al., 2002; Pasarica et al., 
2009). In adult human tissues, oxygen concentration varies widely depending on 
the vascularisation and the type of microenvironment within the respective organ, 
and they are considerably lower than the inhaled ambient oxygen concentration 
(21%). The partial pressure or oxygen concentration of inspired air gradually 
decreases after it enters the lungs and then in the blood flowing from the alveolar 
capillaries that carry oxygen, towards the organs and tissues for their oxygenation. 
By the time oxygen reaches the organs and tissues, oxygen concentration drops to 
2-9%, with a mean of 3% (Simon and Keith, 2008). Although highly vascularized, 
it is speculated that the oxygen concentration in the dental pulp is low. A study 
with rats found approximately 3% pO2 in the pulp tissue (Yu et al., 2002).  
In the last few decades there has been a great improvement in the 
development of culture medium and different matrix substrates as well as soluble 
factors that optimize cell proliferation and their maintenance (Villa-Diaz et al., 
2013; Laitinen et al., 2016). However, not all the factors that compose the niche 
have received the same attention. Currently, the vast majority of cell cultures are 
performed under a hyperoxic ambient which is composed of approximately 21% 
oxygen tension.  
The advances in cell-based therapies and regenerative medicine have 
aroused interest in the factors that control stem cell characteristics (Muscari et al., 
2013). In vivo, the stem cell niche is regulated by growth factors, cytokines and 
low oxygen tension (Simon and Keith, 2008). Within these niches, stem cells are 
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present in an undifferentiated and self-renewable state (Schofield, 1983). To mimic 
this environment in vitro, simulating low oxygen tension is one of the hot topics of 
tissue engineering research (Bornes et al., 2015; Hutton and Grayson, 2016; Wakai 
et al., 2016), which aims at improving proliferation rates (Grayson et al., 2006; 
Grayson et al., 2007; Zhang et al., 2014; Fotia et al., 2015) and differentiation 
potential of stem cells (Adesida et al., 2012; Bornes et al., 2015) as well as 
enhancing their viability after transplantation (Yan et al., 2012; Bader et al., 2015).  
The oxygen concentration in vitro culture under ambient oxygen tension is 
4–10 times higher than in the physiological environment. Thus, there has been an 
increasing interest in the growth of cells under 3% oxygen tension over the last few 
years (Forristal et al., 2010; Basciano et al., 2011; Forristal et al., 2013). 
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3.1 MATERIAL 
3.1.1 Patient selection 
This thesis summarizes a prospective, in vitro, and uncontrolled study. Teeth 
were extracted by dentists from the Department of Surgery of the Dental Clinic of 
the Faculty of Medicine and Odontology of the University of Valencia. 
All patients were informed of the characteristics of the study, and freely 
agreed to collaborate, donating the extracted tooth, which was always extracted for 
reasons not related to this study. They were properly informed and signed an 
informed consent together with the patient information sheet (Annexes 1 and 2). 
Throughout the study, patient anonymity and data protection were maintained. 
To perform this study, we used dental pulps of permanent teeth from 5 
patients, men and women between 14 and 25 years old. 
- Inclusion criteria: We included pulps from teeth that did not present any 
clinical and/or radiological sign or symptom of inflammation and/or 
infection. 
- Exclusion criteria:  We excluded all pulps from teeth that presented any 
clinical and/or radiological sign or symptom of the following clinical 
manifestations: pulpitis, apical periodontitis, periodontal disease, fractures 
affecting the dental pulp and those teeth in which a fracture occurred 
during the extraction.  
 
3.1.2 Dissection material 
For dental pulp extraction procedure, it was necessary to use the sterile 
dissection material detailed below: 
- Extra torque 605 Kavo® 
- Diamond cylindrical milling cutter 
- Curettes and tweezers Hu-Friedy 
- Scalpel nº10 
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3.1.3  Equipment 
 
CELL CULTURE 
- Cell culture hood Cultair B100 
- Incubator Thermoscientific HERAcell 150i CO2 
- Incubator Binder CB150 5% pCO2, 3% pO2 
- Water bath P Selecta Preciseterm 
- Inverted Microscope Zeiss ID03 
- Cell counter: Neubauer chamber 
- Sterilizer Selecta Autester-G 
- Precision weighing balance Sartorius Acculab (± 0.0001 g) 
- Centrifuge Sorvall Heraeus Multifuge 3SR plus (for Corning tubes) 
- Vacuum pump Millivac (Millipore) 
 
FLOW CYTOMETRY 
- The BD FACSVerse system includes the BD FACSVerse cytometer, the 
optional BD FACS Universal Loader, and BD FACSuite software running 
on the system workstation. The system includes customyzed steup beads. 
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
- The DIONEX Ultimate 3000 chromatograph (Thermo Scientific), includes 
a quaternary pump, an autoinyector, a UV-Vis detector, the Chromoleon 
software and the Hypersil GOLD column C18 5µm 175 A, 150 x 4.6 mm. 
 
PROTEIN QUANTIFICATION 
- Vortex Heidolph Reax top 
- Spectrophotometer Cecil, CE3021, 3000 series 
- Semi-micro cuvettes 
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WESTERN BLOT AND OXYBLOTTM 
- Weighing balance Gram Precision AHZ (± 0.01 g) 
- Stuart hot plate stirrer multiposition, SB162-3 
- Crison pHmeter, GLP21 
- Fume hood Burdinola, OR-ST 1200 
- Gel making kit:  
o Casting stand, casting frames, gaskets, releaser, glass plates and 
plastic combs (Bio-rad) 
- Electrophoresis kit:  
o Clamping frame with electrode assembly, tank and lid from Mini 
Protean® Tetra Cell (Bio-rad) 
- Transfer kit:  
o Gel holder cassette, filter paper, foam pads, core assembly module, 
tank and lid from Mini Trans-Blot® Cell (Bio-rad) 
- Power supply PowerPac Basic (Bio-rad) 
- Image Quant LAS 4000, GE_Healthcare Bio-Sciences 
 
RNA ISOLATION 
- Fume hood Crumair, 1100-G A 
- Centrifuge Hermle Z216MK (for Eppendorf tubes) 
- Centrifuge Hettich, 35 R (for Eppendorf tubes) 
- Stuart, Block heater, SBH 130 D 
- Spectrophotometer Thermoscientific NanoDrop 2000 
 
REVERSE TRANSCRIPTION 
- Centrifuge Sigma 1-14 (for Eppendorf tubes) 
- Thermal cycler GeneAmp® PCR system 9700 (Applied Biosystems) 
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POLYMERASE CHAIN REACTION 
- Plate centrifuge Eppendorf 5430 
- Thermal cycler 7900HT Fast Real-Time PCR System (Applied 
Biosystems) 
 
STORAGE 
- -80ºC freezer Revco ultima II 
- -80ºC freezer Platinum 500 
- -20ºC freezer Liebherr Comfort Nofrost 
- 2-4ºC refrigerator Lynx 
- Cryogenic freezer and CoolCell LX Freezing containers 
 
WATER PURIFICATION SYSTEM 
- Millipore, Milli-Q 
- Elga, purelab flex 
 
3.1.4 Additional supplies 
- Cell culture vessels (flasks, Petri dishes, multiwell plates) 
- Tubes (15 mL and 50 mL Cornings) 
- Eppendorfs (0.2 – 0.5 – 1.5 – 2 mL) 
- Cryotubes 
- Tips and pipettes 
- Glass pipettes and pipettors 
- Syringes and nylon membrane filters 0.2 µm 
- Waste containers 
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3.2 METHODS 
3.2.1 Cell culture 
3.2.1.1 Description 
Cell culture refers to the removal of cells from an animal and their 
subsequent growth in a favourable artificial environment. The cells may be 
removed from the tissue directly and disaggregated by enzymatic or mechanical 
means before cultivation.  
Primary culture refers to the stage of the culture after the cells are isolated 
from the tissue and proliferated under the appropriate conditions until they occupy 
all of the available surface (i.e., reach confluence). At this stage, the cells have to 
be subcultured (i.e., passaged) by transferring them to a new vessel with fresh 
growth medium to provide more room for continued growth.  
 
3.2.1.2 Reagents 
The necessary reagents for hDPSCs isolation, culture, passaging and 
cryopreservation are: 
• Krebs-Henseleit buffer + 2 mg/mL EDTA (Sigma) 
• Collagenase I and Dispase II (Sigma) 
• Thermolysin (Vitacyte) 
• Trypsin (Invitrogen) 
• Dulbecco’s modified Eagle® medium (DMEM) Low Glucose (1g/L) 
(GIBCO) 
• Inactivated Foetal Bovine Serum (FBS) (Invitrogen) 
• Penicillin/Streptomycin (P/S) 10,000 U/mL (GIBCO) 
• Dimetilsulfoxide (DMSO) (Sigma) 
• Dulbecco’s Phosphate Buffered Saline (PBS) (GIBCO) 
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3.2.1.3 Procedure: pulp extraction and hDPSCs isolation 
Dental pulp extraction was performed by cutting the extracted tooth at the 
level of the amelocementary line with a torque and a milling cutter. Once removed 
from the pulp chamber, the pulp was extracted with tweezers (Figure 3.1).  
 
 
Figure 3.1 Dental pulp extraction. 
 
Once extracted, the dental pulp was introduced into 15 mL Corning tubes 
with 1-2 mL of DMEM Low Glucose + 1% P/S. Between pulp extraction and its 
digestion, there was a time range of between 1h and 24h. During this time the pulp 
was stored at 4°C. hDPSCs were then isolated following this protocol: 
1. Mechanical disaggregation of the dental pulp tissue with the scalpel. 
2. Chemical disaggregation with Krebs-Henseleit buffer + 2 mg/mL EDTA 
for 10 min in a humid incubator at 37ºC, 5% pCO2 and 3% pO2. 
3. Centrifuge at 1000 g for 2 min. 
4. Enzymatic digestion during 40 min in a humid incubator at 37ºC, 5% pCO2 
and 3% pO2. Dilute enzymes on DMEM Low Glucose + 1% P/S: 
a. Collagenase I + Dispase II at a final concentration of 4 mg/mL. 
b. Thermolysin at a final concentration of 13 ng/mL. 
5. Centrifuge at 1000 g for 2 min. 
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6. Resuspend the pellet in new fresh complete media (DMEM Low Glucose + 
10% SBF + 1% P/S). 
7. Seed in T25 flask and incubate in humid incubator at 37ºC, 5% pCO2 and 
3% pO2. 
 
3.2.1.4 Cell culture conditions and cryopreservation 
Culture conditions vary widely for each cell type, but the artificial 
environment in which cells are cultured invariably consists of a suitable container 
containing a substrate or medium that supplies the essential nutrients (amino acids, 
carbohydrates, vitamins and minerals), growth factors, hormones and gases (pO2 
and pCO2), and regulates the physicochemical environment (pH, osmotic pressure 
and temperature).  
hDPSCs, like most cells, are anchorage dependent and must be cultured in a 
flask that provides them with a solid base to adhere to. When the culture reaches 
confluence, cells need to be passaged. The purpose of the passages is to provide 
them with more space so that they can continue to proliferate. In this case, cells are 
washed with PBS and then treated with trypsin (at an average of 1 mL per 5 cm2) 
to detach them. Finally, cells are transferred to a larger flask with complete 
medium.  
For serial passaging we used T75 flasks filled with 15 mL of complete 
medium, which can hold 2 to 3 million hDPSCs. Every 5 passages, we collected 
samples. In this case, we used T25 flasks filled with 5 mL of complete medium 
which can hold 1 to 1.5 million hDPSCs on confluence. The exact amount of cells 
will depend on the morphology of the cells; as passaging number increased, the 
larger, elongated, flattened and irregular the cells were. A total of 25 passages were 
accumulated by hDPSCs cultured at 3% pO2 while only 15 passages were reached 
by hDPSCs cultured at 21% pO2. Each 5 passages, by cell counting in the 
Neubauer chamber, an exact number of cells was seeded in T25 flasks to perform 
the relevant experiments. The T25 flasks with hDPSCs cultured at 3% pO2 were 
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initially seeded with 250,000 cells (50,000 cells/cm2), while hDPSCs cultured at 
3% pO2 were initially seeded with 325,000 cells (65,000 cells/cm2). This is 30% 
more cells, to compensate the loss of cells that do not adhere to the base of the 
flask after seeding.  
As soon as a small surplus of cells becomes available from subculturing, 
they should be frozen as a seed stock, protected, and not be made available for 
general laboratory use. The best method for cryopreserving cultured cells is storing 
them in liquid nitrogen in complete medium in the presence of a cryoprotective 
agent such as dimethylsulfoxide (DMSO). Cryoprotective agents reduce the 
freezing point of the medium and also allow a slower cooling rate, greatly reducing 
the risk of ice crystal formation, which can damage cells and cause cell death. 
hDPSCs surplus were cryopreserved at an average of 1.5 million cells in 1.8 mL of 
complete medium with 20% DMSO in each cryotube. 
 
3.2.2 Small-interfering RNA transfection (siRNA) 
3.2.2.1 Description 
Gene expression can be regulated at both transcriptional and post-
transcriptional levels (Hammond et al., 2001). 
Transcriptional Gene Silencing (TGS) is the result of DNA modification or 
histone alteration. These modifications create a heterochromatin environment 
around a certain gene, which prevents access of the transcriptional machinery 
(transcription factors, RNA polymerases, etc.) by repressing the expression of that 
gene. Post-Transcriptional Gene Silencing (PTGS), on the other hand, is a 
mechanism that involves the degradation of a specific messenger RNA (mRNA). 
The destruction of this mRNA prevents its normal translation and consequently the 
corresponding protein is not synthesized. 
We performed post transcriptional gene silencing. The molecular basis of 
this process can be divided into an initiation step and an effector and maintenance 
step. 
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Initiation step begins with the presence of a double-stranded RNA. It is 
recognized and digested by the Dicer enzyme, which possesses RNase type III 
domains (enzymes that degrade RNA molecules), to form small RNA molecules of 
21-24 nucleotides length. These RNAs were called small interference RNAs 
(siRNA); they are short double-stranded molecules that function as specific 
determinants in RNA-mediated gene silencing. 
During the effector step, the siRNA binds to a complex with nuclease 
activity (nucleic acid degrading enzymes) to form the RISC complex (RNA-
induced silencing complex). RISC is a ribonucleoprotein complex with sequence 
homology dependent endonuclease activity that is responsible for targeted RNA 
degradation. The RISC helicase activity separates the two strands from the siRNA, 
and only one of them remains attached to the complex. Once RISC is activated, it 
targets the degradation of mRNAs homologous to this siRNA. The RISC nucleus is 
composed of proteins belonging to the Argonaute family (AGO), being the best 
known AGO1. These proteins are fundamental partners in the mechanisms of 
interference RNA in various organisms (Figure 3.2).  
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Figure 3.2 Post-transcriptional siRNA mechanism. 
Taken from: Hammond et al. (2001). 
 
3.2.2.2 Reagents 
BMI-1 gene silencing was performed using the following reagents (Santa 
Cruz): 
• BMI-1 siRNA (h) 
• siRNA Control 
• siRNA Transfection Medium 
• siRNA Transfection Reagent 
 
3.2.2.3 Procedure 
The siRNA transfection protocol was completely performed in sterile 
ambient. 
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1. In a six well tissue culture plate, seed 2x105 cells per well in 2 mL DMEM 
Low Glucose + 10% FBS.  
2. Incubate the cells at 37°C in humid incubator at 37ºC, 5% pCO2 and 3% 
pO2 until the cells are 60-80% confluent. This will usually take 18-24 
hours.  
3. Prepare the following solutions:  
a. Solution A: For each transfection, dilute 3 µL of siRNA duplex 
into 100 µL siRNA Transfection Medium.  
b. Solution B: For each transfection, dilute 3 µL of siRNA 
Transfection Reagent into 100 µL siRNA Transfection Medium.  
4. Add the siRNA duplex solution (Solution A) directly to the dilute Trans- 
fection Reagent (Solution B) using a pipette. Mix gently by pipetting the 
solution up and down and incubate the mixture 15-45 minutes at room 
temperature.  
5. Wash the cells once with 2 mL of siRNA Transfection Medium. Aspirate 
the medium and proceed immediately to the next step.  
6. For each transfection, add 0.8 mL siRNA Transfection Medium to each 
tube containing the siRNA Transfection Reagent mixture (Solution A + 
Solution B). Mix gently and overlay the mixture onto the washed cells.  
7. Incubate the cells 5-7 hours in a humid incubator at 37ºC, 5% pCO2 and 3% 
pO2.  
8. Add 1 mL of normal growth medium containing 2 times the normal serum 
and antibiotics concentration (2X normal growth medium) without 
removing the transfection mixture. 
9. Incubate the cells for an additional 18-24 hours. 
10. Aspirate the medium and replace with fresh 1X normal growth medium. 
11. Assay the cells using the appropriate protocol 24-72 hours after the addition 
of fresh medium in the step above.  
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3.2.3 Flow cytometry 
3.2.3.1 Description 
Flow cytometers are powerful analytical instruments that measure certain 
optical properties of particles in flow. A flow cytometer can measure these optical 
properties from any kind of particle as long as it (1) meets certain size 
requirements, and (2) the particles can be prepared as single cell suspensions.  
Additionally, particles must flow through the instrument to be analysed, so they 
must be prepared as a single-particle suspension.  
Flow cytometers typically measure two distinct kinds of optical signals from 
a particle, light scattering and fluorescence. 
Light scattering: Scattering occurs when light interacts with a cell and 
changes its direction as a result of this interaction. Flow cytometers measure two 
kinds of light scattering: forward scatter and side scatter. Forward scatter is 
measured at 180° relative to the illuminating light and is correlative (but not a 
direct measurement of) cell size. Side scatter is collected at 90° relative to the 
illuminating light and is correlative (but also not a direct measurement of) to cell 
granularity or membrane roughness.  
Fluorescence: Fluorescence occurs when molecules are excited by specific 
colours of light and then emit specific colours of lower energy light. When we 
measure fluorescence with a flow cytometer, we essentially measure the intensity 
of specific colours of light emitted by a particle. Flow cytometers can measure 
many different fluorescent signals from a single particle at once. The ability to 
measure many fluorescent signals at once from single particles is what gives this 
technique its power.  
The aspects of a cell that are measured using flow cytometry are called 
parameters. Certain parameters are intrinsic to the cell and others are extrinsic. 
Intrinsic parameters, such as cell size (forward scatter) or cell granularity (side 
scatter) do not require any special reagent to measure. Extrinsic parameters, require 
fluorescent molecules, or probes, to measure (Wood and Hoffman, 1998).  
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A flow cytometer consists of three systems that merge in the instrument to 
accomplish these goals (Figure 3.3):  
- The fluidics system functions to facilitate the transport of particles to the 
analysis point. This system is based on pressure and accomplishes both the 
delivery of particles to the optical interrogation point as well as the 
focusing of particles for single cell analysis. 
- The optical system consists of two sub-systems: the illumination optics 
and the collection optics. The illumination optics are lasers and mirrors 
and lenses that focus these lasers into the particles. The collection optics 
consists of arrays of mirrors and optical filters that direct light to the 
detectors. 
- The electronic system transforms the optical signal into an electronic 
signal and then further process this electronic signal so that it can be output 
as data that is understandable and interpretable. 
 
Figure 3.3 Flow cytometer components. 
Taken from: Wood and Hoffman (1998). 
 
Flow cytometry data is displayed in graphical format as either one-parameter 
histograms (on the right) or two-parameter histograms. The axes corresponding to 
the parameter are labelled with each data bin. In the plot on the right, the x-axis 
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lists the channel values for the forward scatter parameter. The scaling of the x-axis 
is linear. In other words, the intervals increase in a linear fashion. The y-axis is 
marked by number of cells. Therefore, we can get a graphical representation of cell 
count per data channel. We can see that most of the cells (the tallest peak 
corresponding to the biggest cell count) is at about channel 75,000. We can also 
see there is a distribution of cells in a wide range of channel values.  
 
3.2.3.2 Reagents 
A fluorescent compound absorbs light energy over a range of wavelengths 
that is characteristic for that compound. This absorption of light causes an electron 
in the fluorescent compound to be raised to a higher energy level. The excited 
electron quickly decays to its ground state, emitting the excess energy as a photon 
of light. This transition of energy is called fluorescence.  
The range over which a fluorescent compound can be excited is termed its 
absorption spectrum. As more energy is consumed in absorption transitions than is 
emitted in fluorescent transitions, emitted wavelengths will be longer than those 
absorbed. The range of emitted wavelengths for a particular compound is termed 
its emission spectrum.  
When a fluorescent dye is conjugated to a monoclonal antibody, it can be used to 
identify a particular cell type based on the individual antigenic markers of the cell. 
They can also represent specific components of cells such as organelles, enzymes 
or surface markers. 
The following stainings used for hDPSCs analysis by flow cytometry are 
listed below. For ROS detection ROS, we used dihydrorhodamine-123 marker; for 
the analysis of the mitochondrial membrane potential (ΔΨm), the methyl ester 
tetramethylrodamine (TMRM) was used; and finally, for the determination of SA-
β-galactosidase activity, the combination of two dyes, the fluorescein di-β-
galactopyranoside and the propidium iodide (PI), were used. All were purchased 
from Molecular Probes (Thermo Fisher Scientific). 
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• Dihydrorodamine-123 (DHR123) 
Dihydrorhodamine-123 is a non-charged and non-fluorescent dye for reactive 
oxygen species (ROS) that can passively diffuse through membranes where 
rhodamine 123 is oxidized, acquiring a cationic character, located in the 
mitochondria and showing green fluorescence. 
• Tetramethylrodamine methyl ester (TMRM) 
Tetramethylrodamine methyl ester (TMRM) is a red-orange fluorescent cationic 
dye that penetrates the cell, and where active mitochondria easily sequester.  
• Fluorescein di-β-D-galactopyranoside (FDG) 
Non-fluorescent FDG is sequentially hydrolyzed by β-galactosidases, first to 
fluorescein monogalactoside and then to highly fluorescent fluorescein. The 
enzyme-mediated hydrolysis of FDG is proportional to the increase in 
fluorescence. 
• Propidium iodide (PI) 
Propidium iodide (PI) is a popular chromosomal or nuclear fluorescent folk 
counterpart. As propidium iodide is not permeable to living cells, it is often used to 
detect dead cells in a population. PI binds to DNA by intercalation between bases 
with little or no sequence preference. 
 
Figure 3.4 shows the excitation and emission spectra of these four 
molecules. Note that they are curves, which means that they absorb and emit 
photons in a range of wavelengths. This allows the selection of flow cytometer 
detectors; DHR-123 and FDG have very similar spectra and will be recognized by 
the fluorescein isothiocyanate (FITC) detector, which receives the light of 530/30 
nm. Similarly, the TMRM and the PI will be recognized by the phycoerythrin (PE) 
detector, which collects 575/26 nm light.  
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Figure 3.4 Fluorochromes excitation and emission spectra. 
 
Table 3.1 summarizes the fluorochromes used according to their 
corresponding detectors and fluorescent channel. 
 
Table 3.1 Fluorochromes and detectors correlation. 
FLUORO-
CHROME 
FLUORESCENCE 
CHANNEL 
DETECTOR EXCITATION 
maximum 
EMISSION 
maximum 
DHR123 
GREEN FITC 494 nm 519 nm 
FDG 
TMRM 
YELLOW PE 564 nm 
578 nm 
PI 636 nm 
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3.2.3.3 Procedure 
Staining protocol using FDG and PI: 
1. Treat cells with trypsin until they can be removed from the plate by gentle 
agitation. Inactivate trypsin by washing in staining medium (PBS, 4% (v/v) 
FBS, 10 mM HEPES, pH 7.2). 
2. Centrifuge at 1000 g for 2 min. 
3. Resuspend cells in staining medium to ~ 107 cells/mL and pipet 100 µL into 
an appropriate flow cytometer tube. Place cells on ice. 
4. Prepare a 2 mM working solution: thaw and dilute the FDG reagent 10-fold 
in water. Prewarm the FDG working solution to 37ºC for 10 minutes prior 
to use.  
5. Prepare staining medium with 1.5 µM (1 µg/mL) propidium iodide by 
diluting the PI reagent 100-fold in staining medium. Chill on ice.  
6. Prewarm the tube containing 100 µL of cells in a 37ºC water bath for 10 
minutes. 
7. Start FDG loading by adding 100 µL of prewarmed (37ºC) 2 mM FDG 
working solution. Mix rapidly. Return to the 37ºC water bath for exactly 
one minute.  
8. Stop the FDG loading at the end of one minute by adding 1.8 mL ice-cold 
staining medium containing 1.5 µM PI. Use ice-cold pipettes to aliquot the 
staining medium into the cells. Keep the cells on ice prior to flow 
cytometry analysis.  
 
Staining protocol using DHR123 and TMRM: 
1. Treat cells with trypsin until they can be removed from the plate by gentle 
agitation. Inactivate trypsin by washing in tissue culture growth medium. 
2. Centrifuge at 1000 g for 2 min. 
3. Resuspend the cells in complete medium (250,000 cells/mL). 
4. Pipet 500 µL into an appropriate flow cytometer tube. 
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5. Add DHR123 at a final concentration of 200 µg/mL or add TMRM at a 
final concentration of 100 µg/mL. 
6. Incubate for 30 min in a dark incubator at 37ºC prior to flow cytometry 
analysis. 
 
3.2.4 High performance liquid chromatography (HPLC) 
3.2.4.1 Description 
The components of a basic high performance liquid chromatography 
(HPLC) system are shown in the simple diagram in Figure 3.5. 
 
Figure 3.5 High performance liquid chromatography system. 
 
A reservoir holds the solvent (called the mobile phase). A high-pressure 
pump (solvent delivery system) is used to generate and meter a specified flow rate 
of mobile phase, typically millilitres per minute. An injector is able to introduce 
the sample into the continuously flowing mobile phase stream that carries the 
sample into the HPLC column. The column contains the chromatographic packing 
material needed to effect the separation. This packing material is called the 
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stationary phase because it is held in place by the column hardware. A detector is 
needed to see the separated compound bands as they elute from the HPLC column. 
The mobile phase exits the detector and can be sent to waste, or collected, as 
desired. When the mobile phase contains a separated compound band, HPLC 
provides the ability to collect this fraction of the elute containing that purified 
compound for further study. 
We followed Wong and colleagues method (Wong et al., 1987). This 
method is based on the detection of the hydrolysis of the lipoperoxides and 
subsequent formation of an adduct between 2-thiobarbituric acid and 
malondialdehyde (TBA-MDA2) by HPLC. This reaction produces a pink 
chromogen with a maximum absorption at 532-535 nm.  
 
3.2.4.2 Reagents 
1. 50 mM Potassium phosphate-EDTA (KPi-EDTA) buffer 
• Prepare 25 mL of 50 mM K2HPO4 pH 6.8. 
• Prepare 25 mL of 50 mM KH2PO4 pH 3.5. 
• Mix them at about 4:1 until pH 7.4. 
• Add EDTA at a final concentration of 0.1 mM. 
2. 2 M Sodium acetate buffer with 0.2% TBA 
• Prepare 1 L of 2 M sodium acetate pH 6.8. 
• Add 0.2% TBA and mix until complete dissolution. 
3. Standards and standard curves preparation 
• Calibration MDA standards shall be prepared ahead of time for each 
analyte of interest. The calibration standards prepared for each analyte 
shall include not less than a two low end concentrations, two different 
mid-range concentrations, and a high end concentration for a total of five; 
this range of concentration values should bracket the expected range of 
concentrations in the sample. We used 50 – 25 – 12.5 – 6.25 – 3.125 – 
1.562 – 0.781 nmol/mL concentrations. 
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4. Mobile phase preparation. We performed an isocratic method, thus we used 
two different mobile phases: 
• The elution phase (phase A) composition was 50 mM KH2PO4-
acetonitrile (83:17) pH 6.8. 
• The washing phase (phase B) composition was a mixture of acetonitrile 
and purified water both at 70%. 
• All solvents were filtered through a 0.22 µm Millipore filter before use 
and degassed in an ultrasonic bath. 
 
3.2.4.3 Procedure 
1. Derivatization procedure 
• Cell samples should be collected with 200 µL of KPi-EDTA buffer. 
• Mix 500 µL of Sodium acetate TBA buffer with 20 µL of sample or 
standard. 
• Incubate 1 hour at 95ºC. 
• Centrifuge at 13,000 rpm for 5 min at 4ºC. 
• Pipet 200 µL of supernatant and proceed to HPLC analysis. 
2. Chromatographic conditions 
• Flow rate: 1.0 mL/min 
• UV-visible detection at λ 532 nm 
• Reversed-phase C8 column 
3. Chromatographic method  
• Each chromatogram took 30 minutes; the established sequence of mobile 
phases is detailed below (Table 3.2):  
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Table 3.2 HPLC mobile phases sequence. 
PHASE A PHASE B PHASE A 
Sample elution Colum wash Column restoration 
12 minutes 10 minutes 8 minutes 
  
 
3.2.4.4 Data analysis 
HPLC method displays results as a graphical chromatogram in Chromoleon 
software. The area under the curve (AUC) corresponding to the TBA-MDA2 
adduct is measured and compared with the standard curve. Results are presented as 
moles of MDA / mg of total protein.  
 
3.2.5 Lowry method for protein quantification 
3.2.5.1 Description 
The most accurate method of determining protein concentration is probably 
acid hydrolysis followed by amino acid analysis. This procedure has no exception, 
but its sensitivity is moderately constant from protein to protein, and it has been so 
widely used that Lowry protein estimations are a completely acceptable alternative 
to a rigorous absolute determination in almost all circumstances in which protein 
mixtures or crude extracts are involved.  
The method is based on both the Biuret reaction, in which the peptide bonds 
of proteins react with copper under alkaline conditions to produce Cu+, which 
reacts with the Folin reagent, and the Folin Ciocalteu reaction, in which 
phosphomolybdotungstate is reduced to heteropolymolybdenum blue by the 
copper-catalysed oxidation of aromatic amino acids. The reactions result in a 
strong blue colour, which depends partly on the tyrosine and tryptophan content. 
The method is sensitive down to about 0.01 mg of protein/mL, and is best used on 
solutions with concentrations in the range 0.01–10 mg/mL of protein.  
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3.2.5.2 Reagents 
The Lowry method for protein quantification needs the following reagents:  
• Bovine Serum Albumine (BSA) 
• Deionized Milli-Q water 
• Lowry reagent (Sigma-Aldrich) 
• Folin and Ciocalteu’s phenol reagent (Sigma-Aldrich) 
 
3.2.5.3 Procedure 
Prepare the solutions: 
1. Lowry solution 
• Add 40 mL of deionized purified water to the powdered Lowry reagent, 
cover it from light, and mix for 30 minutes, according to manufacturer’s 
instructions. 
2. Folin solution 
• Add 90 mL of deionized purified water to 18 mL of the Folin and 
Ciocalteu’s phenol reagent 2 M, according to manufacturer’s instructions.  
3. BSA standard protein solution 
• Weigh 50 mg of BSA and add it to a flask containing purified water. 
• Stir well to dissolve and adjust the volume to 50 mL with purified water: 
final concentration of the stock is (10 mg/mL). 
• Make serial dilutions in Eppendorf tubes for the standard curve: 0 – 0.01 
– 0.1 – 0.5 – 1 – 2.5 – 10 mg/mL. 
 
Then proceed to the Lowry method for protein quantification: 
1. Vortex all samples and BSA dilutions. 
2. Add 490 µL of purified water and 10 µL of sample or BSA dilution. 
Vortex briefly. 
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3. Add 500 µL of Lowry solution, vortex briefly and incubate for 20 minutes 
in the dark at room temperature. 
4. Add 250 µL of Folin solution, vortex briefly and incubate for additional 30 
minutes in the dark at room temperature. 
5. Transfer the samples to the cuvettes and read absorbance at 660 nm 
starting with blank template. 
 
3.2.5.4 Data analysis 
Light absorption by a substance is a characteristic property of each 
substance, which can be used for its identification and quantification. All 
substances absorb light in some region of the electromagnetic spectrum (VIS, UV, 
IR, etc.). There are different methods for proteins quantification. Many of these 
methods are based on: the property of proteins to absorb light in the UV, the 
formation of chemical derivatives, or the ability of proteins to bind certain dyes. 
Lambert and Beer demonstrated that the absorbance (A) of a substance is 
directly proportional to the concentration (c) of the absorbing substance, the length 
of the light path (l) (thickness of the solution) and a constant called extinction 
coefficient (ε), which is characteristic for each substance at a given wavelength (λ). 
A = ε  . l . c 
The standard curve is obtained by measuring the absorbance of a series of 
solutions of known BSA concentrations treated with the same method and 
measured at the same wavelength in the same instrument. The result is expressed 
on a plot of absorbance (A) as a function of concentration (c). As the Lowry 
method follows Lambert-Beer's law (Stauffer, 1975), a straight line passing near 
the origin is obtained. The linear part is selected and the linear regression line that 
best fits is calculated and the absorption data of our samples are interpolated.  
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3.2.6 Specific protein determination 
3.2.6.1 Description 
Electrophoresis is a transport under the action of an electric field. 
Electrophoresis in gels with a polyacrylamide matrix, commonly referred to as 
polyacrylamide gel electrophoresis, is mostly used for protein separation. 
Specifically, SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) was used under denaturing conditions. For the realization of this 
technique it is imperative that the proteins are completely denatured. To do this, we 
use two denaturants, sodium dodecyl sulfate (SDS) as detergent and 2-
mercaptoethanol as a reducing agent, which causes disulfide bridges to rupture. In 
this way proteins are obtained in their primary structure. 
In the presence of an SDS concentration greater than 8 mM, the proteins 
bind 1.4 g SDS per gram of protein, which is equivalent to the binding of one SDS 
molecule per 2 amino acids. The charges of the proteins are thus masked or 
nullified. As each SDS molecule provides a negative charge, the protein / SDS 
complexes are negatively charged uniformly, so that the separation depends on the 
charge and molecular weight of the different proteins. 
Once separated, they are transferred to a membrane where detection of a 
particular protein is possible by incubation with specific antibodies. 
 
3.2.6.2 Reagents 
To perform western blot of specific protein, we used the reagents detailed 
below: 
• Lysis buffer (TRIS/SDS/Glicerol), supplemented with proteases 
inhibitor, bromophenol blue and 2-mercaptoethanol 
• Gel preparation: Acrilamide/bisacrilamide (40% w/v, 29:1), 0.5 M TRis 
at pH 6.8, 1.5 M Tris at pH 8.8, Milli-Q water, 10% SDS, 10% APS and 
TEMED
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• Running buffer (25 mM Tris, 200 mM Glycin, 0.1% SDS, pH 8.3) 
• Transfer buffer (25 mM Tris, 192 mM Glycin, 20% (v/v) Methanol, pH 
8.3) 
• Blocking buffer (5% BSA in TBS-T) 
• Washing buffer TBS-T (0.1% Tween-20 in 1X TBS (20 mM Tris, 137 
mM NaCl, pH 7.6) 
• Nitrocellulose or PVDF Membranes 
• Primary antibodies: 
o BMI-1 antibody (Santa Cruz Biotechnology) 
o Tubulin antibody (Santa Cruz Biotechnology) 
• Secondary antibodies: 
o Goat Anti-Mouse IgG, Peroxidase Conjugate (Merk Millipore) 
o Anti-Rabbit IgG, HRP-linked (Cell Signaling) 
• Chemiluminescent reagent: Luminata Classico Western HRP Substrate 
(Millipore) 
 
3.2.6.3 Gel electrophoresis and protein transfer 
We prepared gels at a 12.5% polyacrylamide final concentration. Then, we 
loaded prepared samples into wells in volumes corresponding to 30 µg in each 
well.  
Electrophoresis was performed in running buffer at 120 V constant voltage 
until the forefront of the protein ladder almost reached the foot line of the glass 
plate.  
Finally, separated proteins were transferred to a PVDF membrane in transfer 
buffer. Blotting transfer was performed at 170 mA per membrane for 1 hour in 
cold conditions.   
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3.2.6.4 Blocking, antibody incubation and detection 
1. Incubate the membrane in blocking buffer for 1 hour with gentle shaking. 
2. Wash the membrane with 1X PBS-T once for 15 min, then twice for 5 min 
each. 
3. Dilute the primary antibody following manufacturer’s instructions in 
blocking buffer. Incubate the membrane overnight at 4ºC with gentle 
shaking. 
4. Wash the membrane as in step 2. 
5. Dilute the secondary antibody following manufacturer’s instructions in 
blocking buffer. Incubate the membrane for 1 hour at room temperature 
with gentle shaking. 
6. Wash the membrane as in step 2. 
7. Drain the excess buffer from the membrane, place it on a plastic sheet with 
the protein side up. Prepare the chemiluminescent reagents according to 
manufacturer's directions just before use. Make just enough to cover the 
membrane with chemiluminescent reagent. 
8. Incubate for 1 min in the dark prior to exposure and analysis. 
Figure 3.6 summarizes the whole western blot procedure. 
 
Figure 3.6 Western blot workflow. 
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3.2.6.5 Data analysis 
Images obtained were stored in ".tif" digital format in order to perform the 
densitometry using "Image J" software. The values of the proteins studied were 
expressed in relation to the values obtained from α-tubulin in the same samples. 
This protein is part of the microtubules of eukaryotic cells, without significant 
changes in the different organisms (Little and Seehaus, 1988; Doolittle, 1992). 
Since it is a protein that is not altered, it is a good reference to control that the same 
amount of protein of each of our samples has been loaded during the experiment.  
 
3.2.7  Carbonylated protein determination 
3.2.7.1 Description 
Oxidative modification of proteins by oxygen free radicals and other 
reactive species occurs in physiologic and pathologic processes. As a consequence 
of the modification, carbonyl groups are introduced into protein side chains by a 
site-specific mechanism. The carbonyl groups in the protein side chains are 
derivatized to 2,4-dinitrophenylhydrazone (DNP-hydrazone) by reaction with 2,4-
dinitrophenylhydrazine (DNPH). The DNP-derivatized protein samples are 
separated by polyacrylamide gel electrophoresis followed by western blot.  
 
3.2.7.2 Reagents 
To perform western blot of protein carbonylation, we used OxyblotTM 
Protein Oxidation Detection Kit (Merk Millipore), which includes these reagents: 
• 1X 2,4-Dinitrophenylhydrazine (DNPH) solution 
• Neutralisation solution 
• 1X Derivatization control solution 
• 12% SDS 
• Blocking buffer (1% BSA in PBS-T) 
• Washing buffer PBS-T (0.05% Tween-20 in 1X PBS (pH 7.2-7.5) 
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• Primary antibody: Rabbit Anti-DNP 
• Secondary antibody: Goat Anti-Rabbit IgG (HRP-conjugated) 
 
3.2.7.3 Procedure 
It is recommended that a reducing agent, such as either 1-2% 2-
mercaptoethanol or 50 mM DTT, be added to the lysis buffer to prevent the 
oxidation of proteins that may occur after cell lysis.  
1. Transfer 5 µL of a protein sample into Eppendorf tubes. 
2. Denature each 5 µL aliquot of protein by adding 5 µL of 12% SDS for a 
final concentration of 6% SDS. 
3. Derivatize the sample by adding 10 µL of 1X DNPH Solution.  
4. Incubate tubes at room temperature for 15 minutes. 
5. Add 7.5 µL of Neutralization Solution. 
6. Samples are ready to load into a polyacrylamide gel. 
7. Proceed as in 3.2.6.3. and 3.2.6.4 following manufacturer’s instructions. 
 
3.2.8 RNA isolation 
3.2.8.1 Description 
TRIzol® Reagent is a ready-to-use reagent, designed to isolate high quality 
total RNA (as well as DNA and proteins) from cell and tissue samples of human, 
animal, plant, yeast, or bacterial origin, within one hour. TRIzol® Reagent is a 
monophasic solution of phenol, guanidine isothiocyanate, and other proprietary 
components which facilitate the isolation of a variety of RNA species of large or 
small molecular size.  
TRIzol® Reagent maintains the integrity of the RNA due to highly effective 
inhibition of RNase activity while disrupting cells and dissolving cell components 
during sample homogenization (Chomczynski and Sacchi, 1987). After 
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homogenizing the sample with TRIzol® Reagent, chloroform is added, and the 
homogenate is allowed to separate into a clear upper aqueous layer (containing 
RNA), an interphase, and a red lower organic layer (containing the DNA and 
proteins). RNA is precipitated from the aqueous layer with isopropanol. DNA is 
precipitated from the interphase/organic layer with ethanol. Protein is precipitated 
from the phenol-ethanol supernatant by isopropanol precipitation. 
 
3.2.8.2 Reagents 
The following additional reagents are needed: 
• TRIzol® buffer 
• Chloroform  
• Isopropyl alcohol  
• 75% ethanol (in DEPC-treated water)  
• RNase free water or 0.5% SDS  
 
3.2.8.3 Procedure 
1. Homogenizing adherent cells (monolayer) 
• Remove growth media from culture dish.  
• Add 1 mL TRIzol® Reagent directly to the cells in the culture dish per 
10 cm2 of culture dish surface area.  
• Lyse the cells directly in the culture dish by pipetting the cells up and 
down several times.  
2. Phase separation 
• Incubate the homogenized sample for 5 minutes at room temperature to 
permit complete dissociation of the nucleoprotein complex.  
• Add 0.2 mL of chloroform per 1 mL of TRIzol® Reagent used for 
homogenization. Cap the tube securely.  
• Shake tube vigorously by hand for 15 seconds.  
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• Incubate for 2-3 minutes at room temperature. 
• Centrifuge the sample at 12,000 g for 15 minutes at 4°C. The mixture 
separates into a lower red phenol-chloroform phase, an interphase, and a 
colourless upper aqueous phase. RNA remains exclusively in the aqueous 
phase. The upper aqueous phase is ~50% of the total volume.  
• Remove the aqueous phase of the sample by angling the tube at 45° and 
pipetting the solution out.  
• Place the aqueous phase into a new tube. 
3. RNA precipitation 
• Add 0.5 mL of 100% isopropanol to the aqueous phase, per 1 mL of 
TRIzol® Reagent used for homogenization.  
• Incubate at room temperature for 10 minutes. 
• Centrifuge at 12,000 g for 10 minutes at 4°C. The RNA is often invisible 
prior to centrifugation, and forms a gel-like pellet on the side and bottom 
of the tube.  
4. RNA wash 
• Remove the supernatant from the tube, leaving only the RNA pellet.  
• Wash the pellet, with 1 mL of 75% ethanol per 1 mL of TRIzol® 
Reagent used in the initial homogenization.   
• Vortex the sample briefly, then centrifuge the tube at 7500 g for 5 
minutes at 4°C. Discard the wash.  
• Air dry the RNA pellet for 5-10 minutes.  
5. RNA resuspension 
• Resuspend the RNA pellet in RNase free water or 0.5% SDS solution 
(20-50 µL) by passing the solution up and down several times through a 
pipette tip.  
• Incubate in a water bath or heat block set at 55-60°C for 10-15 minutes.   
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3.2.8.4 RNA yield determination 
Absorbance measurements were made on a NanoDropTM 2000 
Spectrophotometer, which include the absorbance of all molecules in the sample 
that absorb at the wavelength of interest. Since nucleotides, RNA, ssDNA, and 
dsDNA all absorb at 260 nm, they will contribute to the total absorbance of the 
sample.  
• 260/280 ratio 
The ratio of absorbance at 260 nm and 280 nm is used to assess the purity of 
DNA and RNA. A ratio of ~1.8 is generally accepted as “pure” for DNA; a ratio of 
~2.0 is generally accepted as “pure” for RNA. If the ratio is appreciably lower in 
either case, it may indicate the presence of protein, phenol or other contaminants 
that absorb strongly at or near 280 nm.  
• 260/230 ratio 
This ratio is used as a secondary measure of nucleic acid purity. The 
260/230 values for “pure” nucleic acid are often higher than the respective 260/280 
values. Expected 260/230 values are commonly in the range of 2.0-2.2. If the ratio 
is appreciably lower than expected, it may indicate the presence of contaminants 
which absorb at 230 nm.   
 
3.2.9  cDNA reverse transcription 
3.2.9.1 Description 
Reverse transcription consists of obtaining a DNA copy (cDNA) from a 
messenger RNA (mRNA), the reverse process of transcription. For this, particular 
DNA polymerases, called reverse transcriptases are necessary. The enzymes used 
come from retroviruses, which are viruses that present RNA as a genome, rather 
than DNA. In order to express their proteins, they have to pass the information to 
DNA. To obtain the cDNA, a reverse transcription was performed using the 
Applied Biosystems kit “High-Capacity cDNA Reverse Transcription”. 
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3.2.9.2 Reagents 
The High Capacity cDNA reverse transcription kit includes the reagents: 
• 10X RT Buffer 
• 10X RT Random Primers 
• 25X dNTP Mix 
• MultiScribeTM Reverse Transcriptase 
• RNase inhibitor 
• RNase free water 
 
3.2.9.3 Procedure 
1. To prepare the 2X Reverse Transcription Master Mix: 
• Allow the kit components to thaw on ice.  
• Referring to the Table 3.3, calculate the volume of components needed to 
prepare the required number of reactions. Prepare it on ice. 
• Place the 2X RT master mix on ice and mix gently.  
Table 3.3 Reverse transcription components mixture. 
Component Volume / Reaction (µL) 
10X RT Buffer 2.0 
25X dNTP Mix (100 mM) 0.8 
10X RT Random Primers 2.0 
MultiScribe Reverse Transcriptase 1.0 
RNases Inhibitor 1.0 
Nuclease free water 3.2 
Total volume per reaction 10.0 
 
2. To prepare the cDNA RT reactions: 
• Pipet 10 µL of 2X RT master mix into each well of a 96-well plate. 
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• Pipet 10 µL of RNA sample into each well, pipetting up and down to 
mix.  
• Seal the plates. 
• Briefly centrifuge the plate or tubes to spin down the contents and to 
eliminate any air bubbles.  
• Place the plate or tubes on ice until ready to load the thermal cycler.  
3. To perform reverse transcription: 
• Program the thermal cycler conditions referring to the Table 3.4. 
• Set the reaction volume to 20 µL.  
• Load the reactions into the thermal cycler.  
• Start the reverse transcription run.  
Table 3.4 Temperature conditions in reverse transcription assay. 
 Step 1 Step 2 Step 3 Step 4 
Temperature 25ºC 37ºC 85ºC 4ºC 
Time 10 min 120 min 5 min ∞ 
 
 
3.2.10 Quantitative polymerase chain reaction (qPCR) 
3.2.10.1 Description 
The real-time polymerase chain reaction (RT-PCR) is a variant of the 
standard PCR, which is based on simultaneous detection and quantification of the 
fluorescence emitted by the PCR products that accumulate during the amplification 
process. 
The fluorescent substance used in our experiments is SYBR Green I, which 
binds to DNA and emits fluorescence only when two strands of DNA are 
complementarily attached. 
For quantitative PCR (qPCR), the measurement parameter of the expression 
of a given gene is not the fluorescence, but the cycle in which the amplification 
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begins to be exponential. This cycle is called the threshold cycle (Ct), since it is 
from which the amplification begins to be really appreciable (Figure 3.7). Thus, the 
threshold cycle values will decrease linearly as the amount of starting cDNA 
increases, since the more copies of starting mRNA of the gene being studied, the 
more cDNA will be obtained in the reverse transcription, and before the 
amplification will start to be exponential. 
 
Figure 3.7 The PCR threshold cycle value. 
 
3.2.10.2 Reagents 
Maxima SYBR Green/ROX qPCR Master Mix (2X) is a ready-to-use 
solution optimized for quantitative real-time PCR. The master mix includes 
Maxima Hot Start Taq DNA Polymerase and dNTPs in an optimized PCR buffer. 
It contains SYBR Green dye and is supplemented with ROS passive reference dye. 
Only template and primers need to be added. Maxima Hot Start Taq DNA 
Polymerase in combination with an optimized buffer ensure PCR specificity and 
sensitivity. The SYBR Green intercalating dye allows for DNA detection and 
analysis without using sequence-specific probes. 
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1. Gently vortex and briefly centrifuge all solutions after thawing. 
2. Prepare a reaction master mix by adding the following components as listed 
in Table 3.5 (except template DNA) for each reaction to a tube on ice. 
 Table 3.5 qPCR components mixture. 
Component Volume / Reaction (µL) 
MAXIMA SYBR Green/ROX  
qPCR Master Mix (2X) 5.0 
Primer sense 0.3 
Primer antisense 0.3 
DNA template 1.0 
RNase free water 3.4 
Total volume per reaction 10.0 
 
3. Mix the master mix thoroughly and dispense 9 µL into each well of the 
PCR plate. 
4. Add template DNA (≤ 500 ng/reaction) to each of the individual wells 
containing the master mix. 
5. Gently mix the reactions without creating bubbles (do not vortex). 
Centrifuge briefly if needed. 
6. Program the thermal cycler according to the recommendations below, place 
the samples in the machine and start the program (Table 3.6). 
Table 3.6 Thermal cycling conditions in qPCR assay. 
Step Temperature (ºC) Time Number of cycles 
Initial denaturation 95 10 min 1 
Denaturation 95 15 sec 
40 Annealing 60 30 sec 
Extension 72 30 sec 
 
Material and methods 
 88 
The "primers" used for the determination of gene expression levels were 
designed using the GCG program from the gene sequences obtained in the 
"Genebank" of PubMed. For each of the genes to be studied, the following 
sequences are listed in Table 3.7.  
Table 3.7 Gene primers: sense and antisense sequences. 
PRIMER Sense sequence Antisense sequence 
BMI-1 GCATCACAGTCATTGCTGCT CAGGGCTTTTCAAAAATGA 
SOX2 CTCGTCGATGAACGGCCGCT AAAACAGCCCGGACCGCGTC 
OCT4 GACTCCTGCTTCACCCTCAG GATCCTCGGACCTGGCTAAG 
c-MYC CGTCGTCCGGGTCGCAGATG CGCCCTCCTACGTTGCGGTC 
KLF4 CAGGTCCAGGAGATCGTTGAA CCCACATGAAGCGACTTCCC 
p14ARF CATCATGACCTGGTCTTCTAGGAA CCCTCGTGCTGATGCTACTG 
p16INK4a GGTTGTGGCGGGGGCAGTT GGGGGCACCAGAGGCAGT 
GAPDH TCCACCACCCTGTTGCTGTA TGAACGGGAAGCTCACTGG 
 
 
3.2.10.3 Procedure 
The thermo cycling reaction begins once the PCR reagents are put into a 
thermo cycler machine, which is programmed to precisely heat and cool the 
reaction. 
The PCR cycle begins with denaturation, which occurs for 20 to 30 seconds 
at 95°C, well above the melting temperature of DNA. The melting temperature is a 
state where half of the DNA is a double stranded helix and the other is a single 
stranded random coil. The denaturation temperature is well above the melting 
temperature, in order to ensure that all the hydrogen bonds between 
complementary base pairs are broken yielding only single stranded DNAs. Paired 
single strands are termed the sense and antisense strands. The sequence of the 
sense, or coding strand, is identical to the sequence of mRNA, which will 
ultimately code for protein. 
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In the second step, annealing, primers bind to the sense antisense strand. 
Depending on the length of primers used the annealing temperature for this step is 
usually 3 to 5°C below the lower melting temperature of your two primers. 
Annealing tends to occur between 50 and 65°C and lasts for 20 to 40 seconds. 
Once the primers bind to DNA they prime the reaction by creating a 3’ 
hydroxyl group end to which a polymerase, an enzyme that replicates DNA, will 
bind. 
The next step called elongation or extension occurs at 72°C, which is 
optimal for polymerase activity. Once bound the polymerase begins to add free 
nucleotide triphosphates, or dNTPs, to the ends of the primer one at a time in the 5’ 
to 3’ direction to make double stranded DNA. 
Once elongation completes the next cycle begins. The amount of amplicon 
will then increase exponentially in subsequent cycles. Figure 3.8 summarizes the 
qPCR procedure. 
 
 
Figure 3.8 The PCR cycle steps. 
 
Material and methods 
 90 
3.2.10.4 Data analysis 
When measuring gene expression, qPCR will tell how much of a specific 
mRNA there is in the samples. It amplifies a small region of this mRNA with 
oligos and a fluorescent probe. The qPCR machine measures the intensity of 
fluorescence emitted by the probe at each cycle. During the first cycles, there is not 
enough fluorescence to be detected, but the reaction rapidly produces more and 
more amplicons and the fluorescence builds up. As previously said, a qPCR curve 
has typically an exponential phase followed by a plateau phase. The cycle 
threshold (Ct) measure needs to be taken in the exponential phase, where the curve 
is linear.  
The Ct is defined as the number of cycles required for the fluorescent signal 
to cross the threshold (i.e., exceeds background level). Ct levels are inversely 
proportional to the amount of target nucleic acid in the sample (i.e., the lower the 
Ct level the greater the amount of target nucleic acid in the sample).  
- Cts < 29 are indicative of abundant target nucleic acid in the sample. 
- Cts of 30-37 are indicative of moderate amounts of target nucleic acid. 
- Cts of 38-40 are weak reactions indicative of minimal amounts of target 
nucleic acid which could represent an infection state or environmental 
contamination.  
The Relative Standard Curve experiment is used to determine relative target 
quantity in samples. In a Relative Standard Curve experiment: 
1. The software measures amplification of the target of interest and of an 
endogenous control target in a standard dilution series, in a reference 
(calibrator) sample, and in test samples. 
2. The endogenous control here used is GAPDH, which is a target that is 
expressed equally in all samples. 
3. The software generates standard curves for the target of interest and the 
endogenous control using data from the corresponding standard dilution 
series. 
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In order to have high efficiency, the slopes must be similar, since the 
efficiency of the amplification reaction is given by the following equation:  
Efficiency = [10 (-1 / slope)] – 1 
For a slope of -3.322 we obtain an efficiency of 100%, which means that the 
increase of one cycle of amplification during the exponential phase of the reaction 
supposes exactly the duplication of the amplified material. An amplification 
reaction should have an efficiency close to 100% to be optimized. 
4. Using the standard curves, the software interpolates the quantities of the 
target of interest and the endogenous control in each sample. The target 
quantity in each sample is then normalized to the sample’s endogenous 
control quantity. 
5. To determine the relative quantity of the target in test samples, the software 
divides the normalized target quantity in the sample by the normalized 
target quantity in the reference sample. 
 
3.2.11 Statistical analysis 
For statistical analysis, the IBM SPSS statistics program, version 19, has 
been used. A 95% confidence interval (p = 0.05) has been taken to accept that there 
is a statistically significant difference between the means of the groups. 
The T-Student test was used to compare 2 means, and the analysis of 
variance (ANOVA) if more than 2 means were compared with a variation factor. If 
the n of the groups to compare is not the same in all of them, the Scheffé 
comparison was been used. If the n of the groups to be compared is the same in all 
of them, it will depend on the homogeneity test of the variances (Levene test). If it 
is not significant, Tukey's post-hoc comparison, if meaningful, has been used by 
Games-Howell. 
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4.1 AMBIENT OXYGEN TENSION INDUCES OXIDATIVE STRESS IN 
hDPSCs LONG-TERM CULTURE 
It is well known that oxygen pressure (pO2) is a critical cell culture 
parameter which can cause oxidative stress. As previously mentioned, oxidative 
stress can damage DNA, carbohydrates, proteins and lipids. However, other 
molecular biological markers can also be measured to provide a more immediate, 
quantitative risk assessment of potentially deleterious environmental exposures. 
We first studied some parameters of oxidative stress in hDPSCs cultured 
under ambient oxygen tension compared to their physiological oxygen tension. 
Specifically, we assessed ROS production by dihydrorhodamine-123 (DHR123) 
staining, and mitochondrial membrane potential (ΔΨm) using 
tetramethylrhodamine methyl ester (TMRM) staining. We next analysed protein 
damage by measuring protein carbonylation and finally, lipid damage by setting 
malondialdehyde (MDA) levels.  
Antioxidant enzymes regulate the balance between production and/or 
accumulation of ROS and their neutralization. Under physiological conditions, this 
redox balance is maintained by various enzymes including superoxide dismutases 
(SOD), catalase, and glutathione peroxidases (GPx) (Halliwell and Gutteridge, 
1995). Thus, we also analysed the expression levels of those antioxidant enzymes.  
All those parameters were measured every 5 passages in hDPSCs cultured at 
3% or 21% pO2. 
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4.1.1 Reactive oxygen species (ROS) levels 
In the presence of high oxygen pressure, the formation of ROS is favoured 
(Ross et al., 2001) and in the presence of ROS, such as hydrogen peroxide, the 
non-fluorescent dye dihydrorhodamine-123 (DHR123) passively enters into the 
cells, and is oxidized to rhodamine-123 (R123), a cationic green fluorescent dye 
that can accumulate and localize into the mitochondria (O'Connell et al., 2002).  
We compared the extent of ROS production in hDPSCs grown at 3% or 21% 
pO2 along passages by flow cytometry. As shown in Figure 4.1, ROS levels were 
higher in hDPSCs cultured at 21% pO2 than in those cultured at 3% pO2. As 
passaging number raised, the intensity of DHR123 in hDPSCs increased under 
either both oxygen pressure percentage. However, less ROS were accumulated 
when cells were cultured under physiological oxygen tension. Thus, high oxygen 
tension may accelerate ROS accumulation in hDPSCs during long-term culture. 
 
Figure 4.1 Intracellular ROS levels in hDPSCs cultured at 3% or 21% oxygen tension along passages.  
ROS levels measured using dihydrorhodamine-123 (DHR123) staining by flow cytometry. The data 
are shown as means ± SD (n=5). The statistical significance is expressed as ***p<0.001 for 3% pO2 
versus 21% pO2, ###p<0.001 versus 3% pO2 at passage 5 and &&&p<0.001 versus 21% pO2 at passage 
5. 
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4.1.2 Mitochondrial membrane potential 
Mitochondrial membrane potential (ΔΨm) is critical for maintaining the 
physiological function of the respiratory chain to generate ATP (Joshi and 
Bakowska, 2011). Fluorescence probes used to assess ΔΨm are single-wavelength 
indicators, which increase or decrease their fluorescence intensity, proportional to 
a stimulus that increases or decreases the levels of ΔΨm. In our case, cells were 
loaded with tetramethylrhodamine methyl ester (TMRM) prior to flow cytometry 
analysis.  
As we can observe in Figure 4.2, at 3% pO2, hDPSCs mitochondrial 
membrane potential values were significantly higher in comparison to 21% pO2. 
As cells were serially passaged, the ΔΨm dropped gradually. Such findings show 
that mitochondria depolarize during long-term culture, and high oxygen tension 
can precipitate such functional deterioration.  
 
Figure 4.2 Mitochondrial membrane potential in hDPSCs cultured at 3% or 21% oxygen tension 
along passages. 
Mitochondrial membrane potential determined using tetramethylrhodamine methyl ester (TMRM) 
staining by flow cytometry. The data are shown as means ± SD (n=5). The statistical significance is 
expressed as ***p<0.001 for 3% pO2 versus 21% pO2, ###p<0.001 versus 3% pO2 at passage 5 and 
&p<0.05 versus 21% pO2 at passage 5. 
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4.1.3 Protein carbonylation 
All amino-acid residues in the proteins are subjected to ROS attack 
(Stadtman, 1992). As a consequence, site-specific amino acid modification, peptide 
chain fragmentation, altered electric charge and increased susceptibility of proteins 
to proteolysis occur. Tissues injured by oxidative stress contain increased 
concentrations of carbonylated proteins, which is a widely used marker of protein 
oxidation (Moller and Kristensen, 2004). Protein carbonyl groups detection by 
western blot after their derivatization with 2,4-Dinitrophenylhydrazine (DNPH) is 
one of the most widely used measurement for protein oxidation. 
As shown in Figure 4.3, protein carbonylation levels increased along 
passages during long-term culture. hDPSCs cultured at 21% pO2 showed higher 
levels of protein carbonyls than those cultured at 3% pO2. Thus, high oxygen 
tension may accelerate the damage accumulation to proteins. 
 
Figure 4.3 Protein carbonylation in hDPSCs cultured at 3% or 21% oxygen tension along passages. 
Protein carbonylation levels assessed by western blot. The data are shown as means ± SD (n=5). The 
statistical significance is expressed as *p<0.05 for 3% pO2 versus 21% pO2, #p<0.05 versus 3% pO2 
at passage 5 and &p<0.05 versus 21% pO2 at passage 5. 
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4.1.4 Lipid oxidation 
Lipid peroxidation plays an important role in cell aging and is most likely to 
be a key factor in lowering membrane fluidity (Shigenaga et al., 1994). 
Malondialdehyde (MDA) is one of the final products of peroxidation of 
unsaturated fatty acids in phospholipids (Halliwell and Gutteridge, 1989). Lipid 
peroxidation determined as TBA-MDA2 adduct formation is an established 
method of accurately measuring oxidative damage to lipids (Nielsen et al., 1997).  
As shown in Figure 4.4, hDPSCs cultured at 21% pO2 displayed higher 
levels of MDA, which increased successively as passaging number did. In contrast, 
MDA levels in hDPSCs cultured at 3% pO2 were lower and remained stable all 
along the 25 passages. Thus, high oxygen tension may be a cause for the increasing 
lipid damage in hDPSCs. 
 
Figure 4.4 Lipid oxidation in hDPSCs cultured at 3% or 21% oxygen tension along passages. 
Malondialdehyde (MDA) levels determined by high performance liquid chromatography (HPLC). 
The data are shown as means ± SD (n=5). The statistical significance is expressed as *p<0.05 for 3% 
pO2 versus 21% pO2 and &p<0.05 versus 21% pO2 at passage 5. 
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4.1.5 Antioxidant gene expression 
Since ROS could potentially damage lipids, proteins and DNA, cells 
developed several defence mechanisms, which include antioxidant enzymes and 
targeted degradation pathways (Fan et al., 2008). Associated with their isoforms, 
manganese superoxide dismutase (MnSOD), catalase (CAT) and glutathione 
peroxidase (GPx), are easily induced by oxidative stress (Hermes-Lima and 
Zenteno-Savı ́n, 2002). The MnSOD decomposes superoxide radicals and produce 
H2O2. H2O2 is subsequently removed to water by CAT in the peroxisomes, or by 
GPx oxidizing GSH in the cytosol (Droge, 2002; Lee and Choi, 2003).  
The mRNA levels of antioxidant enzymes in hDPSCs at passage 5 were 
detected by qPCR and compared. Figure 4.5 shows that mRNAs levels of MnSOD, 
CAT and GPx were affected by oxygen tension. Apparently, more mRNAs of all 
three enzymes were observed in young hDPSCs cultured at 21% compared to 3% 
pO2, suggesting that these cells might need to increase their antioxidant 
mechanisms to face ROS accumulation since early stages.  
 
Figure 4.5 Antioxidant enzymes gene expression levels in hDPSCs cultured at 3% or 21% oxygen 
tension. 
MnSOD, GPx and CAT mRNA levels analysed by qPCR against housekeeping gene. The data are 
shown as means ± SD (n=5). The statistical significance is expressed as ***p<0.001 for 3% pO2 
versus 21% pO2. 
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4.2 OXIDATIVE STRESS INDUCES PREMATURE SENESCENCE 
UNDER AMBIENT OXYGEN TENSION DURING LONG-TERM 
CULTURE OF hDPSCs 
Long-term in vitro culture undergoes the risk of senescence (Fu et al., 2015). 
Therefore, we measured some senescence biomarkers in hDPSCs cultured at both 
oxygen pressures. We first analysed hDPSCs morphology and proliferation 
kinetics, then cells were stained for senescence-associated expression of β-
galactosidase by flow cytometry. 
 
4.2.1 hDPSCS morphology 
After a long period of in vitro culture, hDPSCs showed abnormalities typical 
of the Hayflick model of cellular aging. The cells varied in size and shape, the 
cytoplasm began to be granular with many cell inclusions, and debris was observed 
in the medium. However, as we can observe in Figure 4.6, hDPSCs cultured under 
ambient oxygen tension showed larger shapes at passage 15 than to those cultured 
at 3% pO2 at passage 25.  
 
Figure 4.6 Morphological changes of hDPSCs cultured at 3% or 21% oxygen tension.  
Optical microscope images (20x). 
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4.2.2 hDPSCS proliferation 
In order to examine long-term growth kinetics of hDPSCs culture, we 
performed serial passaging until culture exhaustion. hDPSCs from the same donor 
were separated and cultured at 21% or 3% pO2; the beginning of the serial 
passaging was the same in both conditions. As passage number increased, the cells 
cultured at 21% pO2 began to proliferate more slowly and the time between sub-
culturing doubled. As a consequence, we can see in Figure 4.7 that hDPSCs 
cultured under ambient oxygen tension barely achieved 15 passages while hDPSCs 
cultured under physiological oxygen tension reached 25 passages. This is the 
reason why all figures show data up to 15 passages when hDPSCs were cultured at 
21% pO2, and up to 25 passages when cultured at 3% pO2. 
Taken together, these facts suggest that after 25 passages, hDPSCs cultured 
in physiological oxygen tension were less senescent according to their morphology 
and their proliferative potential than those cultured at 21% pO2. Thus, hDPSCs 
cultured at standard culture condition, are prone to premature senescence upon 
serial passage.  
 
Figure 4.7 Proliferation potential of hDPSCs cultured at 3% or 21% oxygen tension. 
Passaging number achieved by hDPSCs cultured under both oxygen conditions. 
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4.2.3 Senescence-associated β-galactosidase (SA-β-Gal) activity 
SA-β-Gal is a commonly used senescence biomarker (Dimri et al. 1995; 
Debacq-Chainiaux et al. 2009). Accordingly, the increase in SA-β-Gal activity in 
senescent cells is likely due to an expansion of the lysosomal compartment, giving 
rise to an increase in β-galactosidase activity that can be measured also at 
suboptimal pH 6 (Kurz et al. 2000; Yang and Hu 2005; Lee et al. 2006).  
To confirm our morphological observations of senescence, cells were 
stained for senescence-associated expression of β-galactosidase and analysed by 
flow cytometry. The proportion of cells staining positive for such expression 
increased as passage number did (Figure 4.8) either at 3% and 21% pO2. However, 
hDPSCs cultured at 21% pO2 showed significantly higher levels of SA-β-Gal at all 
stages. This result confirms our morphological studies, suggesting that senescence 
increases with long-term culture, and is accelerated by ambient oxygen pressure.  
 
 
Figure 4.8 SA-β-Gal activity in hDPSCs cultured at 3% or 21% oxygen tension along passages. 
Senescence-associated β-galactosidase activity measured using FDG staining by flow cytometry. The 
data are shown as means ± SD (n=5). The statistical significance is expressed as ***p<0.001 for 3% 
pO2 versus 21% pO2, ###p<0.001 versus 3% pO2 at passage 5 and &&p<0.01 versus 21% pO2 at 
passage 5. 
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4.3 OXIDATIVE STRESS-INDUCED PREMATURE SENESCENCE 
(SIPS) IS MEDIATED BY p16INK4A PATHWAY 
It is now clear that many stimuli, including oxidative stress, cause cells to 
arrest growth with a senescent phenotype (Serrano et al., 1997; Dimri et al., 2000; 
Sherr and DePinho, 2000). In vitro, premature senescence can result from 
inadequate culturing conditions. When cells are explanted from an organism and 
placed in culture, they have to adapt to an artificial environment, characterized by 
abnormal concentrations of nutrients and growth factors and the presence of 
ambient oxygen levels, as well as the absence of surrounding cell types and 
extracellular matrix components. One or more of these conditions can induce a 
culture shock, resulting in stress-induced senescence (Kuilman et al., 2010). 
Long-term exit from the cell cycle is the central and indispensable marker 
for the identification of all types of cellular senescence in vitro. Cell cycle is 
controlled by the CDKN2A-CDKN2B locus, also known as the INK/ARF locus. 
This locus encodes 3 tumour suppressor genes; the CDKN2B gene encodes 
p15INK4b, and the CDKN2A gene encodes both p16INK4a and p14ARF. On one hand, 
p15INK4b and p16INK4a proteins inhibit cyclin D-dependent CDK4 and CDK6 to 
prevent phosphorylation of pRb, thus inhibiting the transcription of genes involved 
in the transition to S phase (importantly the pRb/E2F pathway), so regulating cell 
cycle progression (Yaswen et al., 2015). On the other hand, p14ARF protein binds to 
MDM2 E3 ubiquitin ligase to prevent p53 polyubiquitination and to facilitate p53 
activation and stabilization of p53 (Matheu et al., 2008). Finally, this leads to 
induction of various p53 target genes involved in cell cycle arrest and apoptosis. 
Both cascades commonly mediate the activation of the senescence program 
(Sharpless and Sherr, 2015). 
We therefore sought to determine which pathway, either p14ARF/MDM2/p53 
or p16INK4a/pRb/E2F, was mediating the oxidative stress-induced premature 
senescence of hDPSCs when culturing at 21% pO2.  
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4.3.1 p14ARF gene expression pattern 
p14ARF mRNA levels were assessed in hDPSCs cultured under both oxygen 
pressures and compared. As shown in the figure below, hDPSCs expressed p14ARF, 
but its levels remained unchanged along passages when cells were cultured at 3% 
pO2 as no statistical difference was detected (Figure 4.9). This result may suggest 
that p14ARF/MDM2/p53 pathway is not mediating the oxidative stress-induced 
premature senescence of hDPSCs cultured at 21% pO2.  
Furthermore, as we can see in the same figure, hDPSCs cultured under 
ambient oxygen tension showed a downregulation of p14ARF expression levels as 
passages accumulated. At passage 15, p14ARF levels of hDPSCs cultured at 21% 
pO2 are significantly lower than those of hDPSCs cultured at 21% pO2. 
 
Figure 4.9 p14ARF gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen tension. 
p14ARF mRNA levels determined by qPCR against housekeeping gene. The data are shown as means 
± SD (n=5). The statistical significance is expressed as *p<0.05 for 3% pO2 versus 21% pO2 and 
&&p<0.01 versus 21% pO2 at passage 5. 
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4.3.2 p16INK4a gene expression pattern  
We next compared p16INK4a mRNA levels in hDPSCs cultured under both 
oxygen pressures. Figure 4.10 shows that hDPSCs also expressed p16INK4a, but in 
this case, the levels of p16INK4a increased along passages in 21% pO2 cultured-
hDPSCs. Furthermore, 3% pO2-cultured hDPSCs retained a lower level of the 
p16INK4a expression, which was constant along passages.  
Taken together, these results may suggest that p16INK4a, but not p14ARF 
pathway, is mediating oxidative stress-induced premature senescence in hDPSCs 
cultured under ambient oxygen tension.  
 
Figure 4.10 p16INK4a gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen 
tension. 
p16INK4a mRNA levels determined by qPCR against housekeeping gene. The data are shown as means 
± SD (n=5). The statistical significance is expressed as ***p<0.001 for 3% pO2 versus 21% pO2 and 
&&p<0.01 versus 21% pO2 at passage 5. 
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4.3.3 Trolox can reverse oxidative stress effect on p16INK4a expression 
In order to further investigate the p16INK4a implication on this ROS-mediated 
upregulation, we wanted to ensure if its expression was effectively submitted to 
ROS production at 21% pO2 culture. We therefore treated hDPSCs cultured under 
ambient oxygen tension with an antioxidant. We used Trolox, a water soluble 
derivate of vitamin E, at a final concentration of 50 µM. 
hDPSCs cultured under ambient oxygen tension and treated with Trolox 
showed comparable levels of p16INK4a mRNA expression as hDPSCs cultured at 
3% pO2, which means that Trolox can restore p16INK4a levels under oxidative stress 
conditions (Figure 4.11). Taken together, this result suggests that the p16INK4a-
associated premature senescence observed in hDPSCs cultured under ambient 
oxygen tension, is due to an increased ROS. 
 
Figure 4.11 p16INK4a gene expression levels in hDPSCs with 50 µM Trolox treatment. 
p16INK4a mRNA levels determined by qPCR against housekeeping gene. The data are shown as means 
± SD (n=5). The statistical significance is expressed as ***p<0.001 versus 3% pO2 and &&&p<0.001 
versus 21% O2 + 50 µM Trolox. 
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4.4 LOSS OF STEMNESS UNDER AMBIENT OXYGEN TENSION 
DURING LONG-TERM CULTURE OF hDPSCs 
Senescence-associated markers are usually not restricted to senescent 
passages but are continuously acquired since the beginning of the in vitro culture. 
Moreover, no marker or hallmark has been proved completely unique to the 
senescent state in cells, and not all senescent cells express all senescence markers. 
Thus, alternative markers would be useful in the assessment of cellular senescence 
(Wagner et al., 2008). 
Because they exhibit an opposite biological function compared to 
senescence, pluripotency-related transcription factors could be pointed as a 
potential candidate marker of the senescent state of cells, especially for stem cells. 
In fact, it has been suggested that the expression of these markers is essential in 
maintaining the stem cell properties (Takahashi and Yamanaka, 2006; Takahashi et 
al., 2007; Yu et al., 2007). 
Low oxygen tension in cell culture has proved to have positive effects on the 
in vitro survival and self-renewal of stem cells. However, the effects of low oxygen 
tension on the expression of these pluripotency markers and stemness maintenance 
in hDPSCs has not been investigated yet. In this study, we examined the gene 
expression pattern of the above mentioned pluripotency markers in hDPSCs under 
both ambient and physiological oxygen tension culture conditions along passages. 
To this end, we analysed the gene expression of four stemness markers, OCT4, 
SOX2, KLF4 and c-MYC, which make the core transcription network responsible 
for the regulation of stem cell self-renewal and pluripotency, by using quantitative 
real-time polymerase chain reaction technique. 
 
 
 
 
 
Results 
 109 
4.4.1 OCT4 gene expression pattern 
As we can see in Figures 4.12 to 4.15, hDPSCs expressed all four 
transcription factors.  
Focusing just on Figure 4.12, we can observe that OCT4 expression levels 
were higher at passage 5, and then, as passages accumulate, they rapidly 
plummeted. Furthermore, cells cultured at 3% pO2 showed significantly higher 
levels of this transcription factor at passage 5 in comparison with hDPSCs cultured 
at 21% pO2.  
Thus, high oxygen tension seems to have a negative effect on OCT4 
expression at early passages. 
 
 
Figure 4.12 OCT4 gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen tension. 
OCT4 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means ± 
SD (n=5). The statistical significance is expressed as *p<0.05 for 3% pO2 versus 21% pO2 and 
#p<0.05, ##p<0.01 or ###p<0.001 versus 3% pO2 at passage 5. 
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4.4.2 SOX2 gene expression pattern 
Similarly, hDPSCs also expressed SOX2 transcription factor. As we can see 
in the figure below, both OCT4 and SOX2 appeared to have a comparable 
expression pattern (Figure 4.13).  
SOX2 gene expression levels were higher at early stages, and they were 
downregulated along passages. Moreover, ambient oxygen tension caused a 
reduction of SOX2 expression levels at passage 5. 
Taken together, our data suggest that ambient oxygen tension may reduce 
SOX2 and OCT4 expression levels in young hDPSCs. 
 
 
Figure 4.13 SOX2 gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen tension. 
SOX2 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means ± 
SD (n=5). The statistical significance is expressed as *p<0.05 for 3% pO2 versus 21% pO2 and 
#p<0.05 or ##p<0.01 versus 3% pO2 at passage 5. 
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4.4.3 KLF4 gene expression pattern 
Figure 4.14 reveals that hDPSCs also expressed KLF4 transcription factor. 
Contrarily to OCT4 and SOX2 expression pattern, KLF4 gene expression levels 
increased along passages at 3% pO2. Interestingly, KLF4 expression was not 
affected by oxygen tension at passages 5 and 10, as no statistical difference were 
found. However, KLF4 expression levels in hDPSCs cultured under ambient 
oxygen tension were significantly reduced at passage 15. 
 
 
Figure 4.14 KLF4 gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen tension. 
KLF4 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means ± 
SD (n=5). The statistical significance is expressed as **p<0.01 for 3% pO2 versus 21% pO2, #p<0.05, 
##p<0.01 or ###p<0.001 versus 3% pO2 at passage 5, and &p<0.05 versus 21% pO2 at passage 5. 
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4.4.4 c-MYC gene expression pattern 
Finally, hDPSCs also expressed c-MYC transcription factor. In the below 
figure, we can observe that c-MYC expression pattern was similar to the one of 
KLF4 (Figure 4.15). c-MYC expression levels increased along passages in hDPSCs 
cultured at 3% pO2. We did not found statistical differences at passages 5 and 10, 
but we did found at passage 15 when comparing both oxygen culture pressures. 
Taken together, we can establish that high oxygen tension has a negative 
effect on OSKM gene expression during long-term culture of hDPSCs. 
 
 
Figure 4.15 c-MYC gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen 
tension. 
c-MYC mRNA levels determined by qPCR against housekeeping gene. The data are shown as means 
± SD (n=5). The statistical significance is expressed as ***p<0.001 for 3% pO2 versus 21% pO2, 
##p<0.01 or ###p<0.001 versus 3% pO2 at passage 5 and &&&p<0.001 versus 21% pO2 at passage 5. 
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4.5 BMI-1 CAN RESCUE SOX2 AND OCT4 GENE EXPRESSION 
UNDER AMBIENT OXYGEN TENSION 
Polycomb group (PcG) genes, such as BMI-1, are epigenetic gene silencers 
that preserve transcription patterns to maintain cell identity, a function clearly 
compatible with a role in self-renewal and stem cell maintenance (Lund and van 
Lohuizen, 2004; Seo et al., 2011). Understanding the molecular events downstream 
of BMI-1 should provide valuable insight into how stem cells regulate proliferation 
and self-renewal.  
Although p16INK4a and p14ARF have been shown to be BMI-1 downstream 
targets in the context of stem cell self-renewal, they do not account for all BMI-1 
actions (Sparmann and van Lohuizen, 2006; Fasano et al., 2007). Recently, a 
relationship between BMI-1, SOX2 and OCT4 has been described (Seo et al., 
2011; Kaufhold et al., 2016), as well as BMI-1 and c-MYC (Sahasrabuddhe et al., 
2011). Thus we wanted to investigate whether BMI-1 was responsible for the loss 
of the stemness properties observed in hDPSCs cultured under ambient oxygen 
tension.  
We first aimed to describe both BMI-1 gene and BMI-1 protein expression 
in order to see if oxygen tension could also have any effect on its regulation. We 
next investigated the role of BMI-1 by using small interference RNA silencing to 
reduce BMI-1 levels in hDPSCs cultured under ambient oxygen tension at early 
stages, and then assessing downstream OSKM gene expression changes. 
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4.5.1 BMI-1 gene expression pattern 
BMI-1 gene expression levels in hDPSCs cultured under both oxygen 
pressures were assessed by qPCR and compared. As we can observe in Figure 
4.16, BMI-1 gene expression levels in hDPSCs cultured at 3% pO2 increased as 
passaging number did. However, BMI-1 expression remained constant at 21% pO2.   
Interestingly, ambient oxygen tension upregulated BMI-1 expression at 
passage 5 in hDPSCs cultured at 21% pO2 in comparison to 3% pO2. Thus, oxygen 
tension may have an influence on BMI-1 gene expression. 
 
Figure 4.16 BMI-1 gene expression levels in hDPSCs long-term culture at 3% or 21% oxygen 
tension. 
BMI-1 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means 
± SD (n=5). The statistical significance is expressed as *p<0.05 for 3% versus 21% pO2 and #p<0.05 
versus 3% pO2 at passage 5. 
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4.5.2 BMI-1 protein expression pattern 
Figure 4.17 shows BMI-1 protein levels assessed by western blot technique. 
We can observe that BMI-1 levels in hDPSCs cultured at 3% pO2 remained 
constant along 20 passages, and then they began to decrease. By contrast, ambient 
oxygen tension accelerated the decrease of BMI-1 levels in hDPSCs, significantly 
reducing its levels from passage 5 to passage 15 when comparing to 3% pO2. 
Furthermore, 21% pO2 cultured hDPSCs showed significantly higher levels 
of BMI-1 at passage 5 but significantly lover levels at passage 15 in comparison to 
those cultured at 3% pO2. 
Taken together, our data suggest that ambient oxygen tension may accelerate 
BMI-1 protein degradation machinery in hDPSCs. 
 
 
Figure 4.17 BMI-1 protein levels in hDPSCs long-term culture at 3% or 21% oxygen tension. 
(A) BMI-1 protein levels assessed by western blot and (B) representative western blot image. The 
data are shown as means ± SD (n=5). The statistical significance is expressed as *p<0.05 or 
***p<0.001 for 3% pO2 versus 21% pO2, ##p<0.01 versus 3% pO2 at passage 5 and, &p<0.05 or  
&&&p<0.001 versus 21% pO2 at passage 5. 
Results 
 116 
4.5.3 BMI-1 gene and BMI-1 protein knockdown 
Given the fact that there is a possibility that SOX2 and OCT4 expression are 
regulated by BMI-1 under oxidative stress conditions, we aimed to test whether 
restoring BMI-1 protein levels in hDPSCs cultured at 21% pO2 could also recover 
SOX2 and OCT4 gene expression levels. To this end, we performed a mild 
knockdown of BMI-1 gene expression using siRNA transfection protocol.  
Figure 4.18, shows in (A) BMI-1 gene expression levels (determined by 
quantitative real-time polymerase chain reaction) and in (B) BMI-1 protein levels 
(determined by western blot). After transfection, hDPSCs cultured at 21% pO2 
expressed significantly reduced levels of BMI-1 at passage 5, both at gene and 
protein level. Furthermore, silenced BMI-1gene and BMI-1 protein levels in 
hDPSCs cultured at 21% pO2 were comparable to those in hDPSCs cultured under 
physiological oxygen pressure. 
 
 
Figure 4.18 BMI-1 gene and BMI-1 protein knockdown confirmation. 
(A) BMI-1 mRNA levels determined by qPCR against housekeeping gene and (B) BMI-1 protein 
levels measured by western blot. The data are shown as means ± SD (n=3). The statistical 
significance is expressed as ***p<0.001 versus 21% pO2. 
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4.5.4 SOX2 and OCT4 rescue following BMI-1 knockdown 
As previously stated, hDPSCs cultured at 21% pO2, showed at early stages, 
significantly increased BMI-1 protein levels, as well as a reduced expression of 
SOX2 and OCT4 transcription factors. Thus, we focused on BMI-1 silencing effect 
on the expression of these two transcription factors.  
To this end, we analysed SOX2 and OCT4 expression levels in transfected 
hDPSCs cultured at 21% pO2 using quantitative real-time polymerase chain 
reaction. The following figures show SOX2 (Figure 4.19) and OCT4 (Figure 4.20) 
gene expression levels in non-transfected hDPSCs cultured at 3% and 21% pO2, as 
well as in transfected hDPSCs cultured at 21% pO2.  
As we can observe in both figures, after transfection, SOX2 and OCT4 
expression levels were significantly increased. Moreover, SOX2 and OCT4 
expression levels achieved in transfected hDPSCs cultured at 21% pO2 were 
comparable to those expressed by hDPSCs cultured at 3% pO2.  
 
 
Figure 4.19 SOX2 gene expression following BMI-1 knockdown in young hDPSCs. 
SOX2 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means ± 
SD (n=3). The statistical significance is expressed as ***p<0.001 versus 21% pO2. 
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Figure 4.20 OCT4 gene expression following BMI-1 knockdown in young hDPSCs. 
OCT4 mRNA levels determined by qPCR against housekeeping gene. The data are shown as means ± 
SD (n=3). The statistical significance is expressed as ***p<0.001 versus 21% pO2. 
 
In accordance to our hypothesis, BMI-1 knockdown restores SOX2 and 
OCT4 expression levels in young hDPSCs cultured under oxidative stress 
conditions.  
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5.1 AMBIENT OXYGEN TENSION INDUCES OXIDATIVE STRESS IN 
hDPSCs LONG-TERM CULTURE 
5.1.1 Low oxygen tension alleviates oxidative damage in hDPSCs long-term 
culture 
hDPSCs normally reside in low oxygen concentrations. In mammals, 
including humans, hDPSCs are located in perivascular niches close to the vascular 
structure in almost all tissues (Shi and Gronthos, 2003; Crisan et al., 2008; 
Zannettino et al., 2008). By the time oxygen reaches the organs and tissues, oxygen 
concentration drops to 2-9%, with a mean of 3% in the dental pulp tissue (Yu et al., 
2002; Simon and Keith, 2008). Despite this fact, it is still common to culture cells 
at high non-physiological 21% pO2. However, the normal cell function requires a 
stable oxidation-reduction environment. The excess in the oxygen tension has been 
described as an important factor which could destabilize the cellular redox 
homeostasis (Fan et al., 2008).  
In the present study, we show that reduction of the oxygen level led to 
decreased intracellular oxidative stress and damage during long-term culture. This 
was evidenced by reduced ROS production, less protein and lipid damage, as well 
as a better conservation of the mitochondrial membrane potential (ΔΨm). Such 
effects were prominent for hDPSCs cultured at 3% pO2. 
In accordance with our results, it has been demonstrated that high 
concentrations of oxygen can cause oxidative stress damage via production of 
reactive oxygen species (ROS) and free radicals that can damage lipids, proteins 
and DNA (Wiseman and Halliwell, 1996). Accumulation of damaged 
macromolecules, including oxidative damaged proteins, is a hallmark of cellular 
and organismal aging. This accumulation has been viewed as the combined result 
of increased production of ROS, and other toxic compounds coming from cellular 
metabolism and external factors as well as the failure of protein maintenance (i.e. 
degradation and repair) with age. Protein oxidation is particularly detrimental as 
the resulting damages can render oxidized proteins inactive and lead to cellular 
Discussion 
 122 
functional abnormalities (Berlett and Stadtman, 1997). Various types of oxidative 
damage to proteins are induced either directly by ROS or indirectly by reactions 
with secondary products of oxidative stress such as reactive aldehydes as 4-
hydroxy-2-nonenal and MDA (Baraibar and Friguet, 2013). In accordance with 
this, we recently published a study that correlates high levels of MDA in hDPSCs 
with ambient oxygen pressure culture (El Alami et al., 2014). 
There is growing evidence that mitochondria are a critical player in the 
vicious cycle of ROS-mediated oxidative damage and cellular replicative 
senescence. In fact, it has been demonstrated that mitochondrial depolarization, 
together with increased ROS generation, was indicative of mitochondrial 
dysfunction during continual passage of G6PD-deficient cells (Ho et al., 2007). 
Furthermore, it has also been suggested that low oxygen tension protects 
mitochondria from oxidative damage, helps to maintain mitochondrial function, 
and prevents the increase in mitochondrial mass. This is in consistence with 
previous reports that mitochondrial membrane potential is reduced in cells from 
aged animals (Hagen et al., 1997; Rottenberg and Wu, 1997). 
In this work, we also linked oxygen tension to altered mRNA expression of 
MnSOD, CAT and GPx. The analysis of antioxidant enzyme expression showed 
that MnSOD, CAT or GPx were overexpressed in response ambient oxygen 
environment. This indicates that cellular anti-oxidative system was triggered to 
resist oxidative damage. Fan and colleagues already demonstrated that higher 
oxygen concentrations resulted in more H2O2 generation in CD34+ cells, which 
implied that the increase of H2O2 levels could interact with more efficiently 
transcription of MnSOD, CAT and GPx (Fan et al., 2008). 
Taken together, our data suggest that hDPSCs cultured under ambient 
oxygen tension are exposed to a hyperoxic environment which leads to oxidative 
stress conditions. 
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5.2 OXIDATIVE STRESS INDUCES PREMATURE SENESCENCE 
UNDER AMBIENT OXYGEN TENSION DURING LONG-TERM 
CULTURE OF hDPSCs 
5.2.1 Low oxygen tension delays hDPSCs senescence during long-term 
culture 
In this study, we demonstrate that hDPSCs cultured under ambient oxygen 
tension began to show flattened or lengthened shapes, and debris in the culture 
medium increased. Furthermore, hDPSCs proliferation rate was significantly 
reduced under ambient oxygen tension, as cells cultured at 3% pO2 reached 25 
passages while at 21% pO2 they only reached 15 passages by the same time. These 
observations were accompanied with an increased activity of the senescence-
associated β-galactosidase enzyme along passages, suggesting that these cells were 
entering a senescent state. 
Hayflick and Moorhead proposed in 1961 that serial sub-cultivations of WI-
38 HDFs under the usual laboratory conditions available more than 48 years ago 
(namely at 21% pO2), exhaust the proliferative potential of these cells. This in vitro 
phenomenon has been historically termed as replicative senescence (Reddel, 2000). 
We shall review how it was shown later that cultivating human diploid fibroblasts 
under more physiological oxygen partial pressure (2-5% pO2) prolongs their in 
vitro lifespan. This led to the question whether cells cultivated under usual 
laboratory conditions (21% pO2) show accelerated senescence and whether the 
molecular mechanisms of normal senescence are really the same, even if both are 
characterized by critical telomere shortening (Serrano and Blasco, 2001; Toussaint 
et al., 2011). 
The beneficial effect of low oxygen tension on mesenchymal stem cells 
from different sources has been demonstrated in many studies (Aranha et al., 2010; 
Adesida et al., 2012; Choi et al., 2014; Peng et al., 2016). The advantages of low 
oxygen tension in cell proliferation were reported for bone-marrow-derived 
mesenchymal stem cells (Grayson et al., 2006; Grayson et al., 2007; Bornes et al., 
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2015). When exposed to 2-3% pO2, the cells increased their regenerative potential 
(Volkmer et al., 2010) and achieved the cumulative population up to ten times 
compared to cells cultured in high oxygen tension (Fehrer et al., 2007). A higher 
regenerative potential was also observed in mesenchymal stem cells isolated from 
the umbilical cord at 5% pO2 (Drela et al., 2014) and in the placental mesenchymal 
stem cells (Mathew et al., 2013). Adipose-derived mesenchymal stem cells 
submitted to low oxygen tension (2-5% pO2) increased their regenerative potential 
(Kang et al., 2014).   
In fact, here we show that hDPSCs can be cultured over at least 25 passages 
without losing their stem cell-like morphology and proliferation kinetics when 
cultured under physiological oxygen pressure. However, under ambient oxygen 
tension, hDPSCs gradually lose their proliferative potential during long-term 
culture and show increasing signs of senescence such as larger phenotypes and 
increased SA-β-Gal levels.  
It has been described that depending on the senescence trigger, cells can 
become large, flat, and multinucleated, or rather refractile. A flat cell phenotype is 
commonly seen in cells undergoing H-RASV12-induced senescence (Serrano et al., 
1997; Denoyelle et al., 2006), stress-induced senescence (Parrinello et al., 2003) or 
DNA damage-induced senescence (Chen and Ames, 1994; Chen et al., 2001). Cells 
senescing due to BRAFE600 expression or the silencing of p400, however, acquire a 
more spindle-shaped morphology (Chan et al., 2005; Michaloglou et al., 2005). 
Melanocytes undergoing RASV12-induced senescence display extensive 
vacuolization as a result of endoplasmic reticulum stress caused by the unfolded 
protein response (Denoyelle et al., 2006). 
SA-β-Gal is the most commonly used senescence biomarker (Dimri et al., 
1995; Debacq-Chainiaux et al., 2009). This marker is detectable by histochemical 
staining in most senescent cells. However, it is also induced by stresses such as 
prolonged confluence in culture (Campisi and d'Adda di Fagagna, 2007). Still, 
even under normal physiological circumstances, β-galactosidase activity is 
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enriched in particular cell types, such as mature tissue macrophages and osteoclasts 
(Bursuker et al., 1982; Kopp et al., 2007), and it is detected in cells undergoing 
increased lysosomal activity during autophagy (Young and Narita, 2010; Ivanov et 
al., 2013). The SA-β-Gal probably derives from the lysosomal β-galactosidase and 
reflects the increased lysosomal biogenesis that commonly occurs in senescent 
cells (Lee et al., 2006a). Accordingly, the increase in SA-β-Gal activity in 
senescent cells is likely due to an expansion of the lysosomal compartment, giving 
rise to an increase in β-galactosidase activity that can be measured also at 
suboptimal pH 6 (hence, SA-β-Gal) (Kurz et al., 2000; Yang and Hu, 2005). 
Taken together, our results suggest that hDPSCs cultured under ambient 
oxygen tension are submitted to a premature senescence, which is evidenced by 
enlarged phenotype, reduced proliferative potential and increased SA-β-Gal 
activity. This phenomenon seems to be caused by ROS accumulation, leading to 
the so-called stress-induced premature senescence or SIPS (Sherr and DePinho, 
2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 126 
5.3 OXIDATIVE STRESS-INDUCED PREMATURE SENESCENCE 
(SIPS) IS MEDIATED BY p16INK4A PATHWAY 
5.3.1 ROS-induced p16INK4a upregulation mediates SIPS in hDPSCs 
Senescence is a normal feature of cells whereby they lose their replicative 
capacity after a finite number of divisions (Ivanchuk et al., 2001). The 
p16INK4a/pRb and p14ARF/p53 cell cycle inhibitory pathways represent two 
important pathways controlling proliferation, and their inactivation can extend the 
limited division number of mitotic cells in culture (Sherr and DePinho, 2000).  
Current culture conditions in vitro generally entails mitogenic hyper-
stimulation, which in most primary cells results in upregulation of the INK/ARF 
locus (Sharpless, 2004; Li et al., 2009). In fact, reduced oxygen tension has long 
been known to promote the growth and extend the replicative life span of cultured 
human cells (Packer and Fuehr, 1977; Saito et al., 1995). ROS have important 
functions in cell signalling but their role in regulating cell cycle progression is 
poorly understood. ROS levels increase significantly as cells pass from G1 into S 
phase of cell cycle (Havens et al., 2006) and they are required for S phase entry, as 
demonstrated by the cell cycle arrest induced by quenching ROS (Menon et al., 
2003; Conour et al., 2004). However, cell cycle checkpoints are also activated by 
increased ROS (Menon and Goswami, 2007), indicating that cellular proliferation 
relies on maintaining ROS levels within a functional range (Macleod, 2008).  
Given the role of p16INK4a in cell cycle regulation and the recent implication 
of oxidative stress in stem cell senescence, we investigated a potential link between 
ROS and p16INK4a regulation. Our results show that hDPSCs cultured at 21% pO2 
revealed signs of senescence, which were accompanied by an increasing p16INK4a 
expression levels as passaging number did, and a reduction in p14ARF expression 
levels in relation to passaging number. This might be suggesting that these cells 
could have become resistant to apoptosis while they entered senescence. 
In accordance with this, cultured primary human cells generally express 
increasing amounts of p16INK4a as they approach their lifespan limit in vitro 
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(Serrano et al., 1996). It was recently suggested that stressful culture conditions 
can induce p16INK4a, and subsequent premature senescence, in mammary epithelial 
cells, keratinocytes, and some fibroblasts (Ramirez et al., 2001; Rheinwald et al., 
2002). In fact, low levels of expression are detected initially in primary human 
fibroblasts but p16INK4a accumulates to high levels as these cells undergo 
senescence (Hara et al., 1996). Furthermore, p16INK4a expression has been 
correlated to population doubling number, that was confirmed statistically by SA-
β-Gal staining (Shibata et al., 2007). Several researchers have shown that the 
upregulation of p16INK4a gene expression is important to induce cellular senescence 
in human MSCs (Shibata et al., 2007; Jin et al., 2010). In fact, stress signals such 
as ROS stimulate the activation of p16INK4a transcription (Jenkins et al., 2011) and 
play important roles in initiation, as well as maintenance, of cellular senescence 
(Okamoto et al., 2002; Takahashi et al., 2006; Yang et al., 2008). Ito and 
colleagues described, both in vitro and in vivo, that activation of p16INK4a/pRb gene 
product pathway in response to elevated ROS led to the failure of hematopoietic 
stem cells (HSCs), and that treatment with antioxidant agents restored the 
constitutive capacity of HSCs, resulting in the prevention of bone marrow failure 
(Ito et al., 2004; Ito et al., 2006). These results support our data that treatment with 
50 µM Trolox can rescue p16INK4a levels in hDPSCs long-term culture at 21% pO2.  
If senescence and apoptosis are truly alternative cell fates, cellular changes 
that are pro-senescent are actively anti-apoptotic and that senescent cells are 
resistant to apoptosis (Childs et al., 2014). There is strong evidence for the 
existence of apoptosis resistance in replicative senescent fibroblasts, which they 
showed occurs through p14ARF/p53 signalling (Chen et al., 2000). The outcome of 
apoptosis resistance can also be cell survival. Senescence induced by mild H2O2 
promotes survival rather than apoptosis in response to apoptotic stimuli such as 
high-dose H2O2, which upregulates p53, leading to p53-dependent apoptosis 
(Sanders et al., 2013).  
Taken together, we could say that low oxygen tension might delay 
senescence of hDPSCs by downregulation of p16INK4a expression. 
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5.4 LOSS OF STEMNESS UNDER AMBIENT OXYGEN TENSION 
DURING LONG-TERM CULTURE OF hDPSCs 
5.4.1 OSKM expression pattern in hDPSCs cultured at 3% pO2 
Here we demonstrate that OCT4 and SOX2 expression levels were 
upregulated at early stages, suggesting that these two transcription factors might be 
involved in stemness induction. These data are in accordance with those of Wan 
Safwani and colleagues; they showed in adipose-derived stem cells during long-
term manipulation that the expression of the stemness biomarkers SOX2, NANOG 
and OCT4 was declined along passages (Wan Safwani et al., 2011). 
Our results also show that KLF4 and c-MYC expression levels were 
upregulated at advanced stages. The successive increase in the expression of those 
two transcription factors, could be explained as they have been shown to contribute 
to the long-term maintenance of the embryonic stem cell (ESC) phenotype, and the 
rapid proliferation of ESCs in culture (Takahashi and Yamanaka, 2006). 
This indicates a close interaction between these four genes, that control the 
stemness status of stem cells.  
 
5.4.2 OSKM expression pattern in hDPSCs cultured at 21% pO2 
The current results suggest that although hDPSCs were capable of being 
maintained under ambient conditions, pluripotency was reduced before the 
appearance of morphological differentiation. In fact, our data show that hDPSCs 
cultured at 21% pO2 only expressed reduced levels of SOX2 and OCT4 compared 
with cells cultured at 3% pO2 at passage 5, before these cells appeared to be 
morphologically differentiated.  
These data are in agreement with similar OCT4 results obtained by Ludwig 
(Ludwig et al., 2006). However, they are contrary to those of Forsyth and Westfall, 
who both observed no difference in the expression SOX2, OCT4 and NANOG 
between human ESCs cultured at 2% and 4% pO2 respectively compared with 
atmospheric oxygen tensions (Forsyth et al., 2008; Westfall et al., 2008). However, 
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the latter investigators did show that OCT4-regulated genes were down-regulated 
under atmospheric oxygen tensions, suggesting that although mRNA expression of 
pluripotency markers was not reduced under 20% oxygen, their downstream 
targets displayed decreased expression.  
 
5.4.3 Low oxygen tension retains hDPSCs stemness potential 
hDPSCs cultured under physiological oxygen tension expressed OCT4 and 
SOX2 at early stages, and KLF4 and c-MYC at advanced stages, which in turn 
might mean that pluripotency is conserved along passages. Ambient oxygen 
tension was accompanied by a reduction of all four transcription factors. 
According with our results, a recent study revealed that ROS accumulation in 
tendon stem cells was accompanied by reduced colony formation and proliferation, 
decreased expression of the stemness markers NANOG, OCT4 and SSEA4, and 
impaired differentiation capability (Chen et al., 2016a). There is no further mention 
to the expression pattern of c-MYC or KLF4 in relation to long-term culture or 
oxidative stress.  
It has been suggested that culturing human embryonic stem cells by constant 
low oxygen tension condition may maintain pluripotency by sustaining Notch 
activation (Prasad et al., 2009). In a recent study, an enhanced expression of the 
stemness markers OCT4, NANOG, REX1 and SOX2 under low oxygen tension was 
observed, indicating that adult stem cells (ASCs) had a greater ability to maintain 
their stemness properties under low oxygen tension as compared to high oxygen 
tension (Choi et al., 2014). This result was consistent with other findings, 
suggesting that a low oxygen microenvironment provides an optimal condition for 
the maintenance of ASCs properties (D'Ippolito et al., 2006).  
Recent research data also showed that using normoxic conditions (5% pO2) 
increases the efficiency of generation of iPSCs from mouse embryonic fibroblasts 
using OCT4, SOX2, and KLF4 retroviral transduction, as well as with non-viral 
vectors, such as plasmid expression vectors or piggyback transposition system 
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(Yoshida et al., 2009). Low oxygen tension also shows increased efficiency in the 
derivation of human iPSCs from dermal fibroblasts on transduction of OCT4, 
SOX2, KLF4 and c-MYC retroviral vectors (Yoshida et al., 2009). In accordance to 
this, endothelial cells reprogrammed by the transduction of transcription factors in 
low oxygen conditions increased the number of colonies by 2.5-fold compared to 
ambient oxygen (Panopoulos et al., 2012). Similar results were obtained for the 
reprogramming of mice embryonic fibroblasts and human dermal fibroblasts, 
showing that low oxygen tension promotes higher reprogramming efficiencies 
(Yoshida et al., 2009) and accelerate the generation of iPSC colonies (Shimada et 
al., 2012). Thus, low oxygen tension seems to have a role not only in sustaining but 
also inducing pluripotency in stem cells. 
Although it is true that we have not measured any parameters of stem cell 
differentiation potential, stem cell plasticity is also an important factor for 
prospective use of MSCs in regenerative medicine. Trilineage mesenchymal 
differentiation, known as the ability to differentiate into osteogenic, chondrogenic, 
and adipogenic lineages, is a unique biological property of MSCs (Dominici et al., 
2006). Several researchers reported the effect of different culture oxygen 
concentrations on the trilineage differentiation of MSCs. In an elegantly designed 
experiment, Raheja and colleagues seeded and induced MSCs for differentiation 
under an atmosphere of 5% carbon dioxide (CO2) along with 1 of 4 pO2 
concentrations (1%, 2%, 5%, and 21%). According to their results, MSCs 
differentiated into osteoblast most rapidly at 21% pO2, and oxygen below 5% 
showed reduced differentiation potential. However, no statistically significant 
difference in osteogenic marker was reported when oxygen tension was between 
5% and 21% (Raheja et al., 2010). In addition, Basciano and colleagues have 
reported improved osteoblastic and adipogenic differentiation potential of early 
passaged MSCs at 5% pO2 concentration (Basciano et al., 2011). Several other 
recent reports support that the multilineage differentiation potential of MSCs can 
be maintained under low oxygen tension environment (1-5% pO2 concentration) 
(Grayson et al., 2007; Holzwarth et al., 2010; Nekanti et al., 2010).  
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5.5 BMI-1 CAN RESCUE SOX2 AND OCT4 EXPRESSION UNDER 
AMBIENT OXYGEN TENSION 
5.5.1 Regulation of BMI-1 expression under oxidative stress conditions 
In this study we have seen that, according to passage number, BMI-1 gene 
expression levels increased while BMI-1 protein levels decreased in hDPSCs. This 
process was accelerated under oxidative stress conditions.  
Very little is known about the post-transcriptional regulation of BMI-1. 
Recently, it has been reported that BMI-1 is a short-lived protein, which undergoes 
rapid turnover (Yadav et al., 2010; Sahasrabuddhe et al., 2011). In fact, BMI-1 is 
reported to be modified by several factors in context- and lineage-dependent 
manner. BMI-1 is phosphorylated by several kinases for different physiological 
consequences (Sahasrabuddhe, 2016).  
Some researchers have published that BMI-1 may be a substrate of AKT and 
upregulation of AKT signalling coincides with upregulation of BMI-1 
phosphorylation, and that phosphorylated BMI-1 is more stable. In contrast, 
activated oxidative stress-dependent p38 signalling causes BMI-1 to degrade, and 
to lose its chromatin modifying ability. Furthermore, they also show that post-
transcriptional regulation of BMI-1 via proteasomal degradation causes defective 
proliferation in Atm-/- neural stem cells (NSCs) as a result of p21 upregulation 
(Kim and Wong, 2009). 
Other researchers demonstrated that BMI-1 expression is modulated through 
transcriptional and posttranscriptional regulation in hematopoietic stem cells 
(HSCs) (Bhattacharyya et al., 2009). They further investigated whether oxidative 
stress could affect BMI-1 degradation. After 1 hour of treatment with H2O2, the 
BMI-1 band was significantly reduced, and after 4 hours of incubation with H2O2, 
they observed a dramatic reduction in the levels of BMI-1 (Kim et al., 2011).  
Collectively, these observations strongly support the notion that down-
regulation of BMI-1 is associated with oxidative stress-dependent pathways in 
stem cells. 
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5.5.2 BMI-1 levels and stemness potential in hDPSCs  
OCT4 and SOX2 are components of a complex transcriptional network of 
positive and negative feedback loops that maintain ESC identity while repressing 
the expression of genes that promote differentiation (Boyer et al., 2005; 
Lapthanasupkul et al., 2012). Previous studies have established the importance of 
epigenetic modulation of gene expression in ESCs, including the chromatin-
modifying polycomb group (PcG) and trithorax group (TrxG) proteins, which 
predominantly mediate gene repression and activation, respectively (Bernstein et 
al., 2006; Boyer et al., 2006). PcGs exist as two multimeric protein complexes; 
polycomb repressive complex 1 (PRC1) and 2 (PRC2), both of which function as 
gene silencers. BMI-1 is a PRC1 component that acts sequentially to repress 
transcription by H3K27 trimethylation (Yang et al., 2016).  
In the present study, we have previously confirmed a loss in all Yamanaka 
transcription factors (OCT4, SOX2, KLF4 and c-MYC) expression during hDPSCs 
in vitro long-term culture at 21% pO2. Moreover, at passage 5, high oxygen tension 
caused a significant downregulation of SOX2 and OCT4 expression, which was 
accompanied by increased BMI-1 protein levels. Silencing of BMI-1 gene at 
passage 5 resulted in a restoration of SOX2 and OCT4 expression levels in hDPSCs 
cultured at 21% pO2. In fact, most of the transcriptionally silent developmental 
regulators targeted by OCT4, SOX2 and NANOG are also occupied by the 
Polycomb group (PcG) proteins (Boyer et al., 2006; Lee et al., 2006b). 
Furthermore, with respect to transcriptional regulation, it has been shown 
that BMI-1 gene expression is positively regulated by c-MYC, and the E2F family 
of transcription factors (Guney et al., 2006; Nowak et al., 2006; Guo et al., 2007; 
Liu et al., 2014). This is in accordance with our results where hDPSCs cultured at 
3% pO2 overexpressed both BMI-1 and c-MYC genes as passage number increased.  
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5.5.3 BMI-1 levels and hDPSCs senescence 
It has been suggested that BMI-1 controls stem cells via the INK4/ARF 
locus, because BMI-1 function in young adult hematopoietic stem cells is 
mediated, in large part, through its transcriptional repression of p16INK4a (Pollina 
and Brunet, 2011). In accordance to this, we can see in the figure below that BMI-
1 and p16INK4a expression patterns are related to each other in hDPSCs cultured 
under both oxygen tension conditions (Figure 5.1). At 3% pO2, BMI-1 and p16INK4a 
levels remain constant and parallel along passages, however, at 21% pO2, p16INK4a 
expression rises as BMI-1 levels plummet. 
 
  
Figure 5.1 Relation between ROS, p16INK4a and BMI-1 expression in hDPSCs long-term culture. 
p16INK4a mRNA levels determined by qPCR against housekeeping gene, and BMI-1 protein levels 
measured by western blot in hDPSCs long-term culture at (A) 3% pO2 and (B) 21% pO2. The data are 
shown as means ± SD (n=5). 
 
The role of PcG proteins is the maintenance of established gene expression 
states to achieve an epigenetic memory of cell identity. Dividing cells must 
preserve epigenetic memory in order to face disruptions such as DNA replication 
or mitosis, where regulatory factors may be disassembled from promoters. PcG is 
thus involved in the competence for switching, with every cell cycle transition 
providing an opportunity to either maintain the repressed state or to switch to a 
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derepressed state. Here we observe that decreased expression of BMI-1 along 
passages in hDPSCs cultured at 21% pO2, increases the probability of a cell 
switching from a p16-off to a p16-on state, reducing its regenerative potential.  
The decline in regenerative capacity and the subsequent loss of tissue 
homeostasis is one of the most striking hallmarks of aging. The results described 
by Ocampo and colleagues and commented by Serrano, suggested that in vivo 
OSKM induction may slow the aging process by preventing molecular changes 
associated with aging, including epigenetic alterations, activation of cellular 
senescence pathways (such as p16INK4a/pRb), and the exhaustion of adult stem cell 
populations (Ocampo et al., 2016; Serrano, 2017b). 
Taken together, BMI-1 maintains adult stem cell pools while controlling 
lifespan extension by suppression of the p16INK4a-dependent senescence pathway. 
Thus, Pollina and colleagues proposed that BMI-1 expression should be kept in a 
balance between stem cell self-renewal and differentiation during aging (Figure 
5.2). This mechanistic balance allows stem cell normal proliferation, while 
preventing stem cell senescence when downregulated. Thus, maintaining the 
proper stem cell homeostasis (Pollina and Brunet, 2011). 
 
 
Figure 5.2 BMI-1 balance and stem cells. 
Taken from: Pollina and Brunet (2011). 
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5.6 OUTLOOK: LOW OXYGEN TENSION AS A STRATEGY TO 
ENHANCE STEM CELL THERAPIES 
There is growing interest in transplantation of ex vivo amplified cell 
preparations for various therapeutic applications. This has been fuelled by novel 
insights from stem cell biology, new molecular tools and promising preclinical 
model systems. To date, mesenchymal stem cells (MSCs) are tested for a wide 
spectrum of diseases, hence, cellular therapeutics needs standardized isolation and 
reliable quality control of cell preparations. This, however, is greatly hampered by 
the multitude of different methods to prepare MSCs (Wagner and Ho, 2007).  
MSCs, which have the ability to divide and remain in an undifferentiated 
state, are present in perivascular niches in close association with blood vessels in 
virtually all tissues (Miura et al., 2003; Shi and Gronthos, 2003; Crisan et al., 2008; 
Zannettino et al., 2008). Even though MSCs are located close to vascular 
structures, the different tissues where these stem cells are found exhibit low 
oxygen tensions (Harrison et al., 2002; Pasarica et al., 2009). Therefore, it is 
possible that maintaining MSCs in an undifferentiated state may require a low 
oxygen environment, in addition to other factors. Furthermore, stem cell therapies 
require a large amount of cells which can only be achieved after long-term in vitro 
culture. There is a growing perception that even under highly standardized culture 
conditions, continuous effects during long-term culture entails senescence, which 
needs to be taken into account (Wagner et al., 2010). 
An unbiased and robust assessment of MSCs senescence – valid for all in 
vitro samples, regardless of donor age and inter-donor variation, would be ideal for 
estimating sufficient cell expansion potential and quality for therapy (Bertolo et al., 
2016). In this study we provide a simple strategy, which is to mimic the organism 
physiological oxygen tension when culturing in Petri dishes. This allows 
investigations on the proliferation, differentiation, senescence, metabolic balance, 
transcriptome, and other physiological aspects of MSCs, which have potentially 
important clinical applications. 
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5.6.1 Timing is everything 
Timing is critical in MSC therapy, from the initial MSC isolation from 
adult-donors, to the best time points for patient treatment (Schepers and Fibbe, 
2016).  
First of all, the time point of cell infusion in relation to the progress of the 
treated indication in patients may affect their therapeutic efficacy. Moreover, 
younger patients may respond better than older patients (Ball et al., 2013). Patient 
clinical responses to MSC batches may not be robust and they may be transient in 
nature, both complicating patient response readout and MSC potency assessment.  
Second, a number of time-dependent variables complicate MSCs production. 
Particularly intrinsic (cell donor age) and extrinsic cell ageing (ex vivo expansion 
process) may affect MSCs therapeutic properties, as reviewed elsewhere 
(Dimmeler and Leri, 2008; Geissler et al., 2013; Dimmeler et al., 2014; Efimenko 
et al., 2015; Kundrotas et al., 2016). It is now well established that bone marrow 
stem cell content decreases with donor age (Caplan, 1994), and that both, donor 
age and comorbidities, may affect cell efficacy (Stolzing et al., 2008). If allogeneic 
cells are applicable, MSCs from younger donors may thus optionally be preferred 
for clinical use.  
As stated before, another evident factor affecting MSCs potency appears to 
be the time in culture. Stemness potential is reduced after in vitro expansion and 
repeated passaging (Banfi et al., 2000; Horwitz et al., 2002; Javazon et al., 2004; 
Crisostomo et al., 2006; von Bahr et al., 2012; Binato et al., 2013; Wagner and 
Henschler, 2013; Bertolo et al., 2016), which results in a gradual loss of progenitor 
properties and tissue forming capacity, reduced long-term engraftment, lower 
clinical response and survival benefit, thus compromising engraftment and 
function (Wagner et al., 2010). 
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5.6.2 Low oxygen tension in vitro preconditioning to prevent senescence 
Aging or replicative senescence negatively affects proliferation of MSCs as 
the cells lose their stemness potential and undergo cell cycle arrest (Yu and Kang, 
2013; Boyette and Tuan, 2014). The delay in developing the senescent phenotype 
in MSCs cultured under low oxygen tension may be because they tend to maintain 
a higher rate of cell proliferation than MSCs cultured under ambient oxygen 
tension (Kim et al., 2016). This opens the prospect of obtaining large amounts of 
cells with the desired biological characteristics during long-term culture. Our 
findings should help to formulate guidelines for the collection of optimal MSCs for 
cell therapy.  
Several researchers are demonstrating in in vivo experiments how low 
oxygen preconditioning of MSCs (such as bone marrow mesenchymal, adipose-
derived and neural stem cells) improves their regenerative potential in common 
diseases such as bone regeneration, diabetes, spinal cord injuries, neurological 
disorders and liver regeneration (Chen et al., 2016b; Lee et al., 2016; Wakai et al., 
2016; Wang et al., 2016; Waseem et al., 2016; Wu et al., 2016). The consensus is 
that inhibition or reversal of senescence onset in adult stem cells would be of 
utmost benefit. 
With potential for bone regeneration, hDPSCs might be an effective 
biological therapy for bone destruction. Wu and collaborators results show that low 
oxygen preconditioning significantly enhanced hDPSCs survival rate, osteogenic 
differentiation and its migration response in vivo. In mouse apical periodontitis 
bone destruction model, after transplantation of low oxygen preconditioned 
hDPSCs via intravenous injection, there is an upregulation of hDPSCs recruitment 
and recovery of alveolar bone mass in infected periapical tissue, and osteogenesis 
and bone mineralization is enhanced (Wu et al., 2016). 
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5.7 LIMITATIONS OF THE STUDY 
There is always another experiment that could have been performed or some 
idea that could have been tested. Thus, this study has some limitations which I 
would like to briefly summarize. 
It would have been of interest to set a deeper characterization of hDPSCs 
senescence in order to establish how low oxygen improves their regenerative 
potential for stem cell therapies.  
Therefore, analysing the senescence associated secretory phenotype (SASP) 
and the immune-modulatory profile would have been very useful as novel 
mechanisms underlying the therapeutic effects of MSCs were shown to include the 
paracrine actions by cytokines, chemokines, growth factors, and their receptors 
(Caplan and Dennis, 2006; Hung et al., 2007; Zhang et al., 2007; Gnecchi et al., 
2008; Figueroa et al., 2012; Liu et al., 2012).  
Another approach could have been to set the senescence associated 
heterochromatin foci (SAHF) and senescence associated DNA-damage foci (SDF), 
along with a chromosome profile and telomere length study. SAHFs are detected 
by the preferential binding of DNA dyes, such as 4,6-diamidino-2-phenylindole 
(DAPI), and the presence of certain heterochromatin-associated histone 
modifications (for example, H3K9 methylation) (Campisi and d'Adda di Fagagna, 
2007). Therefore, it is possible to assume a relation between SAHF formation, 
BMI-1 and p16INK4a expression in hDPSCs. Furthermore, DNA-damage foci arise 
at dysfunctional telomeres that accompany replicative senescence and can be 
triggered by either intrinsic or environmental insults (d'Adda di Fagagna et al., 
2003; Takai et al., 2003; Herbig et al., 2004; Sharpless and Sherr, 2015). Thus, we 
could hypothesise a connection between ROS accumulation under ambient oxygen 
tension and telomere shortening. 
Another limitation of this study is that we could not determine the 
differentiation potential of hDPSCs along passages under both oxygen tension 
conditions. Finally, measuring the multilineage differentiation potential of hDPSCs 
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with biomaterial conjugation could have offer another approach of how in vitro 
culturing may affect survival after in vivo transplantation. 
 
Although we are aware of the limitations of our study, it enabled us to draw 
interesting conclusions regarding new approaches for stem cell therapy. 
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6.1 GENERAL CONCLUSION 
Long-term in vitro culture of hDPSCs at ambient oxygen tension, in 
comparison to those cultured at physiological oxygen tension, caused an oxidative 
stress-related premature senescence and a downregulation of OCT4 and SOX2 
expression. The proteins p16INK4a and BMI-1 are involved in this process. 
 
6.2 SPECIFIC CONCLUSIONS 
The following conclusions can be drawn from the results obtained in this 
study: 
 
1. Ambient oxygen tension induced oxidative stress in hDPSCs long-term 
culture as was evidenced by ROS accumulation, lipid and protein 
damage, mitochondrial membrane potential loss, and antioxidant gene 
upregulation. 
 
2. Oxidative stress induced a premature senescence (SIPS) under ambient 
oxygen tension during long-term culture of hDPSCs as evidenced by a 
senescent phenotype, increased p16INK4a expression levels and SA-β-Gal 
activity. 
 
3. Oxidative stress-induced premature senescence (SIPS) under ambient 
oxygen tension during long-term culture of hDPSCs appeared to be 
mediated by p16INK4a pathway. 
 
4. Oxidative stress-induced premature senescence (SIPS) under ambient 
oxygen tension during long-term culture of hDPSCs was accompanied by 
a stemness potential loss as evidenced by SOX2, OCT4, KLF4 and c-
MYC downregulation. 
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5. BMI-1 proved to control hDPSCs proliferative potential by regulating 
16INK4a expression during long-term culture under ambient oxygen 
tension. Furthermore, BMI-1 knockdown could rescue SOX2 and OCT4 
expression in hDPSCs culture under ambient oxygen tension. 
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8.1 ANNEX 1: INFORMED CONSENT 
 
 
Clínica Odontológica, Unidad de Cirugía 
Facultad de Medicina y Odontología 
Universidad de Valencia 
 
CONSENTIMIENTO INFORMADO 
 
Nombre y apellidos …………………………………………………... 
Edad…………………………………………………………………… 
Sexo……………………………………………………………………. 
 
He sido informado/a y acepto libremente entregar mi diente, extraído por 
motivos ajenos a este estudio, para el cultivo y análisis de las células de la pulpa 
dental. 
 
Fecha: 
 
Firma:  
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8.2 ANNEX 2: PATIENT INFORMATION SHEET 
 
Clínica Odontológica, Unidad de Cirugía 
Facultad de Medicina y Odontología 
Universidad de Valencia 
 
HOJA DE INFORMACIÓN AL PACIENTE 
 
Le invitamos a participar en el presente estudio sobre la obtención de células 
madre de pulpa dental que se está llevando a cabo en la Universidad de Valencia. 
Podrá hablar con el investigador para aclarar sus dudas y si decide no 
participar en el estudio, esto no afectará de ninguna manera a la calidad de su 
tratamiento odontológico.   
 
Objetivos del estudio: 
- Obtener células madre de pulpa dental. 
- Mejorar el método de obtención de estas células. 
 
Tratamiento del estudio: Durante el estudio, se registraran datos referentes a su 
historia médica (edad, sexo), así como a las características clínicas del diente a 
extraer.  
Posibles riesgos: No existen riesgos para el paciente asociados a este estudio. 
Participación voluntaria: Puede retirarse del estudio en cualquier momento sin 
tener que ofrecer explicación alguna sobre sus razones. El abandono del estudio no 
condicionará en absoluto los tratamientos odontológicos en el futuro. 
Confidencialidad: Todos los datos referentes a su participación en el estudio se 
almacenarán y analizarán en una base de datos electrónica, sin mención expresa de 
su nombre. 
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8.3 ANNEX 3: ETHICAL COMITEE 
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8.4 ANNEX 4: ABBREVIATIONS 
Abbreviation Name 
 
Abbreviation Name 
8-oxodG 8-hydroxy-2-
deoxyguanosine 
MnSOD Manganese superoxide 
dismutase 
a.u. Arbitrary units mRNA Messenger Ribonucleic 
acid 
AGO Argonaute family MSC Mesenchymal stem cell 
ANOVA Analysis of variance mtDNA Mitochondrial 
Deoxyribonucleic acid 
APS Ammonium persulfate dNTP Deoxyribose nucleotide 
triphosphates 
ARF Alternative reading 
frame 
n Sample number 
ASC Adult stem cell NaCl Sodium Chloride 
ATP Adenosin-5’-
triphosphate 
NADH Reduced nicotin adenine 
dinucleotide 
AUC Area under curve NADPH Reduced nicotin adenine 
dinucleotide phosphate 
BMI-1 B-cell specific 
moloney murine 
leukaemia virus 
integration region 1 
NFkB Nuclear factor kappa B 
BSA Bovine serum albumin nm Nanometre 
CDK Cyclin dependent 
kinase 
Ct Cycle threshold 
CDKI Cyclin dependent 
kinase inhibitor 
nmol Nanomoles 
CDKN2A Cyclin dependent 
kinase inhibitor 2A 
º Angle degree 
cDNA Complementary 
Deoxyribonucleic acid 
ºC Centigrade degree 
c-MYC avian 
myelocytomatosis 
viral oncogene 
homolog 
OCT4 Octamer-binding 
transcription factor 4 gene 
cm2 Square centimetre OH- Hydroxyl ion 
Cu+ Cupper ion OSKM OCT4, SOX2, KLF4 and 
c-MYC 
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DDR DNA damage response P/S Penicillin / Streptomycin 
DcR2 Decoy death receptor-
2 
PAGE Polyacrylamide gel 
electrophoresis 
Dec1 Differentiated embryo-
chondrocyte 
expressed-1 
PBS Phosphate buffered saline 
DEPC Diethyl pyro carbonate PBS-T Phosphate buffered saline - 
Tween 
DHR123 Dihydrorhodamine-
123 
PcG Polycomb group proteins 
DMEM Dulbecco’s Eagle 
Modified Medium 
pCO2 Carbon dioxyde pressure 
DMSO Dimethyl sulfoxide PE Phycoerythrin 
DNA Deoxyribonucleic acid  PEST Proline (P), glutamic acid 
(E), serine (S), and 
threonine (T) domain 
DNPH 2,4-
Dinitrophenylhydrazin
e 
pH Potential of hydrogen 
DTT Dithiothreitol PI Propidium iodide 
EDTA Ethylene-diamine-
tetra-acetic acid 
pO2 Oxygen pressure 
ESC Embryonic stem cell pRb Retinoblastoma protein 
EZH2 Enhancer zeste 
homolog 2 
PRC Polycomb-repressive 
complex 
FACS Fluorescence activated 
cell sorting 
PTGS Post-Transcriptional Gene 
Silencing 
FBS Foetal bovine serum PVDF Polyvinylidene fluoride 
FDG Fluorescein di-β-D-
galactopyranoside 
qPCR Quantitative polymerase 
chain reaction 
FITC Fluorescein 
isothiocyanate 
RF RING finger domain 
g Grams / Gravities RISC RNA-induced silencing 
complex 
GAPDH Glyceraldehyde 3-
phosphate 
dehydrogenase 
RNA Ribonucleic acid 
GPx Glutathione peroxidase RNS Reactive nitrogen species 
GSC Germ line stem cell ROS Reactive oxygen species 
GSH Reduced glutathione rpm Revolutions per minute 
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GSSG Oxidized glutathione rRNA Ribosomal Ribonucleic 
acid 
h Hours RT Reverse transcriptase 
H2O2 Hydrogen peroxide SA-β-Gal Senescence associated β-
galactosidase 
hDPSCs Human dental pulp 
stem cells 
SAHF Senescence associated 
heterochromatin foci 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethane 
sulfonic 
SASP Senescence associated 
secretory phenotype 
Hg Mercury SD Standard deviation 
HNE 4-Hydroxi-2,3-nonenal SDS Sodium dodecyl sulfate 
HPLC High performance 
liquid chromatography 
SIPS Stress-induced premature 
senescence 
HRP Horse radish 
peroxidase  
siRNA Small interference 
Ribonucleic acid 
HTH Helix-turn-helix 
domain 
SOD Superoxide dismutase 
IgG Immunoglobulin G SOX2 Sex determining region Y-
box 2 gene 
IL Interleukin ssDNA Single strand 
Deoxyribonucleic acid 
INK4 Inhibitor of CDK4 dsDNA Double strand 
Deoxyribonucleic acid 
iPSC Induced pluripotent 
stem cell 
TBA Thio-barbituric acid 
IVF In vitro fertilization TBST-T Tris buffered saline – 
Tween 
K2HPO4 Potassium hydrogen 
phosphate 
TEMED Tetramethylethylenediami
ne 
KH2PO4 Potassium dihydrogen 
phosphate 
TGS Transcriptional Gene 
Silencing 
KLF4 Kruppel like factor 4 
gene 
TMRE Tetramethylrodamine ethyl 
ester 
KPi Potassium phosphate TMRM Tetramethylrodamine 
methyl ester 
L Litre TRIS 2-Amino-2-
(hydroxymethyl)-1,3-
propanediol 
M Molar TrxG Trithorax group proteins 
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mA Milliampere  UPS Ubiquitin proteasome 
system 
MAPK Mitogen-activated 
protein kinases 
UV Ultraviolet 
MDA Malondialdehyde V Volts 
MDM2 Murine double minute 
2 
v/v Volume/volume 
MEF Mouse embryonic 
fibroblast 
VEGFA Vascular endothelial 
growth factor A 
mg Milligram w/v Weight/volume 
min Minutes ΔΨm Mitochondrial membrane 
potential 
miRNA Micro Ribonucleic 
acid 
λ  Wavelength 
mL Millilitre µg Microgram 
mm Millimetre µL Microliter 
mM Millimolar µM Micromolar 
MMP Matrix 
metalloproteinase 
µm Micrometer 
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8.5 ANNEX 5: ARTICLE RELATED TO THIS DOCTORAL THESIS 
 
 
Contents lists available at ScienceDirect
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journal homepage: www.elsevier.com/locate/redox
Research Paper
Role of p16INK4a and BMI-1 in oxidative stress-induced premature
senescence in human dental pulp stem cells
Cristina Mas-Barguesa,e,f, José Viña-Almuniab, Marta Inglésc,e,f, Jorge Sanz-Rosa,e,f,
Juan Gambinia,e,f, José Santiago Ibáñez-Cabellosa,d,e, José Luis García-Giméneza,d,e, José Viñaa,e,f,
Consuelo Borrása,e,f,⁎
a Department of Physiology. Faculty of Medicine and Dentistry. University of Valencia, Av/ Blasco Ibáñez, 15, 46010 Valencia, Spain
b Department of Stomatology. Faculty of Medicine and Dentistry. University of Valencia, Av/ Blasco Ibáñez, 15, 46010 Valencia, Spain
c Department of Physiotherapy. Faculty of Medicine and Dentistry. University of Valencia, Av/ Blasco Ibáñez, 15, 46010 Valencia, Spain
d Center for Biomedical Network Research on Rare Diseases (CIBERER), CIBER-ISCIII, Spain
e INCLIVA Health Research Institute, Av/ de Menéndez y Pelayo, 4, 46010 Valencia, Spain
f Center for Biomedical Network Research on Frailty and Healthy Aging (CIBERFES), CIBER-ISCIII, Spain
A R T I C L E I N F O
Keywords:
Oxygen tension
Regenerative medicine
Aging
A B S T R A C T
Human dental pulp stem cells (hDPSCs) are a source for cell therapy. Before implantation, an in vitro expansion
step is necessary, with the inconvenience that hDPSCs undergo senescence following a certain number of
passages, loosing their stemness properties. Long-term in vitro culture of hDPSCs at 21% (ambient oxygen
tension) compared with 3–6% oxygen tension (physiological oxygen tension) caused an oxidative stress-related
premature senescence, as evidenced by increased β-galactosidase activity and increased lysil oxidase expression,
which is mediated by p16INK4a pathway. Furthermore, hDPSCs cultured at 21% oxygen tension underwent a
downregulation of OCT4, SOX2, KLF4 and c-MYC factors, which was recued by BMI-1 silencing. Thus, p16INK4a
and BMI-1 might play a role in the oxidative stress-associated premature senescence. We show that it is
important for clinical applications to culture cells at physiological pO2 to retain their stemness characteristics
and to delay senescence.
1. Introduction
Organismal aging is associated with a loss of the homeostasis. One
of the elements that contribute to this deterioration is increased cell
senescence [1]. Hayﬂick originally described senescence as a perma-
nent cell cycle arrest due to the limited replicative potential of cultured
human ﬁbroblasts [2]. Senescence after a number of cell doublings
during in vitro culture is inevitable under current culture conditions,
resulting in cellular phenotypic changes and growth arrest [3–5]. This
observation of cellular senescence has been extrapolated to somatic
stem cells in vivo and might reﬂect the aging process of the whole
organism [4].
In vitro cellular senescence refers to both replicative and premature
senescence [6]. Premature or accelerated senescence can be induced by
stress signals, such as activation of oncogenes, strong mitogenic signals,
and/or reactive oxygen species (ROS) levels. As we previously reported,
oxidative stress is responsible for the low proliferation rate under
ambient oxygen tension (21% pO2) through p38, p21, and NRF-2
activation [7]. Cell culture-inherent oxidative stress can cause critical
telomere attrition, accumulation of DNA damage and de-repression of
the INK4/ARF locus, leading to stress-induced premature senescence
(SIPS) [8]. Lysyl oxidase enzymes (LOXL1 and LOXL2) have been also
shown to be oxidative stress-sensitive. Among other roles, such as cell
motility and cell adhesion, they have been related to cell growth control
and cellular senescence [9].
To maintain their replicative and self-renewing potential stem cells
have in place mechanisms to repress activation of cell death pathways.
The Polycomb-group transcriptional repressor BMI-1 has emerged as a
key regulator in several cellular processes including stem cell self-
renewal and cancer cell proliferation. BMI-1 was ﬁrst identiﬁed in 1991
as a frequent target of Moloney virus insertion in virally accelerated B-
lymphoid tumours of E mu-myc transgenic mice [10]. Through repres-
sion of target gene expression in a lineage and context- dependent
manner, BMI-1 regulates a myriad of cellular processes critical for cell
http://dx.doi.org/10.1016/j.redox.2017.04.002
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Abbreviations:MSC, mesenchymal stem cells; hDPSCs, human dental pulp stem cells; SIPS, stress-induced premature senescence; MDA, malondialdehyde; OSKM, OCT4, SOX2, KLF4 and
c-MYC
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growth, cell fate decision, development, senescence, aging, DNA
damage repair, apoptosis, and self-renewal of stem cells [11]. The most
studied and validated BMI-1 target is the INK/ARF locus, which encodes
two structurally distinct proteins, p16INK4a and p14ARF, both of which
restrict cellular proliferation in response to aberrant mitogenic signal-
ling. Thus, collectively BMI-1 regulates p53/pRb axis through repres-
sion of the INK/ARF locus, which has been described as the principle
barrier to the initiation and maintenance of neoplastic transformation
[12]. BMI-1 is known to repress the INK/ARF locus expression, which
encodes two structurally distinct proteins, p16INK4a and p14ARF, both of
which restrict cellular proliferation in response to aberrant mitogenic
signalling [12]. BMI-1 has been implicated in the modulation of self-
renewal in several types of stem cells, including hematopoietic [13],
neural [14], and mammary [15].
Self-renewal of stem cells is critical for their persistence through
life, however the capacity to maintain this characteristic declines with
age [16,17]. Pluripotency genes, OCT4, SOX2, KLF4 and C-MYC
(OSKM) [18], are expressed in both pluripotent and adult stem cells,
such as mesenchymal stem cells (MSCs) and are down-regulated upon
long-term in vitro expansion and diﬀerentiation [19].
Our main purpose was to analyse the role of p16INK4a and BMI-1 in
oxidative stress-induced senescence in long term human dental pulp
stem cells (hDPSCs) cultures. In this study we demonstrate that non-
physiological in vitro cell culture conditions at 21% pO2 induces
premature senescence of hDPSCs, which is mediated by downregulation
of BMI-1 leading to an activation of p16INK4a pathway. By restoring
BMI-1 levels, we were able to rescue SOX2 and OCT4 expression under
oxidative stress conditions, reﬂecting that BMI-1 is not only involved in
stem cell self-renewal, but also in stemness maintenance. In summary,
we show that oxygen tension is critical when culturing hDPSCs.
Ambient oxygen tension (21% pO2) induces premature hDPSCs senes-
cence compared with physiological oxygen tension (3% pO2) due to
activation of p16INK4a pathway. Moreover, this is accompanied by a
BMI-1-dependent stemness potential loss. This is of importance in
regenerative medicine and also in stem cell banking for clinical use.
2. Material and methods
2.1. Dental pulp stem cells isolation and culture
Intact third molars were collected from men and women (aged from
15 to 35 years old). All patients were informed and agreed freely to
participate and signed the informed consent by contributing the
extracted tooth, which was always extracted for reasons independent
of this study. The study was approved by the institutional review board
of the University of Valencia. Cells cultured from dental pulps did not
exhibit any clinical and/or radiological sign or symptom of inﬂamma-
tion and/or infection. To isolate the cells, the pulps were ﬁrstly
fragmented by trituration, then chemically digested with 2 mg/mL
EDTA in Krebs-Henseleit buﬀer, and ﬁnally digested with a combina-
tion of type I collagenase and type II dispase at a ﬁnal concentration of
4 mg/mL during 30 min in a humid incubator at 37 °C, 5% CO2, and 3%
pO2. Digested pulp fragments were centrifuged at 1000g for 2 min, and
the precipitate was resuspended and seeded in culture ﬂasks with
complete DMEM (Dulbecco's Eagle Modiﬁed Medium with low glucose
supplement 1g/L, 10% heat-inactivated FBS and 1% antibiotic) under
the same conditions of temperature and oxygen pressure.
After the ﬁrst passage, hDPSCs were divided in two groups: one
group was moved to a humid incubator with an oxygen pressure of
21%, while the other group was kept in the same incubator used for the
isolation at 3% oxygen tension. Cells were then cultured for 7 months.
All reagents were purchased from Gibco, Invitrogen.
2.2. siRNA transfection for BMI-1 knockdown
Young hDPSCs (5 passages) were seeded in a six well culture plate,
at 2×105 cells per well in 2 mL antibiotic-free normal growth medium
supplemented with 10% FBS and incubated until the cells were 60–80%
conﬂuent. For each transfection, 0.8 mL of siRNA Transfection Medium
was added to each tube containing the siRNA Transfection Reagent
mixture (Solution A+Solution B) following manufacturer's instructions
(Santa Cruz Biotechnologies). The mixture was overlayed onto the
washed cells prior to a 6 h incubation at 37 °C in a CO2 incubator. 1 mL
of normal growth medium containing 2 times the normal serum and
antibiotics concentration was added post-incubation without removing
the transfection mixture. 24 h later, the medium was replaced with
fresh 1x normal growth medium and cells were assayed using the
appropriate protocol 24 h after the addition of fresh medium in the step
above.
2.3. Reactive oxygen species and mitochondrial membrane potential
determination by ﬂow cytometry
Cells were washed twice with warm PBS and treated with trypsin
(Gibco, Invitrogen) and then resuspended in serum-free DMEM contain-
ing 1 g/L glucose. To detect intracellular peroxide levels, cells were
stained with DHR123 (dihydrorhodamine-123, Thermo Fisher
Scientiﬁc) at a ﬁnal concentration of 1 μg/mL. Cells were then
incubated for 30 min at 37 °C in the dark. Mitochondrial membrane
potential was measured after cell staining with 1 μg/mL TMRM
(tetramethylrhodamine methyl ester), Thermo Fisher Scientiﬁc for
30 min at 37 °C in the dark. After incubation, values were read by
FACS-Verse ﬂow cytometry until 20,000 events were recorded.
2.4. Lipid peroxidation measured using high-performance liquid
chromatography
hDPSCs lipid peroxidation was determined as malondialdehyde
(MDA) levels, which were detected using high-performance liquid
chromatography (HPLC) as an MDA-thiobarbituric acid (TBA) adduct
following a method described previously [20]. This method is based on
the hydrolysis of lipoperoxides and subsequent formation of an adduct
between TBA and MDA (TBA-MDA2). This adduct was detected using
HPLC in reverse phase and quantiﬁed at 532 nm. The chromatographic
technique was performed under isocratic conditions, the mobile phase
being a mixture of monopotassium phosphate 50 mM (pH 6.8) and
acetonitrile (70:30).
2.5. Protein carbonylation measured using high-performance liquid
chromatography
The carbonyl groups in the protein side chains were derivatized to
2,4-dinitrophenylhydrazone by reacting with 2,4-dinitrophenylhydra-
zine so that they could be detected using Western blotting using speciﬁc
antibodies. Oxidative modiﬁcation of total proteins was assessed by
immunoblot detection of protein carbonyl groups using the OxyBlot
Protein Oxidation Detection kit in accordance with the manufacturer's
instructions (Merk Millipore). The procedure to quantify total protein
carbonyls using the OxyBlot kit was densitometry of the Oxyblot and
Ponceau staining followed by ﬁnding the ratio between the total density
in the Oxyblot and the Ponceau.
2.6. RNA extraction and RT-qPCR analysis
Total RNA was isolated from hDPSCs by using TRIzol reagent
(Invitrogen), according to the manufacturer's instruction. RNA was
quantiﬁed by measuring the absorbance at 260 nm. The purity of the
RNA preparations was assessed by the 260/280 ratio. cDNA was
synthesized from 0.5 μg total RNA using a MultiScribe reverse tran-
scriptase (RT) system kit of Applied Biosystems (High-Capacity cDNA
Reverse Transcription Kits). The reaction was incubated as recom-
mended by the manufacturer, for 10 min at 25 °C, followed by 120 min
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at 37 °C, and then for 5 min at 85 °C, and ﬁnally cooled to 4 °C to collect
the cDNA and then stored at −20 °C prior to the real-time PCR assay.
The quantitative PCR was performed using the detection system
7900HT Fast Real-Time PCR System (Applied Biosystems). Target and
control were run in separate wells following procedure: 10 min at 95 °C
and then 35 cycles of denaturation at 95 °C for 15 s and annealing and
extension at 62 °C for 1 min per cycle. All experiments were repeated at
least three times for each sample.
Gene-speciﬁc primer pairs and probes for BMI-1
(3’-CCAGGGCTTTTCAAAAATGA-5’ and 5’-GCATCACAGTCA
TTGCTGCT-3’), OCT4 (3’-GATCCTCGGACCTGGCTAAG-5’ and
5’-GACTCCTGCTTCACCCTCAG-3’), SOX2 (3’-AAAACAGCCCG-
GACCGCGTC-5’ and 5’-CTCGTCGATGAACGGCCGCT-3’), KLF4
(3’-CCCACATGAAGCGACTTCCC−5’ and 5’-CAGGTCCAGGAG-
ATCGTTGAA−3’), C-MYC (3’-CGCCCTCCTACGTTGCGGTC-5’ and 5’-
CGTCGTCCGGGTCGCAGATG-3’), p16INK4a (3’-GGGGGCAC-
CAGAGGCAGT-5’ and 5’-GGTTGTGGCGGGGGCAGTT-3’) and p14ARF
(3’-CCCTCGTGCTGATGCTACTG-5’ and 5’-CATCATGACCTGG-
TCTTCTAGGAA-3’) were assayed together with Maxima SYBR Green/
ROX qPCR Master Mix (2X) (Fermentas) and normalized against
GAPDH (3’-TGAACGGGAAGCTCACTGG-5’ and 5’-TCCACCA-
CCCTGTTGCTGTA-3’) housekeeping gene. Relative expression was
analysed using the standard curve method.
Gene-speciﬁc primer pairs and probes for LOXL1 (Hs00935937_m1),
LOXL2 (Hs00158757_m1), and TET1 (Hs04189344_g1), were used
together with 1x TaqMan® Universal PCR Master Mix (Applied
Biosystems) and normalized against GAPDH (Hs00375015_m1). In this
case, the expression was calculated according to the 2−ΔΔCt method.
2.7. Senescence-associated β-galactosidase staining by ﬂow cytometry
SA-β-Gal staining was performed using FluoReporter® LacZ Kit
(Molecular Probes) following manufacturer's instructions. 100 uL of
resuspended cells (107 cells/mL) in staining medium were placed into
an appropriate ﬂow cytometer tube and treated with 100 uL of
prewarmed ﬂuorescein di-β-D-galactopyranoside (FDG) 2 mM working
solution for exactly one minute at 37 °C. FDG loading was stopped by
adding 1.8 mL ice-cold staining medium containing 1.5 μM propidium
iodide. FDG values were read by ﬂow cytometry until 20,000 events
were recorded.
2.8. Protein analysis using western blotting
Total protein was harvested by lysing the cells in a lysis buﬀer
containing a protease inhibitor cocktail (Roche Products). Protein
content was determined by a modiﬁed Lowry method [21]. 30 μg of
protein from each sample was separated on SDS-12.5% polyacrylamide
gels and transferred onto a PVDF membrane (BioRad). Membranes were
blocked with 0.01 g/mL BSA in TBS-0.05% Tween 20 (TBS-T) and
incubated with the following antibodies: anti-BMI-1 (1:200), anti-
Tubulin (1:1000) and anti-Mouse (1:10,000). The protein bands were
detected by chemiluminiscence.
2.9. Statistical analysis
Quantitative variables are expressed as means and SD. Qualitative
data are expressed as total number and percentage. Statistical analysis
consisted of Student's t-test for 2 means and ANOVA to compare 2
means with one variation factor. If the n is not the same in all the
groups, the comparison of Scheﬀé was used. All values are means± SD
of measurements in at least three diﬀerent cultures (three replicates
each). Signiﬁcance was deﬁned as *p< 0.05, **p<0.01, and
***p< 0.001.
Fig. 1. Oxidative stress related parameters in hDPSCs cultured at 21% or 3% oxygen tension along passages. (A) ROS levels measured by dihydrorhodamine-123 (DHR123), (B)
Mitochondrial membrane potential levels measured by tetramethylrhodamine methyl ester (TMRM), (C) Lipid oxidation levels measured by malondialdehyde (MDA) and (D) protein
oxidation levels. The data are shown as means± SD (n=5). The statistical signiﬁcance is expressed as *p< 0.05; ***p< 0.001 versus 3% pO2.
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3. Results
3.1. Ambient oxygen tension induces oxidative stress in hDPSCs long term
culture
hDPSCs cultured under ambient oxygen tension showed signiﬁ-
cantly higher levels of ROS, lipid oxidation and protein carbonylation
than those cultured under physiological oxygen tension, as well as a loss
of their mitochondrial membrane potential. These diﬀerences were
found from early passages and were maintained during long term
culture, showing that hDPSCs at passage 15 at 3% pO2 were less
damaged than their counterparts at 21% pO2 (Fig. 1A–D). According to
this, we found that hDPSCs cultured at 21% pO2 showed signiﬁcantly
increased expression of the antioxidant enzymes manganese superoxide
dismutase (MnSOD), catalase and glutathione peroxidase (GPx) (Fig. 2).
This increase of antioxidant shield might be due to an attempt to
hormetically adapt the metabolism to the increased oxidative stress at
21% pO2.
3.2. Oxidative stress induces premature senescence (SIPS) under ambient
oxygen tension during long term culture of hDPSCs
hDPSCs were cultured under ambient (21% pO2) or physiological
oxygen tension (3% pO2) serially until the cells were exhausted.
hDPSCs cultured under ambient oxygen tension only reached 15
passages, while those cultured under physiological oxygen tension,
were able to achieve 25 passages (Fig. 3A). Moreover, we could observe
that hDPSCs cultured at 21% pO2 began to show enlarged and ﬂattened
shapes around passage 15, while hDPSCs cultured at 3% pO2 at passage
25 were still morphologically thinner (Fig. S1).
β-Galactosidase staining is one of the most commonly used markers
of senescence. hDPSCs cultured at 21% pO2 had signiﬁcantly higher
Fig. 2. Antioxidant genes expression in hDPSCs cultured at 21% or 3% oxygen
tension. Manganese superoxide dismutase (MnSOD) levels, glutathione peroxidase (GPx)
levels and catalase levels. The data are shown as means± SD (n=5). The statistical
signiﬁcance is expressed as ***p< 0.001 versus 3% pO2.
Fig. 3. Oxidative stress induces premature senescence in hDPSCs during long term culture at 21% oxygen tension. (A) Number of passages reached (upper pannel) and survival
curve (lower pannel), (B) β-galactosidase activity measured by ﬂuorescein di-β-D-galactopyranoside (FDG) load, (C) LOXL1 and (D) LOXL2 relative mRNA expression levels. The data are
shown as means± SD (n=5). The statistical signiﬁcance is expressed as ***p<0.001 versus 3% pO2.
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levels of β-galactosidase activity at any passage analysed (5, 10, 15)
when compared with 3% pO2. This diﬀerence increased along passages.
Moreover, hDPSCs cultured at 3% pO2 were even less senescent at
passage 25 than hDPSCs cultured at 21% pO2 at passage 15 (Fig. 3B).
LOXL1 and LOXL2 are lysyl oxidase enzymes involved in cell cycle
regulation. We show in Fig. 3C and D, that hDPSCs cultured at 3% pO2
had lower mRNA levels of both enzymes in comparison to those
cultured at 21% pO2. Furthermore, as passaging number increased, so
did LOXL1 and LOXL2 mRNA levels when cultured at 21% pO2 but not
at 3% pO2.
Therefore, hDPSCs cultured at 21% pO2 undergo premature senes-
cence compared to those cells cultured at 3% pO2.
3.3. Oxidative stress-induced premature senescence (SIPS) is mediated by
p16INK4a pathway
We analysed the mRNA expression pattern of both p14 ARF and
p16INK4a in hDPSCs long term culture at 3% and 21% pO2. p14ARF
mRNA expression levels were not aﬀected by long-term culture or by
oxygen concentration. However, p16INK4a mRNA levels revealed an
expression pattern very similar to β-galactosidase activity levels, i.e.,
there was an increase of its mRNA expression along the passages and it
was always higher at 21% pO2 (Fig. 4A and B).
In order to demonstrate that oxidative stress was mediating the
p16INK4a induced premature senescence at 21% pO2, we cultured
hDPSCs at this oxygen tension with 50 μM Trolox, a hydrosoluble
antioxidant analogue of Vitamin E. We found that Trolox reversed the
eﬀect of ambient oxygen tension on p16INK4a mRNA expression
(Fig. 4C). Therefore, oxidative stress increases p16INK4a expression,
which in turn accelerates senescence in hDPSCs cultured under ambient
oxygen tension.
3.4. Loss of stemness under ambient oxygen tension during long term culture
of hDPSCs
Oxidative stress can aﬀect stemness, therefore we measured the
mRNA expression levels of OSKM transcription factors. SOX2 and OCT4
are implicated in pluripotency induction, while KLF4 and C-MYC are
involved in pluripotency maintenance. Our results show that, compar-
ing hDPSCs cultured at 3% pO2 vs 21% pO2, SOX2 and OCT4 mRNA
expression was signiﬁcantly higher at passage 5, and KLF4 and C-MYC
mRNA expression was signiﬁcantly higher at passage 15 (Fig. 5A). TET1
is one member of a family of enzymes that alter the methylation status
of DNA. They are involved in stem cell self-renewal, proliferation and
diﬀerentiation. We observed that TET1 mRNA levels were downregu-
lated in hDPSCs cultured at 21% pO2, in comparison to 3% pO2
(Fig. 5B).
Therefore, we show that culturing hDPSCs at 3% pO2 increases
OSKM transcription factors compared to 21% pO2.
3.5. BMI-1 can rescue SOX2 and OCT4 expression under ambient oxygen
tension
BMI-1 protein levels were signiﬁcantly higher in hDPSCs cultured at
21% pO2 at passage 5 when compared to 3% pO2. However, they
decreased very rapidly with passages and were signiﬁcantly lower at
passage 15, in comparison to those cultured at 3% pO2 (Fig. 6A and B).
We used siRNA transfection in order to obtain a mild BMI-1
knockdown so that hDPSCs at passage 5 cultured at 3% or 21% pO2
had the same BMI-1 protein expression level (Fig. S2). BMI-1 knock-
down did not have any eﬀect on p16INK4a expression (data not shown),
however it restored SOX2 and OCT4mRNA levels in hDPSCs cultured at
21% pO2 (Fig. 7). This reﬂects a relationship between BMI-1 and
pluripotency transcription factors.
4. Discussion
hDPSCs normally reside in low oxygen concentrations. In mammals
including humans, hDPSCs are located in perivascular niches close to
the vascular structure in almost all tissues [22–24]. By the time oxygen
reaches the organs and tissues, oxygen concentration drops to 2–9%,
with a mean of 3% in the dental pulp tissue [25,26]. Despite this fact, it
is still common to culture cells at high non- physiological 21% pO2.
Here we demonstrate that long term culture of hDPSCs in a physiolo-
gical oxygen tension (3% pO2) has beneﬁcial eﬀects on both cellular
senescence and stemness potential maintenance in comparison to
Fig. 4. Oxidative stress-induced premature senescence. Correlation with p16INK4a
and p14ARF. (A) p14ARF mRNA levels, (B) p16INK4a mRNA levels and (C) p16INK4a mRNA
levels when treatment with 50 μM Trolox. The data are shown as means± SD (n=5). The
statistical signiﬁcance is expressed as ***p<0.001 versus 3% pO2 and ###p<0.001
versus 21% pO2+Trolox.
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culturing cells under ambient oxygen tension.
In the present study, we show that reduction of the pO2 level led to
decreased intracellular oxidative stress and cellular components da-
mage during hDPSCs long term culture. This was accompanied by
reduced ROS levels, less protein and lipid damage, as well as a better
conservation of the mitochondrial membrane potential. In accordance
to this, it has been demonstrated that high concentrations of oxygen can
cause oxidative stress via production of reactive oxygen species (ROS)
and free radicals that damage lipids, proteins and DNA [27]. In this
work, we also linked oxygen tension to altered mRNA expression of
MnSOD, CAT and GPx. The increment of antioxidant enzyme activities
indicated that cellular anti-oxidative system was triggered to resist
oxidative damage. Fan and colleagues already demonstrated that higher
oxygen concentrations resulted in more H2O2 generation in human
cells, which implied that the increase of H2O2 levels could enhance
transcription of MnSOD, CAT and GPx [28].
As passage number increased, cells cultured under ambient oxygen
tension began to show ﬂattened or lengthened shapes, and debris in the
culture medium increased. These morphological changes, have already
been described as a characteristic of senescence [29,30]. In addition to
this, hDPSCs cultured at 21% oxygen tension showed higher levels of
senescence related β-galactosidase activity as well as p16INK4a expres-
sion. This behaviour in long term in vitro culture leads to senescence
and is collectively referred to as oxidative stress induced premature
Fig. 5. Pluripotency markers in hDPSCs cultured at 21% vs 3% oxygen tension along passages. (A) OCT4, SOX2, KLF4 and C-MYC mRNA levels and (B) TET1 mRNA levels relative
expressions. The data are shown as means± SD (n=5). The statistical signiﬁcance is expressed as *p< 0.05; **p<0.01; ***p< 0.001 versus 3% pO2.
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senescence (SIPS) [31]. Lysyl oxidase activity has been shown to
increase under oxidative stress conditions [32]. hDPSCs cultured at
21% pO2 have higher mRNA expression levels of both LOXL1 and
LOXL2. Moreover, it has been described that an increased level of these
enzymes may contribute to escape from cellular senescence [9]. This
could be a defensive mechanism of hDPSCs cultured at 21% pO2 to
escape from oxidative stress-induced senescence. In addition, lysyl
oxidases participate in the carbonylation of several proteins, and
further increase the H2O2 levels as subproduct of this reaction [33].
These results reinforce the observations of Fan and colleagues [28] and
also may contribute to the induction of the antioxidant shield in hDPSCs
incubated at 21% pO2, as we described in this investigation.
The p16INK4a/pRb and p14 ARF/p21/p53 cell cycle inhibitory path-
ways represent two important pathways controlling proliferation, and
their inactivation can extend the limited division number of mitotic
cells in culture [34]. Given the role of p16INK4a in cell cycle regulation
and the recent implication of oxidative stress in stem cell senescence,
we observed a potential link between ROS and p16INK4a regulation. Our
results show that hDPSCs cultured at 21% pO2 have higher levels of
ROS, as well as increasing p16INK4a expression, suggesting that they are
approaching senescence. In fact, stress signals such as ROS stimulate the
activation of p16INK4a transcription and play important roles in initia-
tion, as well as maintenance, of cellular senescence [35–37]. Ito and
colleagues described, both in vitro and in vivo, that activation of
p16INK4a/pRb gene product pathway in response to elevated ROS led
to the failure of hematopoietic stem cells (HSCs) function, and that
treatment with antioxidant agents restored the constitutive capacity of
HSCs, resulting in the prevention of bone marrow failure [38,39]. These
results support our data that treatment with 50 μM Trolox can rescue
p16INK4a levels in hDPSCs long term culture at 21% pO2.
Interestingly, p16INK4a and p14ARF are both encoded by a single
locus; however, ROS speciﬁcally aﬀects p16INK4a but not p14ARF. It may
be that the p16INK4a pathway is of particular importance in the
senescence of stem cells [40,41] as it is considered to be a robust
biomarker for cellular senescence, and at the forefront of cell cycle
inhibition as it binds speciﬁcally to the CDKs, displacing cyclin-D and
thereby arresting cells in G1 phase [42].
Taken together, the fact that hDPSCs cultured at 21% pO2 show
increased p16INK4a expression, higher β-galactosidase activity, over-
expressed LOXL1 and LOXL2, and senescent like morphology, earlier
than those cultured at 3% pO2, means that 21% oxygen induced-
oxidative stress causes premature senescence.
It is well known that one of the BMI-1 downstream targets are
p16INK4a and p14ARF [43,44]. p16INK4a contributes to the regulation of
cell cycle progression by inhibiting the S phase [45]. BMI-1 is a
repressor, so, high levels of BMI-1 should then be followed by a
decrease in p16INK4a expression, and subsequently by a hyper prolifera-
tion rate like in cancer cells [44]. However, we found that BMI-1
overexpression in hDPSC cultured at 21% pO2 at early passages was not
followed by a p16INK4a downregulation. ROS and BMI-1 play an
opposite role on p16INK4a regulation. In fact, oxidative stress induced
by 21% oxygen tension would be strong enough to counteract BMI-1
downstream eﬀects on the INK/ARF locus, as it has been shown that it
can up-regulate p16INK4a expression [46]. As passages succeed, BMI-1
levels plummet because hDPSCs cultured under ambient oxygen tension
suﬀer an accelerated ageing accompanied by a loss of their capacity to
face oxidative stress eﬀects.
Although p16INK4a and p14ARF have been shown to be BMI-1 targets
in the context of stem cell self-renewal, they do not account for all BMI-
1 actions, and other downstream eﬀectors are being sought [47,48].
Recently, a relationship between BMI-1 and SOX2 has been described
[49]. SOX2, as well as OCT4, are transcription factors that are key
players in the induction of pluripotency and stemness [18]. In the
present study, we conﬁrmed a loss in all OSKM transcription factors
expression, as well as a deregulation in TET1 expression, during hDPSCs
in vitro long term culture at 21% pO2. TET proteins are dioxygenases
that regulate 5 hydroxyl-methylcytosine (5-hmC) levels in genes
implicated in self-renewal, proliferation and diﬀerentiation [50,51].
Our results show that TET1 expression levels are inﬂuenced by culture
oxygen pressure and passaging number. In fact, when hDPSCs undergo
long passages, TET1 levels are downregulated, so decreasing the
Fig. 6. BMI-1 expression level in hDPSCs cultured at 21% vs 3% oxygen tension
along passages. (A) BMI-1 protein levels, and (B) representative western-blot images of
BMI-1 protein levels. The data are shown as means± SD (n=5). The statistical
signiﬁcance is expressed as *p< 0.05; ***p< 0.001 versus 3% pO2.
Fig. 7. BMI-1 knockdown eﬀect on SOX2 and OCT4 expression in hDPSCs cultured at 21% vs 3% oxygen tension. (A) SOX2 mRNA expression levels and (B) OCT4 mRNA
expression levels. The data are shown as means± SD (n=3). *p<0.05; **p< 0,01; ***p< 0.001.
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maintenance of stemness in hDPSCs [51,52]. Koh and colleagues also
proposed that OCT4 and SOX2 regulate the expression of TET1 [51].
Interestingly, our results show that the eﬀect of cell passage is greater
than oxygen pressure eﬀect, suggesting that OCT4, SOX2 and NANOG
are more relevant in stem cell maintenance than TET1. In accordance
with this, it has been shown that cells maintained at 21% pO2 expressed
signiﬁcantly less OCT4, SOX2 and NANOG than those cultured at 5%
pO2 [53]. Furthermore, it has also been described that physiological
oxygen tension inhibits senescence and maintains stem cell properties
[54,55].
Our results show that BMI-1 downregulation can rescue SOX2 and
OCT4 levels without aﬀecting p16INK4a expression levels in hDPSCs
cultured at 21% pO2. Again, the opposite eﬀect of BMI-1 and oxidative
stress plays a role in maintaining p16INK4a expression levels.
As it has also recently been described by Izpisúa and colleagues
[56], the in vitro induction of OSKM can ameliorate some cellular
markers of ageing, such as cellular senescence. hDPSCs cultured at 3%
pO2 are able to maintain the expression of this factors during a larger
number of passages, so the preservation of the OSKM factors could play
an important role in the delayed onset of cellular phenotypes associated
with ageing observed in this cells.
In conclusion, the present study suggests that p16INK4a and BMI-1
are involved in the cellular premature senescence of hDPSCs triggered
by oxidative stress. It is important considering this fact when culturing
primary culture cells to improve the extrinsic culture environment, in
order to retain their stemness properties and to delay the process of
senescence prior to clinical application.
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